IVAX CORP /DE
10-Q, 1996-08-14
PHARMACEUTICAL PREPARATIONS
Previous: PAINEWEBBER DEVELOPMENT PARTNERS FOUR LTD, 10-Q, 1996-08-14
Next: CASMYN CORP, 10-Q, 1996-08-14



                                    FORM 10-Q

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1996

                         Commission File Number 1-09623

                                IVAX CORPORATION

           FLORIDA                                           16-1003559
- -------------------------------                          -------------------
(State or other jurisdiction of                           (I.R.S. Employer
 incorporation or organization)                          Identification No.)

            4400 BISCAYNE BOULEVARD, MIAMI, FLORIDA              33137
            ------------------------------------------------------------
            (Address of principal executive offices)          (Zip Code)

                                 (305) 575-6000
                                 --------------
              (Registrant's telephone number, including area code)

         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                          YES  [X]         NO _____

         Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.

                121,467,435 SHARES OF COMMON STOCK, $.10 PAR VALUE, OUTSTANDING
AS OF JULY 30, 1996.


<PAGE>

                                IVAX CORPORATION

                                      INDEX

PART I - FINANCIAL INFORMATION                                          PAGE NO.
                                                                        --------
     Item 1 - Financial Statements

              Condensed Consolidated Balance Sheets as of June 30, 1996
              and December 31, 1995                                         2

              Condensed Consolidated Statements of Operations
              for the three and six months ended June 30, 1996 and 1995     3

              Condensed Consolidated Statements of Cash Flows
              for the six months ended June 30, 1996 and 1995               4

              Notes to Condensed Consolidated Financial Statements          5

     Item 2 - Management's Discussion and Analysis of Financial Condition
              and Results of Operations                                     8

PART II - OTHER INFORMATION

     Item 1 - Legal Proceedings                                            17

     Item 4 - Submission of Matters to a Vote of Security Holders          17

     Item 6 - Exhibits and Reports on Form 8-K                             18


<PAGE>

<TABLE>
<CAPTION>
PART I -- FINANCIAL INFORMATION

ITEM 1 -- FINANCIAL STATEMENTS

                        IVAX CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (In thousands)

                                                                                  JUNE 30,        DECEMBER 31,
                                                                                    1996              1995
                                                                                 (unaudited)       (audited)
                                                                                -------------    -------------
<S>                                                                             <C>              <C>
                             ASSETS

Current assets:
     Cash and cash equivalents                                                  $      16,808    $      14,720
     Accounts receivable, net                                                         378,288          359,165
     Inventories                                                                      310,009          242,260
     Other current assets                                                             107,856           60,673
                                                                                -------------    -------------
         Total current assets                                                         812,961          676,818

Property, plant and equipment, net                                                    406,335          385,419
Cost in excess of net assets of acquired companies, net                               145,268          138,423
Patents, trademarks, licenses and other intangibles, net                               50,971           50,859
Other                                                                                  89,272           83,791
                                                                                -------------    -------------
         Total assets                                                           $   1,504,807    $   1,335,310
                                                                                =============    =============

                  LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
     Loans payable                                                              $       3,111    $       4,807
     Current portion of long-term debt                                                284,065            3,521
     Accounts payable                                                                 104,263           92,343
     Accrued income taxes payable                                                      13,107            8,632
     Accrued expenses and other current liabilities                                    98,273           96,610
                                                                                -------------    -------------
         Total current liabilities                                                    502,819          205,913

Long-term debt, net of current portion                                                111,271          298,857
Other long-term liabilities                                                            26,736           26,314
Minority interest                                                                      13,061           15,054
                                                                                -------------    -------------
         Total liabilities                                                            653,887          546,138
                                                                                -------------    -------------

Shareholders' equity:
     Common stock                                                                      12,146           11,803
     Capital in excess of par value                                                   502,580          461,603
     Retained earnings                                                                341,604          322,117
     Cumulative translation adjustment and other                                       (5,410)          (6,351)
                                                                                -------------    -------------
         Total shareholders' equity                                                   850,920          789,172
                                                                                -------------    -------------
         Total liabilities and shareholders' equity                             $   1,504,807    $   1,335,310
                                                                                =============    =============
</TABLE>

      The accompanying notes to condensed consolidated financial statements
                  are an integral part of these balance sheets.

                                       2

<PAGE>

<TABLE>
<CAPTION>
                        IVAX CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)

PERIOD ENDED JUNE 30,                                           THREE MONTHS                      SIX MONTHS
(In thousands, except per share data)                     1996             1995            1996             1995
                                                     ------------     ------------    ------------     ------------
<S>                                                  <C>              <C>             <C>              <C>
NET REVENUES                                         $    273,883     $    306,684    $    607,928     $    587,764

COST OF SALES                                             191,078          176,849         380,648          338,211
                                                     ------------     ------------    ------------     ------------
     Gross Profit                                          82,805          129,835         227,280          249,553
                                                     ------------     ------------    ------------     ------------
OPERATING EXPENSES:
     Selling                                               54,534           44,412         105,499           87,645
     General and administrative                            32,359           24,876          60,857           49,665
     Research and development                              18,085           16,479          34,607           31,664
     Amortization of intangible assets                      2,797            2,559           5,360            4,942
     Merger expenses                                            -                -             184                -
                                                     ------------     ------------    ------------     ------------
     Total operating expenses                             107,775           88,326         206,507          173,916
                                                     ------------     ------------    ------------     ------------
     Income (loss) from operations                        (24,970)          41,509          20,773           75,637

OTHER INCOME (EXPENSE):
     Interest income                                          171              385             492              946
     Interest expense                                      (6,206)          (5,190)        (11,897)         (10,591)
     Other income (expense), net                             (674)           1,069           3,166            4,280
                                                     ------------     ------------    ------------     ------------
                                                           (6,709)          (3,736)         (8,239)          (5,365)
                                                     ------------     ------------    ------------     ------------
     Income (loss) before income taxes, minority
         interest and extraordinary items                 (31,679)          37,773          12,534           70,272

PROVISION (BENEFIT) FOR INCOME TAXES                      (19,466)           8,793         (13,333)          16,653
                                                     ------------     ------------    ------------     ------------
     Income (loss) before minority interest and
         extraordinary items                              (12,213)          28,980          25,867           53,619

MINORITY INTEREST                                          (1,718)            (855)         (3,902)          (2,191)
                                                     ------------     ------------    ------------     ------------
     Income (loss) before extraordinary items             (13,931)          28,125          21,965           51,428

     Extraordinary items, net of taxes                     (2,072)             (20)         (2,073)              34
                                                     ------------     ------------    ------------     ------------
NET INCOME (LOSS)                                    $    (16,003)    $     28,105    $     19,892     $     51,462
                                                     ============     ============    ============     ============
EARNINGS (LOSS) PER COMMON SHARE:

     Primary:
       Earnings (loss) before extraordinary items    $       (.11)    $        .24    $        .18     $        .44
       Extraordinary items                                   (.02)               -            (.02)               -
                                                     ------------     ------------    ------------     ------------
       Net earnings (loss)                           $       (.13)    $        .24    $        .16     $        .44
                                                     ============     ============    ============     ============

     Fully Diluted:
       Earnings (loss) before extraordinary items    $       (.11)    $        .24    $        .18     $        .43
       Extraordinary items                                   (.02)               -            (.02)               -
                                                     ------------     ------------    ------------     ------------
       Net earnings (loss)                           $       (.13)    $        .24    $        .16     $        .43
                                                     ============     ============    ============     ============

WEIGHTED AVERAGE NUMBER OF
     COMMON SHARES OUTSTANDING:
     Primary                                              121,015          118,741         121,858          118,061
                                                     ============     ============    ============     ============
     Fully Diluted                                        121,015          119,030         121,882          118,586
                                                     ============     ============    ============     ============

</TABLE>

  The accompanying notes to condensed consolidated financial statements are an
                       integral part of these statements.

                                       3

<PAGE>

<TABLE>
<CAPTION>
                        IVAX CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

SIX MONTHS ENDED JUNE 30,                                                            1996             1995
                                                                                -------------    -------------
(In thousands)
<S>                                                                             <C>              <C>
Cash flows from operating activities:
    Net income                                                                  $      19,892    $      51,462
    Adjustments to reconcile net income to net cash
    provided by (used for) operating activities:
       Depreciation and amortization                                                   27,198           27,063
       Provision (benefit) for deferred taxes                                         (20,501)             777
       Provision for allowances for doubtful accounts                                   2,706            1,646
       Gains on sale of long-term assets                                                    -           (2,921)
       Losses (gains) on extinguishment of debt                                         1,640              (63)
       Minority interest                                                                3,902            2,191
       Changes in assets and liabilities:
          Increase in accounts receivable                                             (13,397)         (27,048)
          Increase in inventories                                                     (64,005)         (21,794)
          Increase in other current assets                                            (18,515)          (3,613)
          Increase in other assets                                                     (3,209)          (1,168)
          Increase (decrease) in accounts payable, accrued expenses
              and other current liabilities                                            11,103          (22,066)
          Decrease in other long-term liabilities                                      (3,322)            (629)
          Other, net                                                                     (972)             677
                                                                                -------------    -------------
          Net cash provided by (used for) operating activities                        (57,480)           4,514
                                                                                -------------    -------------
Cash flows from investing activities:
    Capital expenditures, net of proceeds from sales                                  (39,827)         (49,733)
    Acquisitions of patents, trademarks, licenses,
       and other intangibles, net of sales proceeds                                    (1,267)            (401)
    Acquisitions of businesses, net of cash acquired                                  (12,110)          (2,106)
    Other, net                                                                              -             (303)
                                                                                -------------    -------------
          Net cash used for investing activities                                      (53,204)         (52,543)
                                                                                -------------    -------------
Cash flows from financing activities:
    Payments on long-term debt and loans payable                                     (398,224)         (32,134)
    Borrowings on long-term debt and loans payable                                    485,665           56,027
    Issuance of common stock                                                           31,777            8,244
    Cash dividends paid                                                                (6,057)          (4,632)
                                                                                -------------    -------------
          Net cash provided by financing activities                                   113,161           27,505
                                                                                -------------    -------------
          Effect of exchange rate changes on cash                                        (389)            (722)
                                                                                -------------    -------------
          Net increase (decrease) in cash and cash equivalents                          2,088          (21,246)

Cash and cash equivalents at the beginning of the year                                 14,720           37,045
                                                                                -------------    -------------
Cash and cash equivalents at the end of the period                              $      16,808    $      15,799
                                                                                =============    =============
Supplemental disclosures:

    Interest paid                                                               $      14,696    $      11,255
                                                                                =============    =============
    Income tax payments                                                         $       9,775    $       9,799
                                                                                =============    =============

</TABLE>

  The accompanying notes to condensed consolidated financial statements are an
                       integral part of these statements.

                                       4

<PAGE>

                        IVAX CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

(1) GENERAL:

         In management's opinion, the accompanying unaudited condensed
consolidated financial statements of IVAX Corporation and subsidiaries ("IVAX")
contain all adjustments (consisting of only normal recurring adjustments)
necessary to present fairly the financial position of IVAX as of June 30, 1996,
and the results of its operations for the three and six months ended June 30,
1996 and 1995. The results of operations and cash flows for the six months ended
June 30, 1996 are not necessarily indicative of the results of operations or
cash flows which may be reported for the remainder of 1996.

         The accompanying unaudited interim condensed consolidated financial
statements have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission for reporting on Form 10-Q. Pursuant to such
rules and regulations, certain information and footnote disclosures normally
included in financial statements prepared in accordance with generally accepted
accounting principles have been condensed or omitted. The condensed consolidated
financial statements should be read in conjunction with the Consolidated
Financial Statements and the Notes to Consolidated Financial Statements included
in IVAX' Annual Report on Form 10-K for the year ended December 31, 1995.

         The accounting policies followed for interim financial reporting are
the same as those disclosed in Note 2 of the Notes to Consolidated Financial
Statements included in IVAX' Annual Report on Form 10-K for the year ended
December 31, 1995.

(2) EARNINGS (LOSS) PER SHARE:

         Primary earnings (loss) per share is computed by dividing net income
(loss) by the weighted average number of common and dilutive common equivalent
shares outstanding for each period. Common stock equivalents include the
dilutive effect of all outstanding stock options and warrants using the treasury
stock method. Fully diluted earnings (loss) per share assumes the maximum
dilutive effect from stock options and warrants, and if applicable, the
conversion equivalents of the 6-1/2% Convertible Subordinated Notes due 2001
and, for the three and six months ended June 30, 1995, the 9.00% Convertible
Subordinated Debentures due 1995.

(3) INCOME TAXES:

         The provision for income taxes is based on the consolidated United
States entities' and individual foreign companies' estimated tax rates for the
applicable year. IVAX utilizes the liability method and deferred taxes are
determined based on the estimated future tax effects of differences between the
financial statement and tax basis of assets and liabilities using applicable tax
laws. Deferred income tax provisions and benefits are based on the changes in
the deferred tax asset or tax liability from period to period.

                                       5

<PAGE>

         The provision (benefit) for income taxes consists of the following (in
thousands):

<TABLE>
<CAPTION>
                                                          Three Months                        Six Months
Period Ended June 30,                                 1996             1995              1996             1995
                                                 -------------    --------------    -------------    --------------
<S>                                              <C>              <C>               <C>              <C>
Current:
     United States                               $      (1,663)   $        5,802    $      (8,076)   $       11,332
     Foreign, including Puerto Rico
         and U.S. Virgin Islands                         2,703             2,301           15,244             4,544
Deferred                                               (20,506)              690          (20,501)              777
                                                 -------------    --------------    -------------    --------------
Provision (benefit) for income taxes             $     (19,466)   $        8,793    $     (13,333)   $       16,653
                                                 =============    ==============    =============    ==============
</TABLE>

(4) BUSINESS COMBINATIONS:

         On March 1, 1996, IVAX acquired Elvetium S.A. (Argentina), Alet
Laboratorios S.A.E.C.I. y E. and Elvetium S.A. (Uruguay), three affiliated
companies engaged in the manufacture and marketing of pharmaceuticals in
Argentina and Uruguay, in exchange for 1,490,909 shares of IVAX' common stock.
Although the acquisition was accounted for using the pooling of interests method
of accounting, the acquisition was recorded as of January 1, 1996 and the
accompanying historical condensed consolidated financial statements have not
been restated to give retroactive effect to the acquisition due to the
immateriality of the related amounts.

         During the first half of 1996, IVAX purchased additional shares of
Galena a.s. increasing its ownership interest to 74%.

(5) DEBT:

         On May 14, 1996, IVAX entered into a new revolving line of credit with
a bank syndicate permitting borrowings of up to $425,000,000. Pursuant to the
terms of the credit facility, IVAX has agreed not to pledge or dispose of
certain of IVAX' significant subsidiaries. Borrowings under the credit facility
generally accrue interest at the London Interbank Offer Rate (LIBOR) plus .45%
through August 19, 1996, and thereafter at LIBOR plus between .35% to .70%,
depending on certain financial ratios. The credit facility has a five year term
and contains various financial covenants, including a restriction on the payment
of dividends by IVAX in excess of 35% of IVAX' consolidated net income for any
consecutive four-quarter period. Proceeds from the credit facility have been
used to refinance previously existing credit facilities and, as discussed below,
to make an investment in and advances to McGaw, Inc. ("McGaw"), and will be used
for working capital and general corporate purposes, including to finance
acquisitions.

         On June 17, 1996, IVAX made an investment in and advances to McGaw in
the aggregate amount of $91,150,000 using proceeds from the credit facility.
McGaw used the proceeds to redeem the remaining outstanding face value of its
10-3/8% Senior Notes due April 1, 1999 at a purchase price of approximately 102%
of their outstanding principal of $87,420,000, plus accrued interest. The
redemption resulted in a pre-tax extraordinary loss of $3,455,000.

         IVAX was not in compliance with the fixed charge coverage ratio (the
ratio of consolidated earnings before income taxes, depreciation and
amortization less consolidated capital expenditures to consolidated fixed
charges) required by the credit facility at June 30, 1996. IVAX subsequently
obtained a waiver of such noncompliance from the lenders. IVAX intends to
request a permanent amendment to 

                                       6

<PAGE>

the fixed charge coverage ratio covenant. Pending the execution of such an
amendment, the $281,820,330 outstanding under the credit facility at June 30,
1996 has been classified within current portion of long-term debt in the
accompanying condensed consolidated balance sheet. Although management believes
that the lenders will agree to amend the fixed charge coverage ratio covenant,
no assurance can be given that the amendment will be executed or that, as part
of the amendment, the lenders will not require other terms of the credit
facility to be amended, including the interest rate charged on borrowings and
other pricing terms.

(6) DIVIDENDS ON COMMON STOCK:

         On June 3, 1996, IVAX paid a $.05 per share cash dividend to holders of
record of IVAX' common stock as of May 10, 1996.

                                       7

<PAGE>

ITEM 2--MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

     The following discussion and analysis should be read in conjunction with
the Consolidated Financial Statements, the related Notes to Consolidated
Financial Statements and Management's Discussion and Analysis of Financial
Condition and Results of Operations included in IVAX' Annual Report on Form 10-K
for the year ended December 31, 1995 and the Condensed Consolidated Financial
Statements and the related Notes to Condensed Consolidated Financial Statements
included in Item 1 of this Quarterly Report on Form 10-Q. Except for historical
information contained herein, the matters discussed below are forward looking
statements made pursuant to the safe harbor provisions of the Securities
Litigation Reform Act of 1995. Such statements involve risks and uncertainties,
including but not limited to economic, competitive, governmental and
technological factors affecting IVAX' operations, markets, products and prices,
and other factors discussed elsewhere in this report and the documents filed by
IVAX with the Securities and Exchange Commission ("SEC").

RESULTS OF OPERATIONS

                   SIX MONTHS ENDED JUNE 30, 1996 COMPARED TO THE SIX MONTHS
ENDED JUNE 30, 1995

         IVAX reported net income of $19.9 million for the six months ended June
30, 1996, compared to $51.5 million for the six months ended June 30, 1995.
Income before extraordinary items was $22.0 million for the six months ended
June 30, 1996, compared to $51.4 million for the same period of the prior year.
Results for the first half of 1996 included $2.1 million in net extraordinary
losses from the early extinguishment of debt.

         Primary earnings before extraordinary items per common share were $.18
for the six months ended June 30, 1996, compared to $.44 for the six months
ended June 30, 1995. Net earnings per primary common share were $.16 for the
first half of 1996, compared to $.44 for the same period of the prior year. The
net extraordinary loss of $.02 per common share recorded in the first half of
1996 related to the early extinguishment of debt.

<TABLE>
<CAPTION>
NET REVENUES AND GROSS PROFIT BY BUSINESS SEGMENT:
(In thousands)

Six Months Ended June 30,                                     1996                               1995
                                                 -------------------------------    -------------------------------
                                                      NET              GROSS             NET              GROSS
                                                   REVENUES            PROFIT         REVENUES            PROFIT
                                                 -------------    --------------    -------------    --------------
<S>                                              <C>              <C>               <C>              <C>
Pharmaceuticals                                  $     360,127    $      132,989    $     340,496    $      147,246
Intravenous products                                   168,043            56,397          170,839            68,989
Other operations                                        80,663            37,894           76,871            33,318
Intersegment eliminations                                 (905)                -             (442)                -
                                                 -------------    --------------    -------------    --------------
     Total                                       $     607,928    $      227,280    $     587,764    $      249,553
                                                 =============    ==============    =============    ==============
</TABLE>

         Net revenues for the first half of 1996 totaled $607.9 million, an
increase of $20.2 million, or 3%, compared to the same period of the prior year.
Gross profit for the first half of 1996 decreased $22.3 million, or 9%, from the
same period of the prior year. Gross profit was $227.3 million (37.4% of net
revenues) for the first half of 1996, compared to $249.6 million (42.5% of net
revenues) for the first half of 1995.

                                       8

<PAGE>

         Net revenues of IVAX' pharmaceutical operations increased $19.6
million, or 6%, in comparison to the first six months of 1995 due to increased
net revenues from the international pharmaceutical operations, partially offset
by a reduction in net revenues of the domestic pharmaceutical operations.

         Domestic pharmaceutical net revenues totaled $197.9 million for the
first six months of 1996, compared to $212.1 million for the same period of
1995. The $14.2 million, or 7%, decrease in domestic pharmaceuticals net
revenues was primarily due to the factors affecting IVAX' United States generic
pharmaceutical operations during the second quarter of 1996 discussed below,
partially offset by increased net revenues from the sale of certain new generic
products manufactured by IVAX and introduced during the past twelve months.

         Significant customer inventories of many of IVAX' important generic
drugs combined with significant price declines for certain generic drugs in the
1996 second quarter were the primary factors which resulted in the decline in
the United States generic pharmaceutical operations' net revenues. During the
past twelve months, IVAX launched several new generic drugs and customers
established significant inventories of many of these and other IVAX generic
products. During the 1996 second quarter, the net selling price of certain of
these products was significantly reduced due to competition. Primarily as a
result of these factors, customer inventory credits and reserves for expected
returns increased, and net revenues correspondingly decreased, by approximately
$53.8 million as compared to the 1995 second quarter. Customer inventory
credits, which are made consistent with industry practice to adjust customer
accounts for price declines on their existing inventory, represent the majority
of this increase. These credits allow customers with established inventories to
compete with those buying product at the current market price, and allows IVAX
to maintain shelf space, market share and customer loyalty. The increase in
reserves for returns compared to the 1995 second quarter is a result of higher
levels of customer inventories. Significant customer inventories also resulted
in lower reorders and consequently lower sales volume of certain generic drugs.

         As noted in documents previously filed with the SEC, the United States
generic drug industry is highly price competitive, with pricing determined by
many factors, including the number and timing of regulatory approvals and
product introductions by IVAX and its competitors. Although the price of a
generic product generally declines over time as competitors introduce additional
versions of the product, the actual degree and timing of price competition
generally is not predictable. IVAX establises reserves for customer inventory
credits in accordance with generally accepted accounting principles. Adjustments
to these reserves result from, among other things, the actual degree and timing
of additional price declines and the magnitude of customer inventories at the
time, and are recorded when identified.

         Sales of cefadroxil, the generic equivalent of Bristol-Myers Squibb's
antibiotic Duricef(Registered trademark), approved in March 1996, contributed
$27.6 million in net revenues to the first half of 1996. IVAX experienced
limited price competition with respect to sales of cefadroxil during the 1996
second quarter and consequently customer inventory credits had a limited impact
on net revenues of this product. Although IVAX remains the only FDA approved
generic manufacturer of cefadroxil, the company marketing the brand name version
of this drug has launched and is currently marketing its own generic form of
this product.

         Sales of albuterol metered dose inhaler, the generic equivalent of
Glaxo Inc.'s Ventolin(Registered trademark), Inhalation Aerosol, used in the
treatment of asthma, approved late in December 1995, generated $33.8 million of
net revenues during the first half of 1996. Net revenues attributable to sales
of albuterol metered dose inhaler were lower during the second quarter of 1996
as compared to the first quarter of

                                       9


<PAGE>

1996 primarily due to a decline in sales volume resulting from elevated customer
inventory levels following the drug's launch and, to a lesser extent, a higher
level of customer inventory credits in the 1996 second quarter. The company
marketing the brand name version of this drug is also marketing a generic form
of the drug, and in August 1996, at least one other generic manufacturer
received regulatory approval for an albuterol metered dose inhaler product.

         Net revenues attributable to sales of cefaclor, approved in April 1995,
totaled $19.1 million for the first half of 1996 compared to $22.0 million for
the first half of 1995, the period in which the product was launched. The
decline in net revenues of cefaclor was primarily attributable to price
declines and higher levels of customer inventory credits and reserves for
expected returns as compared to the first half of 1995.

         Net revenues attributable to sales of verapamil HCl ER tablets totaled
$17.4 million in the first half of 1996 compared to $42.4 million in the same
period of the prior year. The decline in verapamil net revenues was due
primarily to a reduction in the net selling price and, to a lesser extent, a
decline in unit volume and a higher level of customer inventory credits as
compared to the first half of 1995. During the second quarter of 1996, another
generic version of one of the dosage strengths of verapamil sold by IVAX was
introduced into the market by a competitor.

         IVAX' international pharmaceutical operations generated net revenues of
$162.2 million for the first six months of 1996, compared to $128.4 million for
the same period of the prior year. The $33.8 million, or 26%, increase in
international pharmaceutical net revenues included an increase of $20.2 million
attributable to the combined operations of Elvetium S.A. (Argentina), Alet
Laboratorios S.A.E.C.I. y E. and Elvetium S.A. (Uruguay), (collectively,
"Elvetium"), acquired in March 1996. Although the acquisition of Elvetium was
accounted for as a pooling of interests, the acquisition was recorded as of
January 1, 1996 and IVAX' historical results of operations were not restated to
give retroactive effect to this acquisition due to the immateriality of the
related amounts. The remaining $13.6 million increase in net revenues of the
international pharmaceutical operations was due to higher net revenues of Galena
a.s. as a result of increased sales of several products and higher sales of
branded products in the United Kingdom, partially offset by lower sales volumes
of other products in the United Kingdom and the unfavorable impact of exchange
rate differences in comparison to the prior year period.

         The gross profit percentage of IVAX' pharmaceutical operations was
36.9% in the first six months of 1996 compared to 43.2% for the first six months
of 1995. The decline in the gross profit percentage was primarily attributable
to the higher levels of customer inventory credits and reserves for expected
returns relating to the United States generic pharmaceutical operations
discussed above as well as price declines for U.S. generic drugs.

         Net revenues of the intravenous products division totaled $168.0
million in the first six months of 1996, compared to $170.8 million in the same
period of 1995. The $2.8 million decrease in net revenues was primarily due to
lower net revenues attributable to Hespan(Registered trademark), McGaw's brand
name blood plasma expansion product, principally due to decreased sales prices
caused by generic competition, and, to a lesser extent, lower sales volumes of
basic nutrition solutions. The gross profit percentage of the intravenous
products division decreased from 40.4% for the first six months of 1995 to 33.6%
for the same period in 1996. The $12.6 million reduction in gross profit and the
decrease in the gross profit percentage were due to several factors: the
reduction in the net selling price of Hespan(Registered trademark), a charge to
cost of sales due to a decrease in inventory carrying costs as a result of lower
standard manufacturing costs adopted as a result of manufacturing efficiencies
achieved in 1995, an increase in inventory obsolescence reserves and less
favorable manufacturing variances. In February 1995, another pharmaceutical
company

                                       10


<PAGE>

introduced a generic version of Hespan(Registered trademark) in the United
States resulting in both lower prices and a reduction in the intravenous
products division's share of the market. Gross profit generated by the
intravenous products division is likely to continue to decrease in 1996 as
compared to 1995 as a result of competitive pressures in the industry.

         Net revenues and gross profit of IVAX' personal care products,
diagnostics and specialty chemicals operations, excluding intersegment
eliminations, collectively represent 13.3% and 16.7%, respectively, of
consolidated net revenues and consolidated gross profit for the first half of
1996. Combined net revenues and combined gross profit of these other operations
increased $3.8 million and $4.6 million, respectively, compared with the first
half of 1995, primarily due to the introduction by the personal care products
group of the IMAN(TM) product line, which was acquired in November 1995.

<TABLE>
<CAPTION>
OPERATING EXPENSES BY BUSINESS SEGMENT:
(In thousands)

                                           GENERAL          RESEARCH       AMORTIZATION
                                             AND               AND             OF           MERGER
                            SELLING      ADMINISTRATIVE    DEVELOPMENT     INTANGIBLES     EXPENSES         TOTAL
                          -----------   ---------------   -------------   -------------  -----------    -----------
<S>                       <C>           <C>               <C>             <C>            <C>            <C>
1996 SIX MONTHS
- ---------------
Pharmaceuticals           $    54,066   $       32,017    $      23,805   $      2,052   $        71    $   112,011
Intravenous products           27,605           10,356            8,637          1,741             -         48,339
Other operations               23,828            7,738            2,165          1,554             -         35,285
Corporate and other                 -           10,746                -             13           113         10,872
                          -----------   --------------    -------------   ------------   -----------    -----------
         Total            $   105,499   $       60,857    $      34,607   $      5,360   $       184    $   206,507
                          ===========   ==============    =============   ============   ===========    ===========

1995 SIX MONTHS
- ---------------
Pharmaceuticals           $    38,910   $       23,887    $      22,196   $      1,402   $         -    $    86,395
Intravenous products           27,587           12,157            7,427          2,345             -         49,516
Other operations               21,148            6,635            2,041          1,195             -         31,019
Corporate and other                 -            6,986                -              -             -          6,986
                          -----------   --------------    -------------   ------------   -----------    -----------
         Total            $    87,645   $       49,665    $      31,664   $      4,942   $         -    $   173,916
                          ===========   ==============    =============   ============   ===========    ===========
</TABLE>

         Selling expenses totaled $105.5 million (17.4% of net revenues) for the
first six months of 1996, compared to $87.6 million (14.9% of net revenues) for
the first six months of 1995. Selling expenses of Elvetium, acquired during the
first quarter of 1996, accounted for $5.7 million of the total $17.9 million
increase. The remaining $12.2 million increase was primarily due to increased
sales and marketing expenses associated with the launch of newly approved
products of IVAX' pharmaceutical operations and the introduction by the personal
care products group of the IMAN(TM) product line.

         General and administrative expenses totaled $60.9 million (10.0% of net
revenues) for the first half of 1996, compared to $49.7 million (8.5% of net
revenues) for the first half of 1995, an increase of $11.2 million. General and
administrative expenses of the pharmaceutical operations increased $8.1 million
as compared to the first half of 1995 primarily as a result of general and
administrative expenses associated with Elvetium and an increase in personnel
and office costs in the United Kingdom. Corporate general and administrative
expenses increased $3.8 million, as compared to the first half of 1995,
primarily due to increases in health insurance, personnel, travel and facilities
costs.

         Research and development expenses for the first half of 1996 increased
$2.9 million, or 9%, compared to the first half of 1995, to a total of
$34.6 million. Expenditures by IVAX' pharmaceutical operations represented 69%
of the total research and development expenses for the first half of 1996.
Management intends to continue to increase the level of its research and
development efforts. Actual

                                       11

<PAGE>

expenditures will depend on, among other things, the outcome of clinical testing
of products under development, delays or changes in government required testing
and approval procedures, technological and competitive developments, and
strategic marketing decisions.

         Other expense, net, increased $2.9 million in the first half of 1996,
as compared to the first half of the prior year, primarily due to an increase in
interest expense associated with additional borrowings to fund working capital,
as well as additional income in the first half of 1995 resulting from gains
recorded on the sale of an investment in equity securities of an affiliated
company and the sale of certain trademarks by the personal care products group.

                 THREE MONTHS ENDED JUNE 30, 1996 COMPARED TO THE THREE MONTHS
ENDED JUNE 30, 1995

         IVAX reported a net loss of $16.0 million for the three months ended
June 30, 1996, compared to net income of $28.1 million for the three months
ended June 30, 1995. Loss before extraordinary items was $13.9 million for the
1996 second quarter, compared to income before extraordinary items of $28.1
million for the same period of the prior year. Results for the 1996 second
quarter included a $2.1 million net extraordinary loss from the extinguishment
of debt.

         Net loss per primary common share was $.13 for the second quarter of
1996 compared to $.24 in net earnings per primary common share reported for the
second quarter of 1995. The net loss per primary common share includes a net
extraordinary loss of $.02 per primary common share from the early
extinguishment of debt.

<TABLE>
<CAPTION>
NET REVENUES AND GROSS PROFIT BY BUSINESS SEGMENT:
(In thousands)

Three Months Ended June 30,                                   1996                               1995
                                                 -------------------------------    -------------------------------
                                                      NET              GROSS             NET              GROSS
                                                   REVENUES            PROFIT         REVENUES            PROFIT
                                                 -------------    --------------    -------------    --------------
<S>                                              <C>              <C>               <C>              <C>
Pharmaceuticals                                  $     147,997    $       33,605    $     181,764    $       77,478
Intravenous products                                    84,840            29,569           87,592            36,498
Other operations                                        41,419            19,631           37,690            15,859
Intersegment eliminations                                 (373)                -             (362)                -
                                                 -------------    --------------    -------------    --------------
     Total                                       $     273,883    $       82,805    $     306,684    $      129,835
                                                 =============    ==============    =============    ==============
</TABLE>

         Net revenues for the second quarter of 1996 totaled $273.9 million, a
decrease of $32.8 million, or 11%, compared to the same period of the prior
year. Gross profit in the second quarter of 1996 decreased $47.0 million, or
36%, from the same period of the prior year. Gross profit was $82.8 million
(30.2% of net revenues) for the 1996 second quarter, compared to $129.8 million
(42.3% of net revenues) for the 1995 second quarter.

         Net revenues of IVAX' pharmaceuticals operations decreased $33.8
million, or 19%, in comparison to the second quarter of 1995. An increase of
$21.0 million in net revenues of IVAX' international pharmaceutical operations
was more than offset by a decrease of $54.8 million in net revenues of IVAX'
domestic pharmaceutical operations.

         Domestic pharmaceutical net revenues totaled $63.7 million for the
second quarter of 1996, compared to $118.5 million for the same period of the
prior year. The $54.8 million decrease in net

                                       12

<PAGE>

revenues of the domestic pharmaceutical operations was primarily due to $53.8
million of higher levels of customer inventory credits and reserves for expected
returns as compared to the second quarter of 1995, as a result of price declines
at a time of significant customer inventory levels as discussed in "Results of
Operations - Six months ended June 30, 1996 compared to six months ended June
30, 1995." The decline in net revenues was also attributable to lower sales
volumes as a result of high customer inventory levels and decreased prices of
certain generic products, partially offset by an increase in net revenues
generated by certain new generic products manufactured by IVAX and introduced
into the market over the past twelve months.

         Net revenues attributable to sales of cefadroxil, approved in March
1996, were $17.1 million in the 1996 second quarter. IVAX experienced limited
price competition with respect to sales of cefadroxil during the 1996 second
quarter and consequently customer inventory credits had a limited impact on net
revenues of this product.

         Sales of IVAX' albuterol metered dose inhaler, approved in late
December 1995, contributed $5.4 million in net revenues to the second quarter of
1996.

         Net revenues attributable to sales of cefaclor totaled $2.3 million in
the second quarter of 1996 compared to $22.0 million in the second quarter of
the prior year, the period in which the drug was launched. The decline in net
revenues of cefaclor was due to decreased selling prices and volume and higher
levels of customer inventory credits and reserves for expected returns as
compared to the second quarter of 1995.

         Net revenues attributable to sales of verapamil HCl ER tablets totaled
$1.6 million in the second quarter of 1996 compared to $20.6 million in the
second quarter of the prior year. The decline in net revenues in the 1996 second
quarter compared to the same period of the prior year was due primarily to the
reduction in the net selling price of verapamil and higher levels of customer
inventory credits and, to a lesser extent, a decline in sales volume. During the
second quarter of 1996, another generic version of one of the dosage strengths
of verapamil sold by IVAX was introduced into the market by a competitor.

         IVAX' international pharmaceutical operations generated net revenues of
$84.3 million in the second quarter of 1996, compared to $63.3 million for the
same quarter of the prior year. The $21.0 million, or 33%, increase in
international pharmaceutical net revenues was primarily due to $11.8 million in
net revenues attributable to the operations of Elvetium, acquired in March 1996.
The remaining $9.2 million increase in net revenues of the international
pharmaceutical operations was primarily due to an increase in sales of several
products by Galena a.s. and an increase in sales of branded and generic
products in the United Kingdom, partially offset by the unfavorable impact of
exchange rate differences.

         The gross profit percentage of IVAX' pharmaceutical operations
decreased from 42.6% in the second quarter of 1995 to 22.7% in the second
quarter of 1996. The decline in gross profit percentage of IVAX' pharmaceutical
operations is primarily due to the higher levels of customer inventory credits
and reserves for expected returns relating to the United States generic
pharmaceutical operations discussed in "Results of Operations - Six months ended
June 30, 1996 compared to six months ended June 30, 1995" as well as price
declines for U.S. generic drugs.

         The intravenous products division generated net revenues of $84.8
million during the second quarter of 1996, a decrease of $2.8 million from the
same quarter of 1995. Price decreases for 

                                       13

<PAGE>

Hespan(Registered trademark), McGaw's brand name blood plasma expansion product,
and basic and specialty nutrition sets and solutions were primarily responsible
for the decline in the net revenues of the intravenous products division. The
gross profit percentage of the intravenous products division decreased from
41.7% for the second quarter of 1995 to 34.9% for the same period in 1996. The
$6.9 million reduction in gross profit and the decrease in the gross profit
percentage were due to the reduction in the net selling price of
Hespan(Registered trademark), an increase in inventory obsolescence reserves and
less favorable manufacturing variances.

         Net revenues and gross profit of IVAX' personal care products,
diagnostics and specialty chemicals operations, excluding intersegment
eliminations, collectively represent 15.1% and 23.7%, respectively, of
consolidated net revenues and consolidated gross profit for the second quarter
of 1996. Combined net revenues and combined gross profit of these other
operations increased $3.7 million and $3.8 million, respectively, compared with
the second quarter of 1995, primarily due to the introduction by the personal
care products group of the IMAN(TM) product line, acquired in November
1995.

<TABLE>
<CAPTION>
OPERATING EXPENSES BY BUSINESS SEGMENT:
(In thousands)

                                           GENERAL          RESEARCH      AMORTIZATION
                                             AND               AND            OF           MERGER
                            SELLING     ADMINISTRATIVE     DEVELOPMENT    INTANGIBLES     EXPENSES         TOTAL
                          -----------   --------------    -------------   ------------   -----------    -----------
<S>                       <C>           <C>               <C>             <C>            <C>            <C>
1996 THREE MONTHS
- -----------------
Pharmaceuticals           $    28,301   $       17,335    $      12,658   $      1,303   $         -    $    59,597
Intravenous products           13,760            5,188            4,329            748             -         24,025
Other operations               12,473            3,994            1,098            734             -         18,299
Corporate and other                 -            5,842                -             12             -          5,854
                          -----------   --------------    -------------   ------------   -----------    -----------
         Total            $    54,534   $       32,359    $      18,085   $      2,797   $         -    $   107,775
                          ===========   ==============    =============   ============   ===========    ===========

1995 THREE MONTHS
- -----------------
Pharmaceuticals           $    20,048   $       10,869    $      11,523   $        812   $         -    $    43,252
Intravenous products           13,719            6,030            3,880          1,173             -         24,802
Other operations               10,645            3,040            1,076            574             -         15,335
Corporate and other                 -            4,937                -              -             -          4,937
                          -----------   --------------    -------------   ------------   -----------    -----------
         Total            $    44,412   $       24,876    $      16,479   $      2,559   $         -    $    88,326
                          ===========   ==============    =============   ============   ===========    ===========
</TABLE>

         Selling expenses totaled $54.5 million (19.9% of net revenues) for the
second quarter of 1996, compared to $44.4 million (14.5% of net revenues) for
the second quarter of 1995. Selling expenses of Elvetium, which was acquired in
the first quarter of 1996, accounted for $3.2 million of the total $10.1 million
increase. The remaining $6.9 million increase was primarily due to increased
sales and marketing expenses associated with the launch of newly approved
products of IVAX' pharmaceutical operations and the personal care products
group's IMAN(TM) product line.

         General and administrative expenses totaled $32.4 million (11.8% of net
revenues) for the second quarter of 1996, compared to $24.9 million (8.1% of net
revenues) for the second quarter of 1995, an increase of $7.5 million. General
and administrative expenses associated with Elvetium were responsible for $2.1
million of the increase in this expense category. The remaining $5.4 million
increase is primarily attributable to increases in personnel and office expenses
in the United Kingdom, as well as increases in health insurance costs at
corporate and personnel costs of the domestic pharmaceutical operations.


                                       14

<PAGE>

         Research and development expenses for the second quarter of 1996
increased $1.6 million, or 10%, compared to the 1995 second quarter, to a total
of $18.1 million. Expenditures by IVAX' pharmaceutical operations represented
70% of the total research and development expenses for the second quarter of
1996.

         Other expense, net, increased $3.0 million from the second quarter of
the prior year, primarily due to an increase in interest expense associated with
additional borrowings to fund working capital.

CURRENCY FLUCTUATIONS

         For the three and six months ended June 30, 1996, approximately 26% and
25%, respectively, of IVAX' net revenues were attributable to operations which
principally generated revenues in currencies other than the United States
dollar, compared to approximately 22% and 23% for the three and six months ended
June 30, 1995, respectively. Fluctuations in the value of foreign currencies
relative to the United States dollar impact the reported results of operations
for IVAX. If the United States dollar weakens relative to the foreign currency,
the earnings generated in the foreign currency will, in effect, increase when
converted into United States dollars and vice versa. As a result of exchange
rate differences, net revenues decreased by approximately $3.0 million and $4.7
million for the three and six months ended June 30, 1996, respectively, as
compared to the same periods of the prior year.

INCOME TAXES

         IVAX recognized a $13.3 million tax benefit for the six months ended
June 30, 1996. The tax benefit includes the recognition in the 1996 second
quarter of a deferred tax asset of $7.1 million by McGaw following an adjustment
by the Internal Revenue Service of the tax basis amortization of certain
intangible assets as well as the recognition in the 1996 first quarter of a $1.1
million tax incentive provided by the state of California. The tax benefit also
resulted from domestic losses benefited at the prevailing federal and state
statutory rates.

LIQUIDITY AND CAPITAL RESOURCES

         IVAX used $57.5 million in cash for operating activities during the
first six months of 1996, compared to $4.5 million in cash generated from
operating activities during the first six months of 1995. The increase in cash
used for operating activities, as compared to the first half of 1995, was
primarily the result of a higher rate of growth in inventories and accounts
receivable, partially offset by an increase in accounts payable and other
current liabilities compared to a decrease in the first six months of 1995. The
increase in inventories and accounts receivable is primarily due to the growth
in operations attributable to new generic products introduced into the market
over the past twelve months as well as higher levels of inventory resulting from
lower second quarter 1996 sales as discussed under "Results of Operations - Six
months ended June 30, 1996 compared to the six months ended June 30, 1995."

         Net cash of $53.2 million was utilized for investing activities during
the first half of 1996 as compared to $52.5 million for the same period of the
prior year. A $9.9 million decline in capital expenditures was offset by IVAX'
purchase of additional shares of Galena a.s. increasing its ownership interest
to 74%.


                                       15

<PAGE>

         Net cash of $113.2 million was provided by financing activities during
the first six months of 1996, compared to $27.5 million in the same period of
the prior year, primarily reflecting additional borrowings to finance the growth
in accounts receivable and inventories discussed above, as well as the
receipt of higher levels of cash on the exercise of stock options as compared to
the first six months of 1995.

         As discussed in Note 5, Debt, in the Notes to Condensed Consolidated
Financial Statements, on May 14, 1996, IVAX entered into a new revolving line of
credit with a bank syndicate permitting borrowings of up to $425 million.
Proceeds from the credit facility have been used to refinance previously
existing credit facilities and to make an investment in and advances to McGaw to
permit it to redeem its 10-3/8% Senior Notes due 1999, and will be used for
working capital and general corporate purposes, including to finance
acquisitions.

         IVAX was not in compliance with the fixed charge coverage ratio (the
ratio of consolidated earnings before income taxes, depreciation and
amortization less consolidated capital expenditures to consolidated fixed
charges) required by the credit facility at June 30, 1996. IVAX subsequently
obtained a waiver of such noncompliance from the lender. IVAX intends to request
a permanent amendment to the fixed charge coverage ratio covenant. Pending the
execution of such an amendment, the $281.8 million outstanding under the credit
facility at June 30, 1996 has been classified within current portion of
long-term debt in the accompanying condensed consolidated balance sheet.
Although management believes that the lenders will agree to amend the fixed
charge coverage ratio covenant, no assurance can be given that the amendment
will be executed or that, as part of the amendment, the lenders will not require
other terms of the credit facility to be amended, including the interest rate
charged on borrowings and other pricing terms.

         IVAX' principal sources of short-term liquidity are borrowings under
the credit facility and internally generated funds. In the event that the
lenders do not agree to amend the fixed charge coverage ratio covenant and IVAX
does not satisfy the covenant in future periods, management believes that IVAX
will be able to secure alternate short-term financing to support its ongoing
operational requirements. However, finding alternate lenders and negotiating and
executing a new credit agreement may involve a significant amount of time, and
no assurance can be given that the terms of an alternate credit facility would
be the same or similar to the terms of the existing credit facility. For the
long-term, IVAX believes it will be able to obtain long-term capital and
financing to the extent necessary.

         At June 30, 1996, IVAX' working capital was approximately $310.1
million, compared to $470.9 million at December 31, 1995. The reduction in
working capital is principally due to the classification of the revolving credit
facility within the current portion of long-term debt, as discussed above,
partially offset by a growth in the remaining components of working capital,
also as discussed above. Cash and cash equivalents totaled $16.8 million at June
30, 1996, as compared to $14.7 million at year-end 1995 and $15.8 million as of
June 30, 1995.

         On June 3, 1996, IVAX paid a $.05 per share cash dividend to holders of
record of IVAX' common stock as of May 10, 1996. In each of June and December
1995, IVAX paid cash dividends of $.04 per share. Under the terms of the
revolving credit facility, IVAX is restricted from paying dividends in excess of
35% of consolidated net income for any consecutive four quarter period. The
declaration and payment of future dividends will be made at the discretion of
the board of directors and will depend to a large extent on future results of
operations.

                                       16

<PAGE>

PART II -- OTHER INFORMATION

ITEM 1 -- LEGAL PROCEEDINGS

         In July and August 1996, individuals purporting to be shareholders of
IVAX filed actions styled MALIN VS. IVAX CORPORATION AND PHILLIP FROST, ET AL.;
STEINER, ET AL. VS. IVAX CORPORATION AND PHILLIP FROST, ET AL.; SALTZMAN, ET AL.
VS. IVAX CORPORATION AND PHILLIP FROST, ET AL.; KNOPF, ET AL. VS. IVAX
CORPORATION AND PHILLIP FROST, ET AL.; BRAUNSTEIN VS. IVAX CORPORATION AND
PHILLIP FROST, ET AL.; ZAPHIRIS, ET AL. VS. IVAX CORPORATION AND PHILLIP FROST,
ET AL.; PLEGGENKUHLE, ET AL. VS. IVAX CORPORATION AND PHILLIP FROST, ET AL;
WEISS VS. IVAX CORPORATION AND PHILLIP FROST, ET AL; and FERRETTI VS. IVAX
CORPORATION AND PHILLIP FROST, ET AL. against IVAX and certain of its officers
and directors in the United States District Court for the Southern District of
Florida. The plaintiffs in the MALIN, SALTZMAN, BRAUNSTEIN, ZAPHIRIS,
PLEGGENKUHLE, WEISS AND FERRETTI actions seek to act as representatives of a
class consisting of all purchasers of IVAX' common stock between February 26,
1996 and June 27, 1996. The plaintiffs in the STEINER action seek to act as
representatives of a class consisting of all purchasers of IVAX' common stock
between July 31, 1995 and June 27, 1996. The plaintiffs in the KNOPF action seek
to act as representatives of a class consisting of all purchasers of IVAX'
common stock between April 1, 1996 and June 27, 1996. The complaints, which
contain essentially the same allegations, allege violations of Section 10(b) and
20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated by the
Securities and Exchange Commission. The complaints generally assert that IVAX
made untrue statements of material fact and/or omitted to state material facts
necessary to make statements made not misleading in its public disclosure
documents and in communications to the public regarding its operations and
financial results. These allegations are centered around claims that IVAX failed
to disclose that it offered its customers credits on their inventories of IVAX
pharmaceutical products in the event of subsequent price declines and failed to
establish reserves for such credits. In general, the complaints seek an
unspecified amount of compensatory damages, pre-judgment interest, litigation
costs and attorney's fees. IVAX is aware of, but to date has not been served
with, other lawsuits which make essentially the same allegations and which seek
similar relief. IVAX intends to defend all of the lawsuits vigorously. Although
IVAX believes that these lawsuits are without merit, their respective outcomes
cannot be predicted. If determined adversely to IVAX, any of the lawsuits would
likely have a material adverse effect on IVAX' financial position and results
and operations.

         In connection with the L-Tryptophan litigation previously reported in
IVAX' Annual Report on Form 10-K for the year ended December 31, 1995, as of
August 7, 1996, 109 of the L-Tryptophan lawsuits filed against Goldline
Laboratories, Inc. had been settled and only one remains pending.

ITEM 4 -- SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         At IVAX' annual meeting of shareholders held on June 7, 1996, IVAX'
shareholders elected fourteen directors and approved a proposal to amend the
IVAX Corporation 1994 Stock Option Plan (the "Plan") to increase the number of
shares issuable pursuant to the Plan and to modify the method of payment for the
exercise of stock options under the Plan.


                                       17

<PAGE>
         The number of votes cast for and withheld for each nominee for
directors were as follows:

     DIRECTOR                              FOR                WITHHELD
     --------                              ---                --------
     Mark Andrews                      100,159,551             452,539
     Lloyd Bentsen                      98,980,578           1,631,512
     Ernst Biekert, Ph.D.              100,200,100             411,990
     Dante B. Fascell                   94,478,998           6,133,092
     Jack Fishman, Ph.D.               100,215,333             396,757
     Phillip Frost, M.D.               100,218,543             393,547
     Harold S. Geneen                  100,119,915             492,175
     Jane Hsiao, Ph.D.                 100,222,197             389,893
     Lyle Kasprick                     100,219,872             392,218
     Isaac Kaye                        100,216,616             395,474
     Harvey M. Krueger                  94,638,937           5,973,153
     John H. Moxley, III, M.D.         100,219,478             392,612
     M. Lee Pearce, M.D.               100,215,441             396,649
     Michael Weintraub                 100,210,831             401,259

         The number of votes cast for and against the proposal to amend the
Plan, as well as the number of abstentions, were as follows: For: 91,589,915;
Against: 8,567,093; and Abstain: 455,082.

         There were no broker non-votes with respect to either of the foregoing
matters.

ITEM 6 -- EXHIBITS AND REPORTS ON FORM 8-K

(a)      Exhibits

         10       Revolving Credit and Reimbursement Agreement by and among IVAX
                  Corporation, as Borrower, Norton Healthcare, Limited, as
                  Co-Borrower, and the Lenders party thereto or referenced
                  therein, and NationsBank, National Association, as
                  Administrative and Documentation Agent and Lender, and BA
                  Securities, Inc., as Syndication Agent, dated as of May 14,
                  1996*

         11       Computation of Earnings (Loss) Per Share

         27       Financial Data Schedule

         99       August 2, 1996 press release regarding IVAX' announcement of
                  its 1996 second quarter results

(b)      Current Report on Form 8-K

         On June 27, 1996, IVAX filed a Current Report on Form 8-K relating to
its June 27, 1996 press release regarding its outlook for the 1996 second
quarter earnings.

- ----------

*Certain exhibits and schedules to this document have not been filed. The
Registrant agrees to furnish a copy of any omitted schedule or exhibit to the
Securities and Exchange Commission upon request.

                                       18

<PAGE>

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                             IVAX CORPORATION

         Date:  August 14, 1996              By: /s/ MICHAEL W. FIPPS
                                                 --------------------
                                                 Michael W. Fipps
                                                 Senior Vice President-Finance
                                                 Chief Financial Officer



                                                                      Exhibit 10

                                REVOLVING CREDIT
                                       AND
                             REIMBURSEMENT AGREEMENT


                                  by and among


                         IVAX CORPORATION, as Borrower,

                   NORTON HEALTHCARE, LIMITED, as Co-Borrower

                                       and

                 the Lenders party hereto or referenced herein,

                                       and

                       NATIONSBANK, NATIONAL ASSOCIATION,
                    as Administrative and Documentation Agent
                                   and Lender

                                       and

                              BA SECURITIES, INC.,
                              as Syndication Agent


                                  May 14, 1996


<PAGE>

                                TABLE OF CONTENTS

                                                                           Page

                                    ARTICLE I

                              Definitions and Terms

1.01  Definitions...........................................................  2
1.02  Accounting Terms...................................................... 22

                                   ARTICLE II

                                    The Loans

2.01  Revolving Credit Facility............................................. 23
2.02  Payment of Interest................................................... 27
2.03  Payment of Principal.................................................. 28
2.04  Competitive Bid Loans................................................. 29
2.05  Notes................................................................. 33
2.06  Pro Rata Payments..................................................... 33
2.07  Reductions............................................................ 34
2.08  Decrease in Amounts................................................... 34
2.09  Conversions and Elections of Subsequent
      Interest Periods...................................................... 34
2.10  Unused Fee............................................................ 35
2.11  Deficiency Advances................................................... 35
2.12  Adjustments by Administrative Agent................................... 36
2.13  Use of Proceeds....................................................... 36
2.14  Extension of Revolving Credit Termination Date........................ 36
2.15  Swing Line............................................................ 37

                                   ARTICLE III

                                Letters of Credit

3.01  Letters of Credit..................................................... 39
3.02  Reimbursement......................................................... 40
3.03  Letter of Credit Fronting Fee......................................... 44
3.04  Administrative Fees and Reserves...................................... 44

                                   ARTICLE IV

                         Yield Protection and Illegality

4.01  Additional Costs...................................................... 45
4.02  Suspension of Loans................................................... 46
4.03  Illegality............................................................ 47
4.04  Compensation.......................................................... 47
4.05  Alternate Loan and Lender............................................. 48
4.06  Taxes................................................................. 48
4.07  Restricted Lender..................................................... 50
4.08  Funding............................................................... 50

                                        i

<PAGE>
                                                                           
                                    ARTICLE V                              PAGE

                                    ONE LOAN

5.01  One Loan.............................................................. 51
5.02  Guaranty.............................................................. 51

                                   ARTICLE VI

                     Conditions to Making Loans and Issuing
                                Letters of Credit

6.01  Conditions of Initial Advance and Issuance
      of Letters of Credit.................................................. 53
6.02  Conditions of Loans....................................................54

                                   ARTICLE VII

                         Representations and Warranties

7.01  Representations and Warranties........................................ 56

                                  ARTICLE VIII

                              Affirmative Covenants

8.01  Financial Reports, Etc................................................ 64
8.02  Maintain Properties................................................... 65
8.03  Existence, Qualification, Etc......................................... 65
8.04  Regulations and Taxes................................................. 66
8.05  Insurance.  .......................................................... 66
8.06  True Books............................................................ 66
8.07  Right of Inspection................................................... 66
8.08  Observe all Laws...................................................... 67
8.09  Covenants Extending to Subsidiaries................................... 67
8.10  Officer's Knowledge of Default........................................ 67
8.11  Suits or Other Proceedings............................................ 67
8.12  Notice of Discharge of Hazardous Material or
      Environmental Complaint.  ............................................ 67
8.13  Indemnification....................................................... 67
8.14  Further Assurances.................................................... 68
8.15  ERISA Requirement..................................................... 68
8.16  Continued Operations.................................................. 68
8.17  Use of Proceeds....................................................... 69
8.18  McGaw................................................................. 69
8.19  Significant Subsidiary................................................ 69

                                       ii

<PAGE>

                                                                              

                                   ARTICLE IX                              PAGE

                               Negative Covenants

9.01  Consolidated Tangible Net Worth...................................... 71
9.02  Consolidated Leverage Ratio.......................................... 71
9.03  Consolidated Fixed Charge Ratio...................................... 71
9.04  Indebtedness or Guaranteed Obligations............................... 71
9.05  Liens................................................................ 72
9.06  Transfer of Assets................................................... 73
9.07  Investments; Acquisitions............................................ 74
9.08  Merger or Consolidation.............................................. 75
9.09  Restricted Payments.................................................. 75
9.10  Change in Control.................................................... 75
9.11  Transactions with Affiliates......................................... 76
9.12  ERISA................................................................ 76
9.13  Fiscal Year.......................................................... 77
9.14  Dissolution, etc..................................................... 77
9.15  Rate Hedging Obligations............................................. 77

                                    ARTICLE X

                       Events of Default and Acceleration

10.01  Events of Default................................................... 78
10.02  Administrative Agent to Act......................................... 82
10.03  Cumulative Rights................................................... 83
10.04  No Waiver........................................................... 83
10.05  Default............................................................. 83
10.06  Allocation of Proceeds.............................................. 83

                                   ARTICLE XI

                                   The Agents

11.01  Appointment......................................................... 85
11.02  Attorneys-in-fact................................................... 85
11.03  Limitation on Liability............................................. 85
11.04  Reliance............................................................ 86
11.05  Notice of Default................................................... 86
11.06  No Representations.................................................. 86
11.07  Indemnification..................................................... 87
11.08  Lender.............................................................. 87
11.09  Resignation......................................................... 88
11.10  Sharing of Payments, etc............................................ 88
11.11  Administrative Fees................................................. 89

                                       iii

<PAGE>                                                                        

                                   ARTICLE XII                             PAGE

                                  Miscellaneous

12.01  Assignments and Participations...................................... 90
12.02  Notices............................................................. 92
12.03  Setoff.............................................................. 93
12.04  Survival............................................................ 94
12.05  Expenses............................................................ 94
12.06  Amendments.......................................................... 95
12.07  Counterparts........................................................ 96
12.08  Waivers by Borrowers................................................ 96
12.09  Termination......................................................... 97
12.10  Governing Law....................................................... 97
12.11  Indemnification..................................................... 98
12.12  Headings and References.............................................100
12.13  Severability........................................................100
12.14  Entire Agreement....................................................100
12.15  Agreement Controls..................................................101
12.16  Usury Savings Clause................................................101
12.17  Confidentiality.....................................................101
12.18  Accounts Receivable.................................................102

EXHIBIT A      Commitments

EXHIBIT B      Form of Assignment and Acceptance
EXHIBIT C      Form of Appointment of Authorized Representative
EXHIBIT D      Form of Borrowing Notice
EXHIBIT E-1    Form of Competitive Bid Note
EXHIBIT E-2    Form of Revolving Note
EXHIBIT E-3    Form of Swing Note
EXHIBIT F      Form of Compliance Certificate
EXHIBIT G      Guaranty
EXHIBIT H      LC Account Agreement
EXHIBIT I      Form of Permitted Acquisition Certificate
EXHIBIT J      Form of Competitive Bid Quote Request
EXHIBIT K      Form of Competitive Bid Quote
EXHIBIT L      Form of Opinion of Counsel
EXHIBIT M      Form of NHL Opinion

Schedule 1.01     Guarantors
Schedule 7.01(d)  Significant Subsidiaries
Schedule 7.01(e)  Investments
Schedule 7.01(f)  Liabilities
Schedule 7.01(g)  Liens
Schedule 7.01(h)  Taxes
Schedule 7.01(i)  Material Agreements
Schedule 7.01(j)  Litigation
Schedule 7.01(m)  Patents, Etc.
Schedule 7.01(o)  Consents
Schedule 7.01(t)  Employment Matters
Schedule 9.04     Indebtedness

                                       iv

<PAGE>

                  REVOLVING CREDIT AND REIMBURSEMENT AGREEMENT

         THIS REVOLVING CREDIT AND REIMBURSEMENT AGREEMENT, dated as of May 14,
1996 (the "Agreement"), is made by and among:

         IVAX CORPORATION, a Florida corporation having its principal
place of business in Miami, Florida ("IVAX"); and

         NORTON HEALTHCARE, LIMITED, an organization formed under the laws of
England having its principal place of business in Harlow, Essex, England ("NHL";
together with IVAX, the "Borrowers"); and

         NATIONSBANK, NATIONAL ASSOCIATION, a national banking association
organized and existing under the laws of the United States of America and having
a principal place of business in Miami, Florida ("NationsBank"), and BANK OF
AMERICA ILLINOIS, an Illinois state bank existing under the laws of the State of
Illinois and having its principal place of business in Chicago, Illinois
("BofA") and each other lender that is a signatory hereto or which may hereafter
execute and deliver an instrument of assignment with respect to this Agreement
pursuant to Section 12.01 (hereinafter NationsBank, BofA and such other lenders
may be referred to individually as a "Lender" or collectively as the "Lenders");
and

         NATIONSBANK, NATIONAL ASSOCIATION, in its capacity as the
administrative and documentation agent for the Lenders (in such capacity, the
"Administrative Agent") and BA SECURITIES, INC., in its capacity as syndication
agent for the Lenders (the "Syndication Agent")(the Administrative Agent and the
Syndication Agent being herein, in their role as agents, individually referred
to as an "Agent" and collectively referred to as the "Agents");

                              W I T N E S S E T H:

         WHEREAS, the Borrowers have requested that the Lenders make available
to the Borrowers a revolving credit facility of up to $425,000,000 which shall
include thereunder the NHL borrowing facility of $75,000,000, a letter of credit
facility of up to $20,000,000 and a swing line facility of up to $20,000,000,
the proceeds of such loans to be used to repay existing indebtedness of IVAX to
the Lenders, to redeem outstanding Senior Notes, to finance capital expenditures
and certain acquisitions and for working capital needs; and

         WHEREAS, the Lenders are willing to make such facilities available to
the Borrowers upon the terms and conditions set forth herein;

         NOW, THEREFORE, the Borrowers, the Lenders and the Agents hereby agree
as follows:


<PAGE>

                                    ARTICLE I

                              DEFINITIONS AND TERMS

         1.01 DEFINITIONS. For the purposes of this Agreement, in addition to
the definitions set forth above, the following terms shall have the respective
meanings set forth below:

                  "Absolute Rate" shall have the meaning assigned to such
         term in Section 2.04(c)(ii)(C) hereof;

                  "Absolute Rate Auction" means a solicitation of Competitive
         Bid Quotes setting forth Absolute Rates pursuant to Section 2.04
         hereof;

                  "Absolute Rate Loans" means the Competitive Bid Loans the
         interest rates on which are determined on the basis of Absolute Rates
         set at Absolute Rate Auctions;

                  "Advance" means a borrowing of Loans under this Agreement on
         any date consisting of the aggregate principal amount of such Loans;

                  "Advance Date Exchange Rate" means, with respect to a
         specified Advance or Loan of an Alternative Currency, the Spot Rate of
         Exchange as of the date two LIBOR Business Days preceding the date such
         Advance is originally made, PROVIDED that, if such Advance or Loan is
         continued for a subsequent Interest Period or converted pursuant to
         Section 2.09, the Advance Date Exchange Rate with respect to such Loan
         shall be the Spot Rate of Exchange two LIBOR Business Days preceding
         the effective date of the latest continuation or conversion of such
         Advance or Loan, and the Dollar Value of such Advance or Loan shall be
         adjusted as set forth in Section 2.01(b); PROVIDED, further, that in
         the case of a drawing under a Letter of Credit, the Spot Rate of
         Exchange shall be as of the date of such drawing;

                  "Affiliate" means a Person (i) which directly or indirectly
         through one or more intermediaries controls, or is controlled by, or is
         under common control with either of the Borrowers; (ii) which
         beneficially owns or holds 5% or more of any class of the outstanding
         voting stock (or in the case of a Person which is not a corporation, 5%
         or more of the equity interest) of either of the Borrowers; or (iii) 5%
         or more of any class of the outstanding voting stock (or in the case of
         a Person which is not a corporation, 5% or more of the equity interest)
         of which is beneficially owned or held by either of the Borrowers. The
         term "control" means the possession, directly or indirectly, of the
         power to direct or cause the direction of the management and policies
         of a Person, whether through ownership of voting stock, by contract or
         otherwise;

                                        2

<PAGE>

                  "Alternative Currency" means Pounds Sterling, Deutsche Marks,
         and, with the prior written consent of all Lenders and the
         Administrative Agent, any other lawful currency other than Dollars
         which is freely transferable and convertible into Dollars in the United
         States currency market; PROVIDED, HOWEVER, that an Alternative Currency
         shall only be available to the Borrowers if each Lender shall have
         access to such Alternative Currency on terms reasonably acceptable to
         such Lender;

                  "Alternative Currency Equivalent Amount" means, with respect
         to a specified Alternative Currency and a specified Dollar amount, the
         amount of such Alternative Currency into which such Dollar amount would
         be converted, based on the applicable Advance Date Exchange Rate;

                  "Alternative Currency LIBOR Rate" means, for the Interest
         Period for any Fixed Rate Loan of an Alternative Currency, the rate of
         interest per annum determined pursuant to the following formula:

          Alternative Currency         Base Rate            Applicable
              LIBOR Rate       = ----------------------- +    Margin
                                 1 - Reserve Requirement       

                  "Alternative Currency Loan" means a Loan for which the rate of
         interest is determined by reference to the Alternative Currency LIBOR
         Rate;

                  "Applicable Commitment Percentage" means, for each Lender,
         with respect to the Obligations hereunder (each a type of "credit
         exposure"), including its Participations and its obligations hereunder
         to an Issuer or to NationsBank to acquire Participations, a fraction
         (expressed as a percentage), the numerator of which shall be the then
         amount of such Lender's Revolving Credit Commitment and the denominator
         of which shall be the Total Revolving Credit Commitment, which
         Revolving Credit Commitment for each Lender as of the Closing Date is
         as set forth in EXHIBIT A attached hereto and incorporated herein by
         this reference; PROVIDED that the Applicable Commitment Percentage of
         each Lender shall be increased or decreased to reflect any assignments
         to or by such Lender effected in accordance with Section 12.01 hereof;

                  "Applicable Margin" means for each LIBOR Loan, Alternative
         Currency Loan, Swing Line Loan, Letter of Credit Fee and the unused fee
         that number of basis points per annum set forth below, based upon the
         Consolidated Leverage Ratio for the four-quarter period most recently
         ended as specified below:

                                        3

<PAGE>
      
                                                 LETTER OF             UNUSED
         RATIO                               CREDIT AND LOANS            FEE
         -----                               ----------------          ------

a)       Less than 1.00 to 1.00                     35                  12.5

b)       Equal to or greater than
         1.00 to 1.00 but less than
         2.00 to 1.00
                                                    45                  15

c)       Equal to or greater than 2.00
         to 1.00 but less than 3.00
         to 1.00                                    55                  17

d)       Equal to or greater than 3.00
         to 1.00 (subject in all events
         to Section 9.02 hereof)                    70                  20

         The Applicable Margin shall be established at the end of each fiscal
         quarter of IVAX (the "Ratio Determination Date"). Any change in the
         Applicable Margin following each Ratio Determination Date shall be
         determined based upon the computations set forth in a Compliance
         Certificate delivered to the Administrative Agent pursuant to Section
         8.01(a) and (b), subject to review and approval of such computations by
         the Administrative Agent, and shall be effective commencing on the date
         following the date such certificate is received (or, if earlier, the
         date such certificate is required to be delivered) until the day
         following the date on which a new Compliance Certificate is delivered
         or is required to be delivered, whichever shall first occur; PROVIDED
         however, if the Borrowers shall fail to deliver any such certificate
         within the applicable period set forth in Section 8.01(a) or (b), as
         the case may be, then the Applicable Margin shall be 2% until the
         appropriate certificate is so delivered. From the Closing Date to the
         first Ratio Determination Date, the Applicable Margin shall be 45 basis
         points for LIBOR Loans, Alternative Currency Loans, Swing Line Loans
         and Letters of Credit and the unused fee shall be 15 basis points.

                  "Applicable Rate" means the Alternative Currency LIBOR
         Rate applicable to any Alternative Currency.

                  "Applications and Agreements for Letters of Credit" means,
         collectively, the Applications and Agreements for Letters of Credit
         executed by the Borrowers from time to time and delivered to the Issuer
         to support the issuance of Letters of Credit;

                  "Assignment and Acceptance" shall mean an Assignment and
         Acceptance substantially in the form of EXHIBIT B (with blanks
         appropriately filled in) delivered to the Administrative Agent

                                        4

<PAGE>

         in connection with an assignment of a Lender's interest under
         this Agreement pursuant to Section 12.01;

                  "Authorized Representative" means any of the Presidents,
         Executive Vice Presidents, Chief Operating Officers or Vice Presidents
         or Secretaries of the Borrowers or, with respect to financial matters,
         the Treasurers or chief financial officers of the Borrowers or any
         other person expressly designated by the Boards of Directors of the
         Borrowers (or the appropriate committee thereof) as an Authorized
         Representative of the Borrowers, as set forth from time to time in a
         certificate in the form attached hereto as EXHIBIT C;

                  "Available Revolving Credit Commitment" means (i) until the
         Senior Notes are paid in full and the Company's obligations thereunder
         are extinguished, $337,000,000 and (ii) thereafter, $425,000,000;

                  "Base Rate" means, with respect to a LIBOR Loan and
         Alternative Currency Loan for the Interest Period applicable
         thereto,the average (rounded upward to the nearest one-hundredth
         (1/100th) of one percent) per annum rate of interest determined by the
         office of the Administrative Agent (each such determination to be
         conclusive and binding) as of two LIBOR Business Days prior to the
         first day of such Interest Period, as the effective rate at which
         deposits in immediately available funds in Dollars or an Alternative
         Currency, as the case may be, are being, have been, or would be offered
         or quoted by the Administrative Agent to major banks in the applicable
         interbank market for Eurodollar deposits or deposits of such
         Alternative Currency, as the case may be, at any time during the LIBOR
         Business Day which is the second LIBOR Business Day immediately
         preceding the first day of such Interest Period, for a term comparable
         to such Interest Period and in the amount of the LIBOR Loan and
         Alternative Currency Loan. If no such offers or quotes are generally
         available for such amount, the Administrative Agent shall be entitled
         to determine the Base Rate by estimating in its reasonable judgment the
         per annum rate (as described above) that would be applicable if such
         quote or offers were generally available;

                  "Board" means the Board of Governors of the Federal
         Reserve System (or any successor body);

                  "Borrowing Notice" means the notice delivered by an
         Authorized Representative in the form attached hereto as
         EXHIBIT D;

                  "Business Day" means any day which is not a Saturday, Sunday
         or a day on which banks in the States of Florida, New York and North
         Carolina are authorized or obligated by law, executive order or
         governmental decree to be closed;

                                        5

<PAGE>

                  "Capital Leases" means all leases which are required to be
         capitalized in accordance with Generally Accepted Accounting Principles
         as in effect from time to time including Statement No. 13 of the
         Financial Accounting Standards Board and any successor thereof;

                  "Closing Date" means the date as of which this Agreement is
         executed by the Borrowers, the Lenders and the Agents and on which the
         conditions set forth in Section 6.01 hereof have been satisfied;

                  "Code" means the Internal Revenue Code of 1986, as
         amended, any successor provision or provisions and any
         regulations promulgated thereunder;

                  "Competitive Bid Borrowing" shall have the meaning
         assigned to such term in Section 2.04(b) hereof;

                  "Competitive Bid Loans" means the Loans provided for by
         Section 2.04 hereof;

                  "Competitive Bid Notes" means the promissory notes
         substantially in the form of EXHIBIT E-1;

                  "Competitive Bid Quote" means an offer in accordance with
         Section 2.04(c) hereof by a Lender to make a Competitive Bid Loan with
         one single specified interest rate;

                  "Competitive Bid Quote Request" shall have the meaning
         assigned to such term in Section 2.04(b) hereof;

                  "Compliance Certificate" a certificate delivered at the
         end of each fiscal quarter of IVAX in the form of EXHIBIT F;

                  "Consistent Basis" in reference to the application of
         Generally Accepted Accounting Principles means the accounting
         principles observed in the period referred to are comparable in all
         material respects to those applied in the preparation of the audited
         and interim unaudited financial statements, as the case may be, of IVAX
         referred to in Section 7.01(f)(i) hereof;

                  "Consolidating Balance Sheet" means with respect to NHL and
         its Subsidiaries the consolidating balance sheets, which (i) in the
         case of a quarterly consolidating balance sheet, may not contain
         eliminations of intercompany items and may be subject to normal year
         end adjustments, and (ii) in the case of an annual balance sheet,
         intercompany items shall be eliminated and normal year end adjustments
         shall have been made;

                  "Consolidated Capital Expenditures" means for any period
         the sum of (without duplication) (i) all expenditures for

                                        6

<PAGE>

         items that are classified as "property, plant or equipment" or
         comparable items on the consolidated balance sheet of IVAX and its
         Subsidiaries, plus (ii) the amount of any Capital Leases entered into
         by IVAX and its Subsidiaries during such period, excluding, however,
         the amount of any capital expenditures paid for with the proceeds of
         casualty insurance, all as determined in accordance with Generally
         Accepted Accounting Principles applied on a Consistent Basis;

                  "Consolidated EBITDA" means, with respect to IVAX and its
         Subsidiaries for any period of computation thereof, the sum of, without
         duplication, (i) Consolidated Net Income, plus (ii) Consolidated
         Interest Expense during such period, plus (iii) provision for taxes on
         income during such period, plus (iv) amortization during such period,
         plus (vi) without duplication, any depreciation during such period, all
         determined on a consolidated basis in accordance with Generally
         Accepted Accounting Principles applied on a Consistent Basis;

                  "Consolidated Fixed Charge Ratio" means, with respect to IVAX
         and its Subsidiaries for the Four-Quarter Period ending on the date of
         computation thereof, the ratio of (a) Consolidated EBITDA minus
         Consolidated Capital Expenditures to (b) Consolidated Fixed Charges;

                  "Consolidated Fixed Charges" means, with respect to IVAX and
         its Subsidiaries, for the periods indicated, the sum of, without
         duplication, (i) Consolidated Interest Expense, (ii) dividends and
         other shareholder distributions during such period and (iii) the
         current portion of Consolidated Funded Indebtedness (less "Loans
         Payables" as shown on the consolidated balance sheet of IVAX and its
         Subsidiaries);

                  "Consolidated Funded Indebtedness" means, with respect to any
         period of computation thereof, Indebtedness of IVAX and its
         Subsidiaries determined in accordance with Generally Accepted
         Accounting Principles applied on a Consistent Basis but excluding (i)
         any Indebtedness incurred pursuant to the Receivables Program, and (ii)
         Guaranteed Obligations of IVAX permitted pursuant to Section 9.04;

                  "Consolidated Interest Expense" means, with respect to any
         period of computation thereof, the "interest expense" of IVAX and its
         Subsidiaries, as reflected on the consolidated statement of operations
         of IVAX and its Subsidiaries, all determined on a consolidated basis in
         accordance with Generally Accepted Accounting Principles applied on a
         Consistent Basis;

                  "Consolidated Leverage Ratio" means the ratio of
         Consolidated Funded Indebtedness to Consolidated EBITDA;

                                        7

<PAGE>

                  "Consolidated Net Income" means, for any period of computation
         thereof, the net income of IVAX and its Subsidiaries as reflected on
         the consolidated statement of operations of IVAX and its Subsidiaries,
         all determined on a consolidated basis in accordance with Generally
         Accepted Accounting Principles applied on a Consistent Basis; but
         excluding as income: (i) net gains on the sale, conversion or other
         disposition of capital assets not in the ordinary course of business,
         (ii) net gains on the acquisition, retirement, sale or other
         disposition of capital stock and other securities of IVAX or its
         Subsidiaries, (iii) net gains on the collection of proceeds of life
         insurance policies, (iv) any write-up of any asset to the extent such
         write-up is included in income, and (v) any other net gain or credit of
         an extraordinary nature as determined in accordance with Generally
         Accepted Accounting Principles applied on a Consistent Basis;

                  "Consolidated Shareholders' Equity" means at any time as of
         which the amount thereof is to be determined, the sum of all items
         which are reflected in the "Stockholders' Equity" section in the
         consolidated balance sheet of IVAX and its Subsidiaries, as determined
         in accordance with Generally Accepted Accounting Principles applied on
         a Consistent Basis;

                  "Consolidated Tangible Net Worth" means at any time as of
         which the amount thereof is to be determined, Consolidated
         Shareholders' Equity MINUS the book value of all assets which would be
         treated as intangible assets under Generally Accepted Accounting
         Principles and which are reflected as "Costs in excess of net assets of
         acquired companies, net" and "Patents, trademarks, licenses and other
         intangible assets, net" on the consolidated balance sheet of IVAX and
         its Subsidiaries, such as (without limitation) goodwill (whether
         representing the excess of cost over book value of assets acquired or
         otherwise), capitalized expenses, unamortized debt discount and
         expense, consignment inventory rights, patents, trademarks, trade
         names, copyrights, franchises and licenses;

                  "Cost of Acquisition" means the sum of the cash portion of the
         purchase price, as reflected in any definitive agreement to acquire all
         or any portion of the stock or all or any portion of the assets of any
         Person plus, without duplication, any Indebtedness assumed by IVAX or
         its Subsidiaries in connection with such acquisition;

                  "Default" means any event or condition which, with the giving
         or receipt of notice or lapse of time or both, would constitute an
         Event of Default hereunder;

                  "Default Rate" means (i) with respect to each Fixed Rate Loan,
         until the end of the Interest Period applicable thereto, a rate of two
         percent (2%) plus the Fixed Rate applicable to

                                        8

<PAGE>

         such Loan, and thereafter a rate of interest per annum which shall be
         two percent (2%) plus the Floating Rate, (ii) with respect to Floating
         Rate Loans, a rate of interest per annum which shall be two percent
         (2%) plus the Floating Rate and (iii) in any case, the maximum rate
         permitted by applicable law, if lower;

                  "Deutsche Mark" means the lawful currency of the Federal
         Republic of Germany;

                  "Dollar Equivalent Amount" means, with respect to a specified
         Alternative Currency amount, the amount of Dollars into which an
         Alternative Currency amount would be converted, based on the applicable
         Advance Date Exchange Rate;

                  "Dollar Value" of an Advance or a Loan in an Alternative
         Currency means the Dollar Equivalent Amount of the principal amount of
         such Advance or Loan with respect to such Advance or Loan, as recorded
         in the Administrative Agent's records pursuant to Section 2.01(b);

                  "Dollars" and the symbol "$" means dollars constituting legal
         tender for the payment of public and private debts in the United States
         of America;

                  "Eligible Securities" means the following obligations and any
         other obligations previously approved in writing by the Administrative
         Agent:

                       (a)   Government Securities;

                       (b)   the following debt securities of the following 
                  agencies or instrumentalities of the United States of America
                  if at all times the full faith and credit of the United States
                  of America is pledged to the full and timely payment of all
                  interest and principal thereof:

                               (i)   all direct or fully guaranteed obligations
                       of the United States Treasury; and

                               (ii)  mortgage-backed securities and 
                       participation certificates guaranteed by the Government
                       National Mortgage Association;

                       (c)   the following obligations of the following agencies
                  or instrumentalities of the United States of America:

                               (i)   participation certificates and debt
                       obligations of the Federal Home Loan Mortgage
                       Corporation;

                                        9

<PAGE>
                               (ii)  consolidated debt obligations, and
                        obligations secured by a letter of credit, of the
                        Federal Home Loan Banks; and

                               (iii) debt obligations and mortgage-backed
                        securities of the Federal National Mortgage Association
                        which have not had the interest portion thereof severed
                        therefrom;

                        (d)  obligations of any corporation organized under the
                  laws of any state of the United States of America or under the
                  laws of any other nation, payable in the United States of
                  America, expressed to mature not later than 92 days following
                  the date of issuance thereof and rated in an investment grade
                  rating category by S&P and Moody's;

                        (e)  interest bearing demand or time deposits issued by
                  any Lender or certificates of deposit maturing within one year
                  from the date of acquisition issued by a bank or trust company
                  organized under the laws of the United States or of any state
                  thereof having capital surplus and undivided profits
                  aggregating at least $400,000,000 and being rated A-3 or
                  better by S&P or A or better by Moody's;

                        (f)  Repurchase Agreements

                        (g)  Pre-Refunded Municipal Obligations;

                        (h)  shares of mutual funds which invest in obligations
                  described in paragraphs (a) through (g) above, the shares of
                  which mutual funds are at all times rated "AAA" by S&P;

                        (i)  asset-backed remarketed certificates of
                  participation representing a fractional undivided interest in
                  the assets of a trust, which certificates are rated at least
                  "A-1" by S&P and "P-1" by Moody's;

                        (j)  U.K. Gilts; and

                        (k)  other foreign securities mutually agreed to by the
                  Borrowers and the Administrative Agent.

                  Obligations listed in paragraphs (a), (b) and (c) above which
         are in book-entry form must be held in a trust account with the Federal
         Reserve Bank or with a clearing corporation or chain of clearing
         corporations which has an account with the Federal Reserve Bank;

                  "Environmental Laws" means, collectively, the
         Comprehensive Environmental Response, Compensation and
         Liability Act of 1980, as amended, the Superfund Amendments

                                       10

<PAGE>

         and Reauthorization Act of 1986, the Resource Conservation and Recovery
         Act, the Toxic Substances Control Act, as amended, the Clean Air Act,
         as amended, the Clean Water Act, as amended, any other "Superfund" or
         "Superlien" law or any other federal, or applicable state or local
         statute, law, ordinance, code, rule, regulation, order or decree
         regulating, relating to, or imposing liability or standards of conduct
         concerning, any hazardous, toxic or dangerous waste, substance or
         material;

                  "ERISA" means, at any date, the Employee Retirement Income
         Security Act of 1974, as amended, and the regulations thereunder, all
         as the same shall be in effect at such date;

                  "Event of Default" means any of the occurrences set forth
         as such in Section 10.01 hereof;

                  "Federal Funds Effective Rate" for any day, as used herein,
         means the rate per annum (rounded upward to the nearest 1/100 of 1%)
         announced by the Federal Reserve Bank of New York (or any successor) on
         such day as being the weighted average of the rates on overnight
         Federal funds transactions arranged by Federal funds brokers on the
         previous trading day, as computed and announced by such Federal Reserve
         Bank (or any successor) in substantially the same manner as such
         Federal Reserve Bank computes and announces the weighted average it
         refers to as the "Federal Funds Effective Rate" as of the date of this
         Agreement; provided, if such Federal Reserve Bank (or its successor)
         does not announce such rate on any day, the "Federal Funds Effective
         Rate" for such day shall be the Federal Funds Effective Rate for the
         last day on which such rate was announced;

                  "Fiscal Year" means the 12 month period of each of the
         Borrowers ending on December 31 of each calendar year and commencing on
         January 1 of each calendar year;

                  "Fixed Rate" means a fixed rate for a fixed period of
         time;

                  "Fixed Rate Loan" means any Loan or Advance which shall
         bear interest at a Fixed Rate;

                  "Floating Rate" means the greater of (i) the Prime Rate or
         (ii) the Federal Funds Effective Rate plus one-half of one percent
         (1/2%), each change in the Floating Rate to be effective as of the
         effective date of any change in the Prime Rate or the Federal Funds
         Effective Rate giving rise thereto;

                  "Floating Rate Loan" means a Loan in Dollars for which
         the rate of interest is determined by reference to the
         Floating Rate;

                                       11

<PAGE>

                  "Foreign Benefit Law" means any applicable statute, law,
         ordinance, code, rule, regulation, order or decree of any foreign
         nation or any province, state, territory, protectorate or other
         political subdivision thereof regulating, relating to, or imposing
         liability or standards of conduct concerning any pension, retirement,
         healthcare, death, disability or other employee benefit plan;

                  "Four-Quarter Period" means a period of four full consecutive
         quarter annual periods, taken together as one accounting period;

                  "Funding Bank" means any banking institution approved by the
         Administrative Agent located within a country which country's currency
         has been approved by the Lenders as an Alternative Currency;

                  "Generally Accepted Accounting Principles" means those
         principles of accounting set forth in pronouncements of the Financial
         Accounting Standards Board, the American Institute of Certified Public
         Accountants or which have other substantial authoritative support and
         are applicable in the circumstances as of the date of a report, as such
         principles are from time to time supplemented and amended;

                  "Government Securities" means direct obligations of, or
         obligations the timely payment of principal and interest on which are
         fully and unconditionally guaranteed by, the United States of America
         or the United Kingdom;

                  "Governmental Authority" shall mean any Federal, state,
         municipal, national or other governmental department, commission,
         board, bureau, agency or instrumentality or political subdivision
         thereof or any entity or officer exercising executive, legislative or
         judicial, regulatory or administrative functions of or pertaining to
         any government or any court, in each case whether a state of the United
         States, the United States or foreign;

                  "Guaranteed Obligations" of any Person means (i) all
         guaranties (including guaranties of guaranties and guaranties of
         dividends and other monetary obligations), endorsements (other than
         negotiable instruments for collection), assumptions and other
         obligations with respect to, or to purchase or to otherwise pay or
         acquire, Indebtedness of others including, without duplication,
         reimbursement obligations under applications for letters of credit;
         (ii) monetary obligations under leases and other contracts incurred by
         another Person (other than a wholly-owned Subsidiary of the Borrowers)
         and subsequently assumed by the Person in question; (iii) all
         obligations to advance or supply funds in any manner (a) for the
         purchase or payment of Indebtedness of another Person, or (b) to
         maintain a minimum working capital, net

                                       12
<PAGE>

         worth or other balance sheet condition or any income statement
         condition of another Person and (iv) any request for payment under any
         performance bond or indemnity agreement by the beneficiary thereof;

                  "Guarantors" means collectively (a) the Significant
         Subsidiaries of IVAX and the NHL Guarantors, which on the Closing Date
         are those Subsidiaries listed on SCHEDULE 1.01 and (b) each additional
         Subsidiary designated from time to time by IVAX as a Guarantor;

                  "Guaranty" means each Guaranty and Suretyship Agreement of a
         Guarantor of even date herewith in the form of EXHIBIT G in favor of
         the Administrative Agent, for the benefit of itself and the Lenders, as
         the same may be amended, modified or supplemented;

                  "Hazardous Material" means and includes any hazardous, toxic
         or dangerous waste, substance or material, the generation, handling,
         storage, disposal, treatment or emission of which is subject to any
         Environmental Law;

                  "Indebtedness" means with respect to any Person, without
         duplication, the sum of all items which would be classified as "Current
         portion of long-term debt", "Loans payable" and "Long-term debt, net of
         current portion" on the consolidated balance sheet of IVAX and its
         Subsidiaries (excluding, however, any liability under the Receivables
         Program), all as determined in accordance with Generally Accepted
         Accounting Principles applied on a Consistent Basis;

                  "Interest Period" means:

                  (a)  with respect to each LIBOR Loan and Alternative Currency
         Loan a period commencing on the date such LIBOR Loan and Alternative
         Currency Loan is made or converted and each subsequent period
         commencing on the last day of the immediately preceding Interest Period
         for such LIBOR Loan and Alternative Currency Loan, and ending, at the
         applicable Borrower's option, on the date one, two, three or six months
         thereafter as notified to the Administrative Agent by the Authorized
         Representative of such Borrower three (3) LIBOR Business Days prior to
         the beginning of such Interest Period in the case of a LIBOR Loan and
         four (4) LIBOR Business Days prior to the beginning of such Interest
         Period in the case of a Loan in an Alternative Currency; and

                  (b)  with respect to any Absolute Rate Loan, the period
         commencing on the date such Absolute Rate Loan is made and ending on
         any Business Day up to 180 days thereafter, as IVAX may select as
         provided in Section 2.04(b).

                                       13

<PAGE>

         Notwithstanding the foregoing: (i) if any Interest Period for any
         Competitive Bid Loan would otherwise end after the Revolving Credit
         Termination Date, such Interest Period shall end on the Revolving
         Credit Termination Date; (ii) if any Interest Period for any LIBOR Loan
         or Alternative Currency Loan would otherwise end after the Revolving
         Credit Termination Date, such Interest Period shall end on the
         Revolving Credit Termination Date; (iii) each Interest Period that
         would otherwise end on a day which is not a Business Day shall end on
         the next succeeding Business Day (or, in the case of an Interest Period
         for a LIBOR Loan or Alternative Currency Loan, if such next succeeding
         Business Day falls in the next succeeding calendar month, on the next
         preceding Business Day); (iv) any Interest Period which begins on the
         last Business Day of a calendar month (or on a day on which there is no
         corresponding date in the last month of the Interest Period) shall end
         on the last Business Day of the subsequent month; (v) notwithstanding
         clauses (i), (ii), (iii) and (iv) above, no Interest Period for any
         Fixed Rate Loan (other than an Absolute Rate Loan) shall have a
         duration of less than one month (in the case of a LIBOR Loan) and, if
         the Interest Period for any Fixed Rate Loan (other than an Absolute
         Rate Loan) would otherwise be a shorter period, such Loan shall not be
         available hereunder for such period; and (vi) there shall be no more
         than twelve (12) Interest Periods in effect on any day;

                  "Issuer" means NationsBank as the issuer of one or more
         Letters of Credit as provided in Section 3.01 hereof;

                  "LC Account Agreement" means the LC Account Agreement dated as
         of the date of initial issuance of a Letter of Credit between a
         Borrower and an Issuer, as amended or modified from time to time, in
         the form of EXHIBIT H attached hereto or such other form as shall be
         acceptable to such Issuer;

                  "Lending Office" means, as to each Lender, the Lending Office
         of such Lender designated on the signature pages hereof or in an
         Assignment and Acceptance or such other office of such Lender (or of an
         affiliate of such Lender) as such Lender may from time to time specify
         to the Authorized Representative and the Administrative Agent as the
         office by which its Loans are to be made and maintained;

                  "Letter of Credit" means a standby letter of credit issued by
         the Issuer pursuant to Article III of this Agreement for the account of
         either of the Borrowers in favor of a Person advancing credit or
         securing an obligation on behalf of such Borrower or its Subsidiaries;

                  "Letter of Credit Commitment" means with respect to each
         Lender, the obligation of such Lender to acquire Participations in
         Letters of Credit up to an aggregate stated

                                       14

<PAGE>

         amount at any one time outstanding equal to such Lender's Applicable
         Commitment Percentage of the Total Letter of Credit Commitment as the
         same may be increased or decreased from time to time pursuant to this
         Agreement;

                  "Letter of Credit Facility" means the facility described in
         Article III hereof providing for the issuance by the Issuer for the
         account of either of the Borrowers of Letters of Credit in an aggregate
         stated amount at any time outstanding not exceeding the Total Letter of
         Credit Commitment;

                  "LIBOR Business Day" means a Business Day on which the
         relevant international financial markets are open for the transaction
         of the business contemplated by this Agreement in London, England and
         New York, New York;

                  "LIBOR Loan" means a Loan in Dollars for which the rate
         of interest is determined by reference to the LIBOR Rate;

                  "LIBOR Rate" means, for the Interest Period for any LIBOR
         Loan, the rate of interest per annum determined pursuant to the
         following formula:

                                       BASE RATE            Applicable
                  LIBOR Rate =  -----------------------  +    Margin
                                1 - Reserve Requirement               

                  "Lien" means any interest in property securing any obligation
         owed to, or a claim by, a Person other than the owner of the property,
         whether such interest is based on the common law, statute or contract,
         and including but not limited to the lien or security interest arising
         from a mortgage, encumbrance, pledge, security agreement, conditional
         sale or trust receipt or a lease, consignment or bailment for security
         purposes. For the purposes of this Agreement, each Borrower and its
         Subsidiaries shall be deemed to be the owners of any property which
         either of them have acquired or hold subject to a conditional sale
         agreement, financing lease, or other arrangement pursuant to which
         title to the property has been retained by or vested in some other
         Person for security purposes;

                  "Loan" or "Loans" means any of the Fixed Rate Loans or
         Floating Rate Loans or Competitive Bid Loans or Swing Line
         Loans;

                  "Loan Documents" means this Agreement, the Notes, the
         Guaranties, the Guaranty Agreement of IVAX, Applications and Agreements
         for Letters of Credit, the LC Account Agreement, the Pledge Agreement
         and all other instruments and documents heretofore or hereafter
         executed or delivered to and in favor of any Lender or the
         Administrative Agent in connection with the Loans or the Letters of
         Credit made, issued or created

                                       15

<PAGE>

         under this Agreement as the same may be amended, modified or
         supplemented from the time to time;

                  "McGaw" means McGaw, Inc., a corporation organized and
         existing under the laws of the State of Delaware, all of the issued and
         outstanding capital stock of which is owned by IVAX;

                  "Moody's" means Moody's Investors Service, Inc., a Delaware
         corporation;

                  "Multi-employer Plan" means an employee pension benefit plan
         covered by Title IV of ERISA and in respect of which the Borrower or
         any Subsidiary is an "employer" as described in Section 4001(b) of
         ERISA, which is also a multi-employer plan as defined in Section
         4001(a)(3) of ERISA;

                  "NHL Guarantors" means IVAX and each Subsidiary of NHL which
         has assets that represent more than 10% of the consolidated total
         assets of NHL and its Subsidiaries;

                  "NHL Sublimit" means $75,000,000;

                  "Notes" means, collectively, the Competitive Bid Notes, the
         Swing Note and the Revolving Notes of the Borrowers evidencing Loans,
         executed and delivered to the Lenders as provided in Section 2.05
         hereof, with appropriate insertions as to amounts, dates and names of
         Lenders;

                  "Obligations" means the obligations, liabilities and
         Indebtedness of the Borrowers with respect to (i) the principal and
         interest on the Loans as evidenced by the Notes, (ii) the Reimbursement
         Obligations, (iii) all liabilities of Borrowers to any Lender which
         arise under a Swap Agreement, and (iv) the payment and performance of
         all other obligations, liabilities and Indebtedness of the Borrowers to
         the Lenders, the Administrative Agent or the Agents hereunder, under
         any one or more of the other Loan Documents or with respect to the
         Loans;

                  "Outstanding Letters of Credit" means all undrawn amounts, and
         in the case of Letters of Credit issued in an Alternative Currency the
         Dollar Equivalent Amount thereof, of Letters of Credit plus
         Reimbursement Obligations;

                  "Participation" means, with respect to any Lender (i) (other
         than the Issuer of a particular Letter of Credit), the extension of
         credit represented by the participation of such Lender hereunder in the
         liability of an Issuer in respect of a Letter of Credit issued by such
         Issuer in accordance with the terms hereof or (ii) (other than
         NationsBank), the extension of credit represented by the participation
         of such Lender hereunder in the liability of NationsBank in respect of

                                       16

<PAGE>

         a Swing Line Loan made by NationsBank in accordance with the terms 
         hereof;

                  "Permitted Acquisition" means an acquisition of a Person or
         the assets of a Person which Person is engaged in the same general line
         of business of IVAX or its Subsidiaries, or those lines of business
         related to the health care industry or personal care industry if the
         governing board or shareholders of such Person does not oppose such
         Acquisition and if the Cost of Acquisition exceeds $75,000,000 IVAX
         shall have furnished to the Administrative Agent a certificate in the
         form of EXHIBIT I containing information required therein for IVAX and
         the Person or assets to be acquired on a historical pro forma basis as
         at the most recent date for which a certificate has been delivered to
         the Administrative Agent under Section 8.01 hereof, demonstrating that
         after giving effect to such acquisition no Default or Event of Default
         exists or would exist hereunder;

                  "Person" means an individual, partnership, corporation, trust,
         unincorporated organization, association, joint venture or a government
         or agency or political subdivision thereof;

                  "Personal Care Product Group" means the reporting group, as
         reflected in the consolidating financial statements of IVAX under the
         caption "Personal Care Products Division";

                  "Pledge Agreement" means the Pledge Agreement of even date
         herewith from IVAX to the Administrative Agent, for the benefit of the
         Lenders, pursuant to which IVAX has pledged to the Administrative Agent
         as security for the Obligations all of the issued and outstanding
         capital stock of McGaw;

                  "Pounds Sterling" means the lawful currency of the United
         Kingdom;

                  "Pre-Refunded Municipal Obligations" means obligations of any
         state of the United States of America or of any municipal corporation
         or other public body organized under the laws of any such state which
         are rated, based on the escrow, in the highest investment rating
         category by both S&P and Moody's and which have been irrevocably called
         for redemption and advance refunded through the deposit in escrow of
         Government Securities or other debt securities which are (i) not
         callable at the option of the issuer thereof prior to maturity, (ii)
         irrevocably pledged solely to the payment of all principal and interest
         on such obligations as the same becomes due and (iii) in a principal
         amount and bear such rate or rates of interest as shall be sufficient
         to pay in full all principal of, interest, and premium, if any, on such
         obligations as the same becomes due as verified by a nationally
         recognized firm of certified public accountants;

                                       17

<PAGE>

                  "Prime Rate" means the rate of interest per annum announced
         publicly by the Administrative Agent as its prime rate from time to
         time. The Prime Rate is not necessarily the best or the lowest rate of
         interest offered by the Administrative Agent;

                  "Principal Office" means the office of the Administrative
         Agent at Independence Center, 15th Floor, Charlotte, North Carolina
         28255, Attention: Corporate Credit Support or such other office and
         address as the Administrative Agent may from time to time designate;

                  "Rate Hedging Obligations" means any and all obligations of
         the Borrowers, whether absolute or contingent and howsoever and
         whensoever created, arising, evidenced or acquired (including all
         renewals, extensions and modifications thereof and substitutions
         therefor), under (a) any and all agreements, devices or arrangements
         designed to protect at least one of the parties thereto from the
         fluctuations of interest rates, exchange rates or forward rates
         applicable to such party's assets, liabilities or exchange
         transactions, including, but not limited to, dollar-denominated or
         cross-currency interest rate exchange agreements, forward currency
         exchange agreements, interest rate cap or collar protection agreements,
         forward rate currency or interest rate options, puts, warrants and
         those commonly known as interest rate "swap" agreements; and (b) any
         and all cancellations, buybacks, reversals, terminations or assignments
         of any of the foregoing;

                  "Receivables Program" means a securitization program of IVAX
         and its Subsidiaries yielding net proceeds of up to $75,000,000
         (minimum advance rate 80%);

                  "Regulation D" means Regulation D of the Board as the
         same may be amended or supplemented from time to time;

                  "Regulatory Change" means any change effective after the
         Closing Date in United States federal or state laws or regulations
         (including Regulation D and capital adequacy regulations) or foreign
         laws or regulations or the adoption or making after such date of any
         interpretations, directives or requests applying to a class of banks,
         which includes any of the Lenders, under any United States federal or
         state or foreign laws or regulations (whether or not having the force
         of law) by any court or governmental or monetary authority charged with
         the interpretation or administration thereof or compliance by any
         Lender with any request or directive regarding capital adequacy,
         including with respect to "highly leveraged transactions," whether or
         not having the force of law and whether or not failure to comply
         therewith would be unlawful;

                                       18
<PAGE>

                  "Reimbursement Obligation" shall mean at any time, the
         obligation of the applicable Borrower with respect to any Letter of
         Credit to reimburse an Issuer and the Lenders to the extent of their
         respective Participations (including by the receipt by an Issuer of
         proceeds of Loans pursuant to Section 3.02) for amounts theretofore
         paid by an Issuer pursuant to a drawing under such Letter of Credit;

                  "Repurchase Agreement" means a repurchase agreement entered
         into with any financial institution whose debt obligations or
         commercial paper are rated "A" by either of S&P or Moody's or "A-1" by
         S&P or "P-1" by Moody's;

                  "Required Lenders" means, as of any date, Lenders on such date
         having Credit Exposures (as defined below) aggregating at least 51% of
         the aggregate Credit Exposures of all the Lenders on such date. For
         purposes of the preceding sentence, the amount of the "CREDIT EXPOSURE"
         of each Lender shall be equal to the aggregate principal amount of the
         Loans without regard to any Competitive Bid Loans or Swing Line Loans
         owing to such Lender plus the aggregate unutilized amounts of such
         Lender's Revolving Credit Commitment plus the amount of such Lender's
         Applicable Commitment Percentage of Outstanding Letters of Credit;
         provided that, if any Lender shall have failed to pay to an Issuer its
         Applicable Commitment Percentage of any drawing under any Letter of
         Credit resulting in an outstanding Reimbursement Obligation, such
         Lender's Credit Exposure attributable to Letters of Credit,
         Reimbursement Obligations and the Letter of Credit Commitment shall be
         deemed to be held by the Issuer of such Letter of Credit for purposes
         of this definition;

                  "Reserve Requirement" means, for any day, that percentage
         (expressed as a decimal) which is in effect from time to time under
         Regulation D of the Board or other applicable banking regulator, as
         such regulation may be amended from time to time or any successor
         regulation, as the maximum reserve requirement (including, without
         limitation, any basic, supplemental, emergency, special, or marginal
         reserves) applicable with respect to Eurocurrency liabilities as that
         term is defined in Regulation D (or against any other category of
         liabilities that includes deposits by reference to which the interest
         rate of a Fixed Rate Loan is determined), whether or not the applicable
         Lender has any Eurocurrency liabilities subject to such reserve
         requirement at that time. A Fixed Rate Loan shall be deemed to
         constitute Eurocurrency liabilities and as such shall be deemed subject
         to reserve requirements without benefits of credit for proration,
         exceptions or offsets that may be available from time to time to the
         applicable Lender. The Fixed Rate shall be adjusted automatically on
         and as of the effective date of any change in the Reserve Requirement;

                                       19
<PAGE>
                  "Revolving Credit Advance Account" means an account on the 
         books of the Administrative Agent in which

                       (i)   each Advance by the Administrative Agent pursuant 
                  to Section 2.01 shall be debited thereto by recording therein
                  on the date of such Advance a debit entry in the amount of
                  such Advance; and

                      (ii)   each payment made to the Administrative Agent for 
                  credit to the Revolving Credit Advance Account shall be
                  credited thereto by recording therein on the date paid to the
                  Administrative Agent a credit entry in the amount of such
                  payment;

                  "Revolving Credit Commitment" means with respect to each
         Lender, the obligation of such Lender to make Loans to the Borrowers up
         to an aggregate principal amount at any one time outstanding equal to
         such Lender's percentage as set forth on EXHIBIT A hereto of the Total
         Revolving Credit Commitment as the same may be increased or decreased
         from time to time pursuant to this Agreement;

                  "Revolving Credit Debit Balance" means an amount equal to the
         excess, if any, of all debit entries over all credit entries required
         to be recorded in the Revolving Credit Advance Account up to and
         including the date of computation;

                  "Revolving Credit Facility" means the facility described in
         Article II hereof providing for Loans to the Borrowers by the Lenders
         in the aggregate principal amount of Total Revolving Credit Commitment
         less the aggregate amount of Outstanding Letters of Credit, the
         aggregate amount of outstanding Competitive Bid Loans and the aggregate
         amount of outstanding Swing Line Loans;

                  "Revolving Credit Termination Date" means (i) May 14, 2001 or
         (ii) such earlier date of termination of Lenders' obligations pursuant
         to Section 10.01 upon the occurrence of an Event of Default, or (iii)
         such date as the Borrowers may voluntarily permanently terminate the
         Revolving Credit Facility by payment in full of all Obligations
         (including the discharge of all Obligations of the Lenders with respect
         to Letters of Credit and Participations and Competitive Bid Loans and
         Swing Line Loans) or (iv) such later date as the Borrowers and the
         Lenders shall agree in writing pursuant to Section 2.14 hereof;

                  "Revolving Notes" shall mean the promissory notes
         substantially in the form of EXHIBIT E-2;

                  "S&P" means Standard & Poor's Rating Division of McGraw
         Hill Corporation, Inc., a New York corporation;

                                       20
<PAGE>
                  "Senior Notes" means the 10 3/8% Senior Notes due 1999 of
         McGaw in the original principal amount of $93,000,000;

                  "Significant Subsidiaries" means (a) in the case of IVAX, each
         Subsidiary of IVAX which is an entity organized within the United
         States, and (i) represents more than 10% of the consolidated total
         assets of IVAX and its Subsidiaries or (ii) contributes more than 10%
         of the Consolidated Net Income of IVAX and its Subsidiaries such
         determination to be made at the end of each Fiscal Year of the
         Borrower, and (b) in the case of NHL, each Subsidiary of NHL which
         represents more than 10% of the consolidated total assets of NHL and
         its Subsidiaries;

                  "Single Employer Plan" means any employee pension benefit plan
         covered by Title IV of ERISA and in respect of which either of the
         Borrower or any Subsidiary of such Borrower is an "employer" as
         described in Section 4001(b) of ERISA, which is not a Multi-employer
         Plan;

                  "Solvent" means, when used with respect to any Person, that at
         the time of determination:

                       (i)   the fair value of its assets (both at fair
                  valuation and at present fair saleable value on an orderly
                  basis) is in excess of the total amount of its liabilities,
                  including, without limitation, Guaranteed Obligations; and

                      (ii)   it is then able and expects to be able to pay its 
                  debts as they mature; and

                     (iii)   it has capital sufficient to carry on its business
                  as conducted and as proposed to be conducted;

                  "Specialty Chemicals Group" means the reporting group as
         reflected in the consolidating financial statements of IVAX under the
         caption "Chemical Division";

                  "Spot Rate of Exchange" means, (i) in determining the Dollar
         Equivalent Amount of a specified Alternative Currency amount as of any
         date, the spot exchange rate determined by the Administrative Agent in
         accordance with its usual procedures for the purchase by the
         Administrative Agent of Dollars with such Alternative Currency at
         approximately 10:00 A.M., Charlotte, North Carolina time on the
         Business Day that is two (2) LIBOR Business Days prior to such date,
         and (ii) in determining the Alternative Currency Equivalent Amount of a
         specified Dollar amount on any date, the spot exchange rate determined
         by the Administrative Agent in accordance with its usual procedures for
         the purchase by the Administrative Agent of such Alternative Currency
         with Dollars at approximately 10:00 A.M., Charlotte, North Carolina
         time on the LIBOR

                                       21
<PAGE>

         Business Day that is two (2) LIBOR Business Days prior to such date;

                  "Subsidiary" means any corporation or other entity in which
         more than 50% of its outstanding voting stock or more than 50% of all
         equity interests is owned directly or indirectly by either of the
         Borrowers and/or by one or more of such Borrower's Subsidiaries;

                  "Swap Agreement" means one or more agreements with respect to
         Indebtedness evidenced by the Notes between either Borrower and another
         Person, on terms mutually acceptable to such Borrower and such Person,
         which agreements create Rate Hedging Obligations;

                  "Swing Line" means the revolving line of credit established
         by NationsBank pursuant to Section 2.15;

                  "Swing Line Loans" means Loans made by NationsBank to the
         Borrowers pursuant to Section 2.15;

                  "Swing Note" means the promissory note substantially in
         the form of EXHIBIT E-3;

                  "Syndicated Loans" shall mean the Loans which are not
         Competitive Bid Loans or Swing Line Loans;

                  "Total Letter of Credit Commitment" means an amount not
         to exceed $20,000,000;

                  "Total Revolving Credit Commitment" means $425,000,000.

         1.02  ACCOUNTING TERMS. All accounting terms not specifically defined
herein shall have the meanings assigned to such terms and shall be interpreted
in accordance with Generally Accepted Accounting Principles applied on a
Consistent Basis; provided, however, if any change in Generally Accepted
Accounting Principles in effect on the Closing Date shall result in a change in
any calculation required to determine compliance with any provision contained in
this Agreement, the Borrowers and the Required Lenders will amend such provision
in a manner to reflect such change such that the determination of compliance
with such provision shall yield the same result as would have obtained prior to
such change in Generally Accepted Accounting Principles. Until an amendment is
entered into covenants shall be calculated in accordance with Generally Accepted
Accounting Principles as in effect immediately preceding such change.

                                       22

<PAGE>

                                   ARTICLE II

                                    THE LOANS

        2.01  REVOLVING CREDIT FACILITY

        (a) COMMITMENT. Subject to the terms and conditions of this Agreement,
each Lender severally agrees to make Advances in Dollars or an Alternative
Currency (as specified in the respective Borrowing Notice) to IVAX or NHL, as
the case may be, as specified in the Borrowing Notice, from time to time from
the Closing Date until the Revolving Credit Termination Date, on a pro rata
basis as to the total borrowing requested by such Borrower on any day determined
by its Applicable Commitment Percentage, up to but not exceeding a Dollar Value
equal to the Revolving Credit Commitment of such Lender, PROVIDED, however, that
the Lenders will not be required and shall have no obligation to make any
Advance (i) so long as a Default or an Event of Default has occurred and is
continuing or (ii) if maturity of the Notes has been accelerated as a result of
an Event of Default; PROVIDED further, however, that immediately after giving
effect to each Advance, the Dollar Value of outstanding Loans plus the amount of
all Outstanding Letters of Credit shall not exceed the Available Revolving
Credit Commitment and PROVIDED further that no Advance shall be made to NHL if,
immediately after giving effect to such Advance, NHL's Loans plus the amount of
the outstanding Letters of Credit of NHL exceed the NHL Sublimit. Within such
limits, the Borrowers may borrow, repay and reborrow hereunder, on a Business
Day in the case of a Floating Rate Loan and on a LIBOR Business Day in the case
of a Fixed Rate Loan, from the Closing Date until, but (as to borrowings and
reborrowings) not including, the Revolving Credit Termination Date; PROVIDED,
however, that (x) no Fixed Rate Loan shall be made which has an Interest Period
that extends beyond the Revolving Credit Termination Date and (y) each Fixed
Rate Loan may, subject to the provisions of Section 2.09, be repaid only on the
last day of the Interest Period with respect thereto.

        (b) AMOUNTS, ADVANCES AND RATE SELECTION. (i) Each request for an
Advance of an Alternative Currency under a Borrowing Notice shall constitute
such Borrower's request for a Loan of the Dollar Value of the amount of the
Alternative Currency specified in such Borrowing Notice and for such Loan to be
made available by the Lenders to such Borrower in the Alternative Currency
Equivalent Amount of such Dollar Value (determined based on the Advance Date
Exchange Rate applicable to such Advance). The principal amount outstanding on
any Loan shall be recorded in the Administrative Agent's records in Dollars (in
the case of an Advance of an Alternative Currency as if the Loan had initially
been made in Dollars), based on the amount of such Advance in the case of any
LIBOR Loan Advance or Floating Rate Loan Advance and on the Dollar Value of the
initial Advance in the case of an Alternative Currency Loan Advance, as reduced
from time to time by the Dollar Equivalent Amount (based on the Advance Date
Exchange Rate applicable to such

                                       23
<PAGE>

Advance) of any principal payments with respect to such Advance. In the event a
Fixed Rate Loan of an Alternative Currency is continued, such election to
continue the Fixed Rate Loan shall be treated as an Advance and the
Administrative Agent shall notify the applicable Borrower and the Lenders of the
Advance Date Exchange Rate, Interest Period and the Alternative Currency LIBOR
Rate for such continued Alternative Currency Loan. The Lenders shall each be
deemed to have made an Advance to such Borrower of its Applicable Commitment
Percentage of such Alternative Currency Loan and the Administrative Agent shall
apply the Advance Date Exchange Rate for such new Interest Period to such
continued Alternative Currency Equivalent Amount to determine the new Dollar
Value of such Alternative Currency Loan and shall adjust its books and the
Revolving Credit Debit Balance accordingly. In the event that such adjustment
with respect to a continued Loan would cause the total Dollar Value of
outstanding Loans plus Outstanding Letters of Credit to exceed the Available
Revolving Credit Commitment or the NHL Sublimit, the Borrowers shall,
immediately on the effective date of such continuation, repay (a "Rate
Adjustment Payment") the portion of such converted Alternative Currency Loan
(applying the new Advance Date Exchange Rate) necessary to ensure that the total
Dollar Value of all outstanding Loans plus Outstanding Letters of Credit does
not exceed the Available Revolving Credit Commitment, and, in the case of NHL,
the NHL Sublimit, PROVIDED FURTHER that the Borrowers shall not be required to
pay any additional compensation pursuant to Section 4.04(a) with respect to a
prepayment of a Loan required by this sentence if such prepayment is made
immediately on the effective date of the continuation giving rise to such
prepayment. For the purposes of determining the maximum amount of Loans plus
Outstanding Letters of Credit that may be outstanding hereunder, it is intended
by the parties that all Loans shall be the functional equivalent of Loans made
and repaid (based on the applicable Advance Date Exchange Rate for each Advance)
in Dollars. It is recognized that one or more Lenders may elect to record Loans
or Advances in Alternative Currencies. The Administrative Agent shall maintain
records sufficient to identify at any time, (i) the Advance Date Exchange Rate
with respect to each Advance, and (ii) the portion of the Revolving Credit Debit
Balance attributable to each Advance. There shall be no more than four (4) Loans
of an Alternative Currency outstanding at any one time.

        (ii) The aggregate unpaid amount (including with respect to Loans of 
Alternative Currencies, the total Dollar Value) of the Loans plus Outstanding
Letters of Credit shall not exceed at any time an amount equal to the Available
Revolving Credit Commitment. Each Loan and each conversion under Section 2.09
shall be (A) in the case of Loans in Dollars, in an amount not less than
$1,000,000 and in integral multiples of $1,000,000, and (B) in the case of
Alternative Currencies in an amount not less than $1,000,000 (or the equivalent
thereof in any Alternative Currency), and, if greater, an integral multiple of
$1,000,000 (or the equivalent thereof in any Alternative Currency).

                                       24
<PAGE>

        (iii) An Authorized Officer shall give the Administrative Agent (A) at
least four (4) LIBOR Business Days irrevocable telecopy or telex notice of each
Alternative Currency Loan (whether representing an additional borrowing
hereunder or the conversion of borrowing hereunder) prior to 10:00 A.M.,
Charlotte, North Carolina time, (B) at least three (3) LIBOR Business Days
irrevocable telecopy or telex notice prior to 11:00 A.M., Charlotte, North
Carolina time in the case of Fixed Rate Loans in Dollars (whether representing
an additional borrowing hereunder or the conversion of borrowing hereunder) and,
(C) irrevocable telephonic or telefacsimile notice of each Floating Rate Loan
representing a borrowing or conversion hereunder prior to 11:00 A.M. Charlotte,
North Carolina time on the day of such proposed Floating Rate Loan. Each such
Borrowing Notice, which shall be effective upon receipt by the Administrative
Agent, shall specify the type of Loan (Fixed Rate or Floating Rate), whether
Dollar or Alternative Currency, amount of the Loan for which the Advance is to
be made, the date of borrowing and, in the case of a Fixed Rate Loan, the
Interest Period to be used in the computation of interest. The Authorized
Officer shall provide the Administrative Agent written confirmation of each such
telephonic notice on the same day by telefacsimile transmission in the form of a
Borrowing Notice in the form attached hereto as EXHIBIT D, in each case with
appropriate insertions, but failure to provide such confirmation shall not
affect the validity of such telephonic notice. The duration of the initial
Interest Period for each Loan shall be as specified in the initial Borrowing
Notice. The Borrowers shall have the option to elect the duration of subsequent
Interest Periods and to convert the Loans in accordance with Section 2.09
hereof. If the Administrative Agent does not receive a notice of election of
duration of an Interest Period or to convert by the time prescribed hereby and
by Section 2.09 hereof, the applicable Borrower shall be deemed to have elected
a Floating Rate Loan bearing interest at the Floating Rate.

         (iv) Notice of receipt of each Borrowing Notice shall be provided by
the Administrative Agent to each Lender by telecopy or telex with reasonable
promptness, but not later than 12:00 noon, Charlotte, North Carolina time on the
same day as Administrative Agent's receipt of such notice from the Borrower
prior to 10:00 A.M. in the case of an Alternative Currency Loan and 11:00 A.M.
in the case of a Fixed Rate Loan in Dollars and a Floating Rate Loan. At
approximately 9:30 A.M. Charlotte, North Carolina time two (2) LIBOR Business
Days preceding the date specified for an Advance of an Alternative Currency, the
Administrative Agent shall determine the Advance Date Exchange Rate and the
Applicable Rate. Not later than 10:15 A.M. Charlotte, North Carolina time two
(2) LIBOR Business Days preceding the date specified for each Advance of an
Alternative Currency, the Administrative Agent shall provide the applicable
Borrower and each Lender notice by telefacsimile transmission of the Advance
Date Exchange Rate applicable to such Advance, and the applicable Alternative
Currency Equivalent Amount of the Loan or Loans required to be made by each
Lender on such

                                       25

<PAGE>

date, and the Dollar Value of such Loan or Loans and the Applicable Rate.

         (v) In the case of Advances in Dollars, each Lender shall, pursuant to
the terms and conditions of this Agreement, not later than 12:00 noon,
Charlotte, North Carolina time on the date specified for such Advance in the
case of a Fixed Rate Loan in Dollars and 2:00 P.M. Charlotte, North Carolina
time on the date specified for such Advance for a Floating Rate Loan, make the
amount of the Advance to be made by it on such day available to the
Administrative Agent by depositing or transferring the proceeds thereof in
immediately available funds to the Administrative Agent, at the Principal
Office. The amount so received by the Administrative Agent shall, subject to the
terms of this Agreement, be made available promptly upon receipt to the
applicable Borrower by deposit of the proceeds to an account of such Borrower
maintained at the Principal Office or otherwise as shall be directed in the
applicable Borrowing Notice.

         (vi) In the case of Advances of an Alternative Currency, not later than
9:00 A.M., Charlotte, North Carolina time on the date specified for each
Advance, each Lender shall, pursuant to the terms and subject to the conditions
of this Agreement, make the amount of the Loan or Loans to be made by it on such
day available to the applicable Borrower at the Funding Bank, to the account of
the Administrative Agent with the Funding Bank. The amount so received by the
Funding Bank shall, subject to the terms and conditions of the Loan Documents
and upon instruction from the Administrative Agent to the Funding Bank on the
same day but no later than 9:00 A.M. Charlotte, North Carolina time, be made
available to the applicable Borrower by delivery of the Alternative Currency
Equivalent Amount to such Borrower's account with the Funding Bank.

         (vii) Notwithstanding the foregoing, if a drawing is made under any
Letter of Credit prior to the Revolving Credit Termination Date and the
applicable Borrower shall not immediately reimburse Issuer for the amount of
such draw or payment, then notice of such drawing or payment shall be provided
promptly by Issuer to the Administrative Agent and the Administrative Agent
shall provide notice to each Lender by telephone. If notice to the Lenders of a
drawing under any Letter of Credit is given by the Administrative Agent at or
before 12:00 noon Charlotte, North Carolina time on any Business Day, the
applicable Borrower shall be deemed to have requested, and each Lender shall,
subject to the conditions of this Agreement, make a Floating Rate Loan under the
Revolving Credit Facility in the amount of such Lender's Applicable Commitment
Percentage of such drawing or payment (and in the case of a drawing in an
Alternative Currency, a Floating Rate Loan, in an amount equal to such Lender's
Applicable Commitment Percentage of the Dollar Equivalent Amount of such drawing
or payment determined on the basis of the Spot Rate of Exchange on the date of
drawing under the Letter of Credit) and shall pay such amount to

                                       26

<PAGE>

the Administrative Agent for the account of the Issuer at the Principal Office
in Dollars and in immediately available funds before 2:30 P.M. Charlotte, North
Carolina time on the same Business Day. If notice to the Lenders is given by the
Administrative Agent after 12:00 noon Charlotte, North Carolina time on any
Business Day, the applicable Borrower shall be deemed to have requested, and
each Lender shall, pursuant to the terms and subject to the conditions of this
Agreement, make a Floating Rate Loan under the Revolving Credit Facility in the
amount of such Lender's Applicable Commitment Percentage of such drawing or
payment (and in the case of a drawing in an Alternative Currency, a Floating
Rate Loan, in an amount equal to such Lender's Applicable Commitment Percentage
of the Dollar Equivalent Amount of such drawing or payment determined on the
basis of the Spot Rate of Exchange on the date of drawing under the Letter of
Credit) and shall pay such amount to the Administrative Agent for the account of
the Issuer at the Principal Office in Dollars and in immediately available funds
before 12:00 noon Charlotte, North Carolina time on the next following Business
Day. Such Floating Rate Loan shall continue unless and until the applicable
Borrower converts such Floating Rate Loan in accordance with the terms of
Section 2.09 hereof.

         2.02 PAYMENT OF INTEREST. (a) Each Borrower shall pay its respective
interest to the Administrative Agent for the account of each Lender on the
outstanding and unpaid principal amount of each Loan made by such Lender for the
period commencing on the date of such Loan until such Loan shall be due at the
then applicable Floating Rate for Floating Rate Loans or applicable Fixed Rate
for Fixed Rate Loans, as designated by the Authorized Representative pursuant to
Section 2.01 or Section 2.04 hereof or as otherwise provided herein, such
payments to be made in the same currency as the applicable Loan was made;
PROVIDED, however, that if any amount shall not be paid when due (at maturity,
by acceleration or otherwise), all amounts outstanding hereunder shall bear
interest thereafter (i) in the case of a Fixed Rate Loan, until the end of the
Interest Period with respect to such Fixed Rate Loan, at a rate of two percent
(2%) above such Fixed Rate and (ii) thereafter, and with respect to Floating
Rate Loans, at a rate of interest per annum which shall be two percent (2%)
above the Floating Rate or the maximum rate permitted by applicable law,
whichever is lower, from the date such amount was due and payable until the date
such amount is paid in full.

         (b) Interest on each Loan shall be computed on the basis of a year of
360 days and calculated for the actual number of days elapsed; provided that for
Alternative Currency Loans for which a 365-day basis is the only market practice
available to the Administrative Agent for such Loan, interest shall be
calculated on the basis of a year of 365-366 days, as the case may be, for the
actual days elapsed. Interest on each Loan shall be paid (a) quarterly in
arrears on the last Business Day of each quarter, commencing June 30, 1996, on
each Floating Rate Loan, (b) on the

                                       27

<PAGE>

last day of the applicable Interest Period for each Fixed Rate Loan and, if the
Interest Period extends for more than three months, at intervals of three months
after the first day of the Interest Period and (c) upon payment in full of the
principal amount of such Loan. Interest on amounts not paid when due shall be
payable on demand.

         2.03 PAYMENT OF PRINCIPAL. (a) The principal amount of each Loan (other
than a Competitive Bid Loan) shall be due and payable to the Administrative
Agent for the benefit of each Lender in full on the Revolving Credit Termination
Date. Competitive Bid Loans shall be due and payable on the last day of the
Interest Period for such Loan. The duration of the initial Interest Period for
each Loan that is a Fixed Rate Loan shall be as specified in the initial
Borrowing Notice. The Borrowers shall have the option to elect the duration of
subsequent Interest Periods and to convert the Loans in accordance with Section
2.09 hereof. If the Administrative Agent does not receive a notice of election
of duration of an Interest Period or to convert by the time prescribed by
Section 2.09 hereof, the applicable Borrower shall be deemed to have elected to
convert such Loan to (or continue such Loan as) a Floating Rate Loan until the
Borrower notifies the Administrative Agent in accordance with Section 2.09.

         (b) Each payment of principal (including any prepayment) and payment of
interest shall be made to the Administrative Agent at the Principal Office, for
the account of each Lender's applicable Lending Office, to be recorded in
Dollars as set forth in Section 2.01(b) and in the definition of Revolving
Credit Advance Account. The repayment of such principal amount shall be made in
the appropriate Alternative Currency as follows: the portion of the Revolving
Credit Debit Balance attributable to each specified Advance (or the continuation
or conversion thereof) (as determined from the Administrative Agent's records)
shall be repaid in the same Alternative Currency as such Advance. Each payment
under this Agreement shall be made in immediately available funds before 12:30
P.M. Charlotte, North Carolina time on the date such payment is due. The
Administrative Agent may, but shall not be obligated to, debit the amount of any
such payment which is not made by such time to any ordinary deposit account, if
any, of the applicable Borrower with the Administrative Agent. The Borrowers
shall give the Administrative Agent prior telephonic notice of any payment of
principal, such notice to be given by not later than 11:00 A.M. Charlotte, North
Carolina time, on the date of such payment. Payments shall be in minimum amounts
of $500,000 (or the equivalent thereof in any Alternative Currency with respect
to an Alternative Currency Loan) and multiples of $100,000 (or the equivalent
thereof in any Alternative Currency with respect to an Alternative Currency
Loan) in excess thereof.

         (c) The Administrative Agent shall deem any payment by or on behalf of
the Borrowers hereunder that is not made both (a) in Dollars in the case of
LIBOR Loans or Floating Rate Loans and the required Alternative Currency in the
case of Loans in Alternative

                                       28
<PAGE>

Currencies and in immediately available funds and (b) prior to 12:30 P.M.
Charlotte, North Carolina time to be a non-conforming payment. Any such payment
shall not be deemed to be received by the Administrative Agent until the time
such funds become available funds in the required currency. The Administrative
Agent shall give prompt telephonic notice to the applicable Authorized
Representative and each of the Lenders (confirmed in writing) if any payment is
non-conforming. Interest shall continue to accrue on any principal as to which a
non-conforming payment is made until such funds become available funds (but in
no event less than the period from the date of such payment to the next
succeeding Business Day) at a rate of interest per annum which shall be two
percent (2%) above the Floating Rate or the maximum rate permitted by applicable
law, whichever is lower, from the date such amount was due and payable until the
date such amount is paid in full.

         (d) In the event that any payment hereunder or under the Notes becomes 
due and payable on a day other than a Business Day, then such due date shall be
extended to the next succeeding Business Day; provided that interest shall
continue to accrue during the period of any such extension.

         2.04  COMPETITIVE BID LOANS.

         (a) In addition to borrowings of Syndicated Loans, at any time prior to
the Revolving Credit Termination Date the Borrowers may, as set forth in this
Section 2.04, request the Lenders to make offers to make Competitive Bid Loans
to the Borrowers in Dollars. The Lenders may, but shall have no obligation to,
make such offers and the Borrowers may, but shall have no obligation to, accept
any such offers in the manner set forth in this Section 2.04. Competitive Bid
Loans shall be Absolute Rate Loans, PROVIDED that:

            (i)  the aggregate amount of outstanding Competitive Bid Loans plus
         Swing Line Loans plus Revolving Credit Loans plus Outstanding Letters
         of Credit shall not exceed the Available Revolving Credit Commitment
         and in the case of NHL the NHL Sublimit;

           (ii)  there may be no more than twelve (12) different Interest 
         Periods for both Syndicated Loans and Competitive Bid Loans outstanding
         at the same time;

          (iii)  the aggregate amount of outstanding Competitive Bid Loans of a
         ender shall not exceed at any time an amount equal to the Available
         Revolving Credit Commitment;

           (iv)  no Competitive Bid Loan shall have a maturity date subsequent
         to the Revolving Credit Termination Date.

         (b) When a Borrower wishes to request offers to make Competitive Bid
Loans, it shall give the Administrative Agent (which shall promptly notify the
Lenders) notice (a "COMPETITIVE

                                       29

<PAGE>

BID QUOTE REQUEST") to be received no later than 10:00 A.M. on the Business Day
next preceding the date of borrowing proposed therein, (or such other time and
date as such Borrower and the Administrative Agent, with the consent of the
Required Lenders, may agree). The Borrowers may request offers to make
Competitive Bid Loans for up to three (3) different Interest Periods in a single
notice; PROVIDED that the request for each separate Interest Period shall be
deemed to be a separate Competitive Bid Quote Request for a separate borrowing
(a "COMPETITIVE BID BORROWING") and there shall not be outstanding at any one
time more than four (4) Competitive Bid Borrowings. Each such Competitive Bid
Quote Request shall be substantially in the form of EXHIBIT J hereto and shall
specify as to each Competitive Bid Borrowing:

            (i)  the proposed date of such borrowing, which shall be a Business
         Day;

           (ii)  the aggregate amount of such Competitive Bid Borrowing, which
         shall be at least $5,000,000 (or a larger multiple of $1,000,000) but
         shall not cause the limits specified in Section 2.04(a) hereof to be
         violated;

          (iii)  the duration of the Interest Period applicable thereto; and

           (iv)  the date on which the Competitive Bid Quotes are to be 
         submitted if it is before the proposed date of borrowing (the date on
         which such Competitive Bid Quotes are to be submitted is called the
         "QUOTATION DATE").

Except as otherwise provided in this Section 2.04(b), no Competitive Bid Quote
Request shall be given within five (5) Business Days (or such other number of
days as the applicable Borrower and the Administrative Agent, with the consent
of the Required Lenders, may agree) of any other Competitive Bid Quote Request.

            (c) (i) Each Lender may submit one or more Competitive Bid Quotes, 
         each containing an offer to make a Competitive Bid Loan in response to
         any Competitive Bid Quote Request; PROVIDED that, if a Borrower's
         request under Section 2.04(b) hereof specified more than one Interest
         Period, such Lender may make a single submission containing one or more
         Competitive Bid Quotes for each such Interest Period. Each Competitive
         Bid Quote must be submitted to the Administrative Agent not later than
         10:00 A.M. Charlotte, North Carolina time on the Quotation Date (or
         such other time and date as the applicable Borrower and the
         Administrative Agent, with the consent of the Required Lenders, may
         agree); PROVIDED, that any Competitive Bid Quote may be submitted by
         the Administrative Agent (or its Applicable Lending Office) only if the
         Administrative Agent (or such Applicable Lending Office) notifies the
         Borrower of the terms of the offer

                                       30

<PAGE>

         contained therein not later than 9:45 A.M. Charlotte, North Carolina
         time on the Quotation Date. Subject to ARTICLE IV, ARTICLE VII and X
         hereof, any Competitive Bid Quote so made shall be irrevocable except
         with the consent of the Administrative Agent given on the instructions
         of the applicable Borrower.

             (ii) Each Competitive Bid Quote shall be substantially in the form
         of EXHIBIT K hereto and shall specify:

                  (A)  the proposed date of borrowing and the Interest Period
             therefor;

                  (B)  the principal amount of the Competitive Bid Loan for 
             which each such order is being made, which principal amount shall
             be at least $5,000,000 (or a larger multiple of $1,000,000);
             PROVIDED that the aggregate principal amount of all Competitive Bid
             Loans for which a Lender submits Competitive Bid Quotes (x) may not
             exceed the Available Revolving Credit Commitment and (y) may not
             exceed the principal amount of the Competitive Bid Borrowing for a
             particular Interest Period for which offers were requested;

                  (C)  the rate of interest per annum (rounded upwards, if 
             necessary, to the nearest 1/10,000th of 1%) offered for each such
             Competitive Bid Loan (the "ABSOLUTE RATE"); and

                  (D)  the identity of the quoting Lender.

Unless otherwise agreed by the Administrative Agent and the applicable Borrower,
no Competitive Bid Quote shall contain qualifying, conditional or similar
language or propose terms other than or in addition to those set forth in the
applicable Competitive Bid Quote Request and, in particular, no Competitive Bid
Quote may be conditioned upon acceptance by the applicable Borrower of all (or
some specified minimum) of the principal amount of the Competitive Bid Loan for
which such Competitive Bid Quote is being made.

         (d)  The Administrative Agent shall, as promptly as practicable after
the Competitive Bid Quote is submitted (but in any event not later than 10:30
A.M. Charlotte, North Carolina time on the Quotation Date), notify the
applicable Borrower of the terms (i) of any Competitive Bid Quote submitted by a
Lender that is in accordance with Section 2.04(c) hereof and (ii) of any
Competitive Bid Quote that amends, modifies or is otherwise inconsistent with a
previous Competitive Bid Quote submitted by such Lender with respect to the same
Competitive Bid Quote Request. Any such subsequent Competitive Bid Quote shall
be disregarded by the Administrative Agent unless such subsequent Competitive
Bid Quote is submitted solely to correct a manifest error in such former

                                       31

<PAGE>

Competitive Bid Quote. The Administrative Agent's notice to the applicable
Borrower shall specify (A) the aggregate principal amount of the Competitive Bid
Borrowing for which orders have been received and (B) the respective principal
amounts and Absolute Rates so offered by each Lender (identifying the Lender
that made each Competitive Bid Quote).

         (e)  Not later than 11:00 A.M. Charlotte, North Carolina time on the 
Quotation Date (or such other time and date as the applicable Borrower and the
Administrative Agent, with the consent of the Required Lenders, may agree), the
applicable Borrower shall notify the Administrative Agent of its acceptance or
nonacceptance of the offers so notified to it pursuant to Section 2.04(d) hereof
(and the failure of the applicable Borrower to give such notice by such time
shall constitute nonacceptance) and the Administrative Agent shall promptly
notify each affected Lender. In the case of acceptance, such notice shall
specify the aggregate principal amount of offers for each Interest Period that
are accepted. The applicable Borrower may accept any Competitive Bid Quote in
whole or in part (PROVIDED that any Competitive Bid Quote accepted in part shall
be at least $5,000,000 or a larger multiple of $1,000,000); PROVIDED that:

            (i)  the aggregate principal amount of each Competitive Bid 
         Borrowing may not exceed the applicable amount set forth in the related
         Competitive Bid Quote Request;

           (ii)  the aggregate principal amount of each Competitive Bid 
         Borrowing shall be at least $5,000,000 (or a larger multiple of
         $1,000,000) but shall not cause the limits specified in Section 2.04(a)
         hereof to be violated;

          (iii)  acceptance of offers may be made only in ascending order of
         Absolute Rates, beginning with the lowest rate so offered; and

           (iv)  the Borrowers may not accept any offer where the Administrative
         Agent has correctly advised the Borrowers that such offer fails to
         comply with Section 2.04(c)(ii) hereof or otherwise fails to comply
         with the requirements of this Agreement (including, without limitation,
         Section 2.04(a) hereof).

If offers are made by two or more Lenders with the same Absolute Rates, for a
greater aggregate principal amount than the amount in respect of which offers
are accepted for the related Interest Period after the acceptance of all offers,
if any, of all lower Absolute Rates offered by any Lender for such related
Interest Period, the principal amount of Competitive Bid Loans in respect of
which such offers are accepted shall be allocated by the applicable Borrower
among such Lenders as nearly as possible (in amounts of at least $5,000,000 or
larger multiples of $1,000,000) in proportion to the aggregate principal amount
of such offers. Determinations

                                       32

<PAGE>

by the applicable Borrower of the amounts of Competitive Bid Loans and the
lowest bid after adjustment as provided in Section 2.04(e)(iii) shall be
conclusive in the absence of manifest error.

         (f)  Any Lender whose offer to make any Competitive Bid Loan has been
accepted shall, not later than 1:00 P.M. Charlotte, North Carolina time on the
date specified for the making of such Loan, make the amount of such Loan
available to the Administrative Agent at the Principal Office in Dollars and in
immediately available funds, for account of the applicable Borrower. The amount
so received by the Administrative Agent shall, subject to the terms and
conditions of this Agreement, be made available to the applicable Borrower on
such date by depositing the same, in Dollars and in immediately available funds,
in an account of the Borrowers maintained at the Principal Office or otherwise
as shall be directed by the applicable Borrower.

         2.05  NOTES.

         (a)  Syndicated Loans made by each Lender shall be evidenced by a
Revolving Note of each Borrower payable to the order of such Lender in the
respective amount of its Applicable Commitment Percentage of the Total Revolving
Credit Commitment, in the case of IVAX, and the NHL Sublimit, in the case of
NHL, which Revolving Note shall be dated the Closing Date and shall be duly
completed, executed and delivered by the respective Borrower.

         (b)  Swing Line Loans made by NationsBank shall be evidenced by the 
Swing Line Note payable to the order of NationsBank, which Swing Line Note shall
be dated the Closing Date and shall be duly completed, executed and delivered by
IVAX.

         (c)  Competitive Bid Loans made by each Lender shall be evidenced by 
the Competitive Bid Note payable to the order of such Lender in the amount of
the Total Revolving Credit Commitment, which Competitive Bid Note shall be dated
the Closing Date and shall be duly completed, executed and delivered by the
respective Borrower.

         2.06 PRO RATA PAYMENTS. Except as otherwise provided herein, (a) each
payment on account of the principal of and interest on the Syndicated Loans and
the fees described in Section 2.10 hereof shall be made to the Administrative
Agent for the account of the Lenders pro rata based on their Applicable
Commitment Percentages, (b) all payments to be made by the Borrowers for the
account of each of the Lenders on account of principal, interest and fees, shall
be made without set-off or counterclaim, and (c) the Administrative Agent will
promptly distribute payments received to the Lenders. Notwithstanding the
foregoing, in the event any Lender shall not be able to make a Fixed Rate Loan
as provided in Section 4.05, interest shall be allocated to each Lender
according to the interest rate payable to such Lender.

                                       33

<PAGE>

         2.07 REDUCTIONS. The Borrowers shall, by notice from an Authorized
Representative, have the right from time to time (but not more frequently than
once during each fiscal quarter), upon not less than five (5) Business Days
written notice to the Administrative Agent to reduce the Total Revolving Credit
Commitment. The Administrative Agent shall give each Lender, within one (1)
Business Day, telephonic notice (confirmed in writing) of such reduction. Each
such reduction shall be in the aggregate amount of $1,000,000 or such greater
amount which is in an integral multiple of $1,000,000, and shall permanently
reduce the Total Revolving Credit Commitment of the Lenders pro rata. No such
reduction shall result in the payment of any Fixed Rate Loan other than on the
last day of the Interest Period of such Loan unless such prepayment is
accompanied by amounts due, if any, under Section 4.04. Each reduction of the
Total Revolving Credit Commitment shall be accompanied by payment of the Notes
to the extent that the sum of the outstanding Loans and the Outstanding Letters
of Credit exceeds the Available Revolving Credit Commitment, after giving effect
to such reduction, together with accrued and unpaid interest on the amounts
prepaid.

         2.08 DECREASE IN AMOUNTS. The amount of the Available Revolving Credit
Commitment which shall be available to the Borrowers shall be reduced by the
aggregate amount of all Outstanding Letters of Credit, outstanding amounts of
Swing Line Loans and Competitive Bid Loans and the Revolving Credit Debit
Balance immediately preceding the making of any Advance.

         2.09 CONVERSIONS AND ELECTIONS OF SUBSEQUENT INTEREST PERIODS. Provided
that no Default or Event of Default shall have occurred and be continuing and
subject to the limitations set forth below and in Sections 4.01(b), 4.02 and
4.03 hereof, the Borrowers may:

         (a)  upon notice to the Administrative Agent on or before 11:00 A.M.
Charlotte, North Carolina time on any Business Day convert all or a part of
Fixed Rate Loans (other than a Competitive Bid Loan) to Floating Rate Loans on
the last day of the Interest Period for such Fixed Rate Loans;

         (b)  on three (3) LIBOR Business Days' notice in the case of a Dollar
Loan and four (4) LIBOR Business Days' notice in the case of an Alternative
Currency Loan to the Administrative Agent on or before 11:00 A.M. Charlotte,
North Carolina time:

            (i)  elect a subsequent Interest Period for all or a portion of 
         Fixed Rate Loans (other than Competitive Bid Loans) of Dollars or any
         Alternative Currency to begin in the same currency on the last day of
         the current Interest Period for such Fixed Rate Loans;

           (ii)  elect that any Fixed Rate Loan (other than Competitive Bid
         Loans) be converted from Dollars or an

                                       34

<PAGE>

         Alternative Currency into another Dollar denominated Loan or
         Alternative Currency Loan of the same Alternative Currency,
         respectively, on the last day of the Interest Period for such Fixed
         Rate Loan;

          (iii)  convert Floating Rate Loans to Fixed Rate Loans (other than
         Competitive Bid Loans) on any Business Day, or LIBOR Business Day, 
         as applicable.

         Notice of any such elections or conversions shall specify the effective
date of such election or conversion and the Interest Period to be applicable to
the Loan as continued or converted. Each election and conversion pursuant to
this Section 2.09 shall be subject to the limitations on Fixed Rate Loans set
forth in the definition of "Interest Period" herein and in Section 2.01 and
Article IV hereof. All such continuations or conversions of Loans shall be
effected pro rata based on the Applicable Commitment Percentages of the Lenders.

         2.10 UNUSED FEE. For the period beginning on the Closing Date and
ending on the Revolving Credit Termination Date (or such earlier date on which
the Revolving Credit Facility has terminated), IVAX agrees to pay to the
Administrative Agent, for the pro rata benefit of the Lenders based on their
Applicable Commitment Percentages, an unused fee equal to the Applicable Margin
times the sum of the daily amount by which the Total Revolving Credit Commitment
exceeds the sum of average daily (i) Revolving Credit Debit Balance and (ii)
Outstanding Letters of Credit. Swing Line Loans and Competitive Bid Loans shall
not be outstanding Loans for purposes of determining such fee. Such payments of
fees provided for in this Section shall be due in arrears on the last Business
Day of each December, March, June and September beginning June 30, 1996 to and
on the Revolving Credit Termination Date. Notwithstanding the foregoing, so long
as any Lender fails to make available any portion of its Revolving Credit
Commitment when requested, such Lender shall not be entitled to receive payment
of its pro rata share of such fee until such Lender shall make available such
portion. Such fee shall be calculated on the basis of a year of 360 days for the
actual number of days elapsed.

         2.11 DEFICIENCY ADVANCES. No Lender shall be responsible for any
default of any other Lender in respect to such other Lender's obligation to make
any Loan hereunder nor shall the Revolving Credit Commitment of any Lender
hereunder be increased as a result of such default of any other Lender. Without
limiting the generality of the foregoing, in the event any Lender shall fail to
advance funds to a Borrower as herein provided, the Administrative Agent may in
its discretion, but shall not be obligated to, advance under the applicable Note
in its favor as a Lender all or any portion of such amount or amounts (each, a
"deficiency advance") and shall thereafter be entitled to payments of principal
of and interest on such deficiency advance in the same manner and at the

                                       35

<PAGE>

same interest rate or rates to which such other Lender would have been entitled
had it made such advance under its applicable Note; provided that, upon payment
to the Administrative Agent from such other Lender of the entire outstanding
amount of each such deficiency advance, together with accrued and unpaid
interest thereon, from the most recent date or dates interest was paid to the
Administrative Agent by the applicable Borrower on each Loan comprising the
deficiency advance at the interest rate per annum for overnight borrowing by the
Administrative Agent from the Federal Reserve Bank, then such payment shall be
credited against the applicable Note of the Administrative Agent in full payment
of such deficiency advance and the applicable Borrower shall be deemed to have
borrowed the amount of such deficiency advance from such other Lender as of the
most recent date or dates, as the case may be, upon which any payments of
interest were made by such Borrower thereon.

         2.12  ADJUSTMENTS BY ADMINISTRATIVE AGENT. Notwithstanding the
construction of "pro rata" to mean based on the Applicable Percentage
Commitments and any provisions contained herein for the advancement of funds or
distribution of payments on a pro rata basis, the Administrative Agent may, in
its discretion, but shall not be obligated to, adjust downward or upward (but
not in excess of any applicable Revolving Credit Commitment) the principal
amount of any Loan to be made by any Lender to the nearest amount which is
evenly divisible by $100, and make appropriate related adjustment in the
distribution of payments of principal and interest on the Loans.

         2.13  USE OF PROCEEDS. The proceeds of the Loans made pursuant to the
Revolving Credit Facility hereunder shall be used by the Borrowers to repay
existing Indebtedness to any or all of the Lenders and Indebtedness assumed in
connection with any Permitted Acquisition, to redeem the outstanding Senior
Notes, to finance Capital Expenditures and Permitted Acquisitions and for other
working capital and general corporate needs of the Borrowers and their
Subsidiaries, to the extent permitted under this Agreement.

         2.14  EXTENSION OF REVOLVING CREDIT TERMINATION DATE. At the request 
of the Borrowers the Lenders may, in their sole discretion, elect to extend the
Revolving Credit Termination Date then in effect for up to two additional
periods of one year each. The Borrowers shall notify the Lenders of their
request for such an extension by delivering to the Administrative Agent notice
of such request signed by an Authorized Representative not more than one hundred
and twenty (120) days nor less than sixty (60) days prior to either or both of
the third or fourth anniversary of the Closing Date. If all Lenders shall elect
to so extend, the Administrative Agent shall notify the Borrowers in writing
within sixty (60) days of its receipt of such request for extension of the
decision of the Lenders of whether to extend the Revolving Credit Termination
Date. Failure by the Administrative Agent to give such notice shall

                                       36

<PAGE>

constitute refusal by the Lenders to extend the Revolving Credit Termination
Date.

         2.15 SWING LINE. Notwithstanding any other provision of any other
Section of this Agreement to the contrary, in order to administer the Revolving
Credit Facility in an efficient manner and to minimize the transfer of funds
between the Administrative Agent and the Lenders, NationsBank shall make
available Swing Line Loans to IVAX in Dollars prior to the Revolving Credit
Termination Date. NationsBank shall not make any Swing Line Loan pursuant hereto
(i) if the Borrowers are not in compliance with all the conditions to the making
of Loans set forth in this Agreement, (ii) if after giving effect to such Swing
Line Loan, the Swing Line Loans outstanding exceed $20,000,000, or (iii) if
after giving effect to such Swing Line Loan, the sum of the outstanding Loans
and the Outstanding Letters of Credit exceeds the Available Revolving Credit
Commitment. Loans made pursuant to this Section 2.15 shall be limited to Loans
bearing interest at the Federal Funds Effective Rate PLUS the Applicable Margin.

            (i)  IVAX may borrow, repay and reborrow under this Section 2.15. 
         Borrowings under the Swing Line may be made in amounts of $500,000 and
         multiples of $100,000 in excess thereof, with a minimum outstanding
         amount at all times of $500,000, upon telephonic (confirmed in writing)
         or telefacsimile request by an authorized officer of IVAX made to
         NationsBank not later than 12:00 noon Charlotte, North Carolina time on
         the Business Day of the requested borrowing. Each repayment of a Swing
         Line Loan shall be in integral multiples of $100,000 with a minimum
         amount of $100,000.

           (ii)  If IVAX instructs NationsBank to debit its demand deposit
         account in an amount of any payment with respect to a Swing Line Loan,
         or NationsBank otherwise receives repayment after 2:00 P.M. Charlotte,
         North Carolina time, on a Business Day, such payment shall be deemed
         received on the next Business Day. The Borrower shall pay interest on
         Swing Line Loans on the last Business Day of each quarter, commencing
         June 30, 1996 and continuing on each September, December, March and
         June thereafter. Interest shall be calculated on the basis of a year of
         360 days and calculated for the actual number of days elapsed.

          (iii)  The Borrowers and each Lender which is or may become a party 
         hereto acknowledge that all Swing Line Loans are to be made solely by
         NationsBank to IVAX but that such Lender shall share the risk of loss
         with respect to such Advances in an amount equal to such Lender's
         Applicable Commitment Percentage of such Swing Line Loan. Upon demand
         according to its Applicable Commitment Percentage of such Swing Line
         Loan, each Lender shall promptly provide to NationsBank its purchase
         price therefor in an amount equal to its Participation therein, in
         which case such Swing Line Loan shall be deemed

                                       37

<PAGE>

         from and after such date (to the extent IVAX has not converted such
         loan pursuant to Section 2.09) a Syndicated Loan made in accordance
         with the Agreement. The obligation of each Lender to so provide its
         purchase price to NationsBank shall be absolute and unconditional and
         shall not be affected by the occurrence of an Event of Default or any
         other occurrence or event.

           (iv)  IVAX at its option may request an Advance as a Loan pursuant 
         to Section 2.01 in an amount sufficient to repay any or all Swing Line
         Loans on any date and the Administrative Agent shall upon the receipt
         of such Advance, provide to NationsBank the amount necessary to repay
         such Swing Line Loan or Loans (which NationsBank shall then apply to
         such repayment) and credit any balance of the Loan in immediately
         available funds to an account of IVAX at the Principal Office or as
         otherwise directed by IVAX. The proceeds of such Advances shall be paid
         to NationsBank for application to the outstanding Swing Line Loans and
         the Lenders shall then be deemed to have made Loans in the amount of
         such Advances. The obligation of NationsBank to fund the Swing Line
         shall cease upon the earlier of (i) the occurrence of a Default, or
         (ii) the Revolving Credit Termination Date; provided that when a
         Default is no longer continuing NationsBank shall be obligated to
         provide Swing Line Loans unless payment of the Obligations has been
         accelerated.

                                       38

<PAGE>
                                   ARTICLE III

                                LETTERS OF CREDIT

         3.01 LETTERS OF CREDIT. (a) The Issuer agrees, subject to the terms and
conditions of this Agreement, upon request of either Borrower to issue from time
to time for the account of such Borrower Letters of Credit upon delivery to the
Issuer of an Application and Agreement for Letter of Credit in form and content
acceptable to such Lender; PROVIDED, that the Outstanding Letters of Credit
shall not exceed the Total Letter of Credit Commitment. No Letter of Credit
shall be issued by the Issuer with an expiry date or payment date (i) of more
than three years or (ii) occurring subsequent to the fifth Business Day
preceding the Revolving Credit Termination Date. The Issuer shall not be
permitted to issue any Letter of Credit if the Outstanding Letters of Credit
when added to the face amount of any requested Letter of Credit and the
outstanding amounts of Loans exceeds the Available Revolving Credit Commitment.
Further, the Issuer shall not issue any Letter of Credit for the benefit of NHL
if NHL's outstanding Loans, when added to the Outstanding Letters of Credit for
the account of NHL and the face amount of any Letter of Credit requested by NHL
exceeds the NHL Sublimit. The Issuer shall furnish the Administrative Agent at
the time of issuance of such Letter of Credit a telefacsimile copy of such
Letter of Credit. In addition, the Issuer shall give the Administrative Agent
telephonic notice of the amount of a Letter of Credit prior to issuing a Letter
of Credit.

         (b)  Subject to the approval by the Lenders of the making available of 
an Alternative Currency not otherwise provided for herein, upon completion of a
proper Application and Agreement for Letter of Credit, the Issuer may issue upon
request and for the account of either Borrower Letters of Credit payable in such
Alternative Currency. For purposes of determining Outstanding Letters of Credit,
any Letter of Credit issued in an Alternative Currency shall be recorded in the
Administrative Agent's account in Dollars based on the Alternative Currency
Equivalent Amount on the date of issuance of such Letter of Credit. Any draw on
a Letter of Credit issued in an Alternative Currency shall be repaid in the same
Alternative Currency and in the Alternative Currency Equivalent Amount
(determined based on the Spot Rate of Exchange on the date of drawing under the
Letter of Credit). To the extent that the Administrative Agent shall determine
at any time that the sum of (i) the Dollar Value of outstanding Loans and
Outstanding Letters of Credit made or issued in Alternative Currencies and (ii)
outstanding Loans and Outstanding Letters of Credit made or issued in Dollars
exceeds the Available Revolving Credit Commitment, the Borrowers shall
immediately repay Loans so that after giving effect to such payment the
outstanding Loans plus Outstanding Letters of Credit do not exceed the Available
Revolving Credit Commitment. The Administrative Agent shall determine the

                                       39

<PAGE>



Dollar Value of Outstanding Letters of Credit made or issued in Alternative
Currencies monthly.

         3.02  REIMBURSEMENT.

               (a)  The Borrowers hereby unconditionally agree immediately to
pay to the Issuer on demand at the Lending Office of the Issuer all amounts
required to pay all drafts drawn under the Letters of Credit issued by the
Issuer to such Borrower and all reasonable expenses incurred by the
Administrative Agent and/or such Issuers in connection with the Letters of
Credit and in any event to place in possession of the Issuer (which shall
include Advances under the Revolving Credit Facility if permitted by Section
2.01(b) hereof) sufficient funds to pay all debts and liabilities arising under
any Letters of Credit issued by such Issuer. The Issuer shall give the Borrowers
prompt notice of its charging of any account of either Borrower for amounts due
to such Issuer hereunder. The Borrowers' obligations to pay the Issuer under
this Section 3.02, and each Issuer's right to receive the same, shall be
absolute and unconditional and shall not be affected by any circumstance
whatsoever. The Issuer agrees to give the Borrowers prompt notice of any request
for a draw under a Letter of Credit. The Issuer may charge any account the
Borrowers may have with it for any and all amounts the Issuer pays under a
Letter of Credit, plus charges and reasonable expenses as from time to time
agreed to by the Issuer and the Borrower; provided that to the extent permitted
by Section 2.01(b)(vii), amounts shall be paid pursuant to Advances under the
Revolving Credit Facility prior to charging any account of the Borrowers for
amounts paid under Letters of Credit. The Borrowers agree that the Issuer may,
in its sole discretion, accept or pay, as complying with the terms of any Letter
of Credit, any drafts or other documents otherwise in order on their face which
may be signed or issued purportedly by an administrator, executor, trustee in
bankruptcy, debtor in possession, assignee for the benefit of creditors,
liquidator, receiver, attorney in fact or other legal representative of a party
who is authorized under such Letter of Credit to draw or issue any drafts or
other documents. The Borrowers agree to pay the Issuer interest on any amounts
not paid when due hereunder at the Floating Rate plus two percent (2%), or the
maximum rate permitted by applicable law, if lower.

               (b) In accordance with the provisions of Section 2.01(b)(vii) 
hereof, the Issuer shall notify the Administrative Agent (and shall also notify
the Borrowers) of any drawing under any Letter of Credit as promptly as
practicable following the receipt by the Issuer of such drawing.

               (c) Each Lender (other than the Issuer) shall automatically 
acquire on the date of issuance thereof, a Participation in the liability of the
Issuer in respect of each Letter of Credit issued by it in an amount equal to
such Lender's Applicable Commitment Percentage of such liability, and to the

                                       40

<PAGE>

extent that Borrower is obligated to pay the Issuer under Section 3.02(a), each
Lender (other than the Issuer) thereby shall absolutely, unconditionally and
irrevocably assume, and shall be unconditionally obligated to pay to the Issuer
as hereinafter described, its Applicable Commitment Percentage of the liability
of the Issuer under such Letter of Credit. Prior to the Revolving Credit
Termination Date, each Lender (including the Issuer in its capacity as a Lender)
shall, subject to the terms and conditions of Article II, make a Floating Rate
Loan to the Borrowers by paying to the Administrative Agent for the account of
the Issuer at the Principal Office in Dollars and in immediately available
funds, an amount equal to its Applicable Commitment Percentage of any drawing
under a Letter of Credit, all as described and pursuant to Section 2.01(b)(vii).
With respect to drawings under any of the Letters of Credit, each Lender, upon
receipt from the Administrative Agent of notice of a drawing in the manner
described in Section 2.01(b)(vii), shall promptly pay to the Administrative
Agent for the account of the Issuer, prior to the applicable time set forth in
Section 2.01(b)(vii), its Applicable Commitment Percentage of such drawing.
Simultaneously with the making of each such payment by a Lender to the
Administrative Agent for the account of such Issuer, such Lender shall,
automatically and without any further action on the part of such Issuer or such
Lender, acquire a Participation in an amount equal to such payment (excluding
the portion thereof constituting interest) in the related Reimbursement
Obligation of the applicable Borrower. The Reimbursement Obligations of the
Borrowers shall be immediately due and payable whether by Advances made in
accordance with Section 2.01(b)(vii) or otherwise. Each Lender's obligation to
make payment to the Administrative Agent for the account of an Issuer pursuant
to this Section 3.02(c), and the right of the Issuer to receive the same, shall
be absolute and unconditional, shall not be affected by any circumstance
whatsoever and shall be made without any offset, abatement, withholding or
reduction whatsoever. If any Lender is obligated to pay but does not pay amounts
to the Administrative Agent for the account of an Issuer in full upon such
request as required by this Section 3.02(c), such Lender shall, on demand, pay
to the Administrative Agent for the account of the Issuer interest on the unpaid
amount for each day during the period commencing on the date of notice given to
such Lender pursuant to Section 2.01(b)(vii) until such Lender pays such amount
to the Administrative Agent for the account of the Issuer in full at the
interest rate per annum for overnight borrowing by the Issuer from the Federal
Reserve Bank. In the event any Lender shall fail to make a Floating Rate Loan as
provided herein (a "Defaulting Lender"), the Borrowers may cause such Defaulting
Lender to be replaced by a financial institution reasonably acceptable to the
Administrative Agent. Any such Defaulting Lender agrees to execute and deliver
to the Administrative Agent an Assignment and Acceptance as provided in Section
12.01 hereof upon payment of all amounts owed hereunder to such Defaulting
Lender.

                                       41

<PAGE>

               (d)  Promptly following the end of each calendar quarter, the 
Issuer shall deliver to the Administrative Agent, and the Administrative Agent
shall deliver to each Lender, a notice describing the aggregate undrawn amount
of all Letters of Credit at the end of such quarter. Upon the request of any
Lender from time to time, the Issuer shall deliver to the Administrative Agent,
and the Administrative Agent shall deliver to such Lender, any other information
reasonably requested by such Lender with respect to each Outstanding Letter of
Credit.

               (e)  The issuance by the Issuer of each Letter of Credit shall,
in addition to the conditions precedent set forth in Section 6.01 hereof, be
subject to the conditions that such Letter of Credit be in such form and contain
such terms as shall be reasonably satisfactory to the Issuer thereof consistent
with the then current practices and procedures of such Issuer with respect to
similar letters of credit, and the applicable Borrower shall have executed and
delivered such other instruments and agreements relating to such Letters of
Credit as the Issuer shall have reasonably requested consistent with such
practices and procedures. All Letters of Credit shall be issued pursuant to and
subject to the Uniform Customs and Practice for Documentary Credits, 1993
revision, International Chamber of Commerce Publication No. 500 and all
subsequent amendments and revisions thereto. Any Borrower requesting the
issuance of a Letter of Credit shall furnish the Issuer an Application and
Agreements for Letter of Credit not later than 10:00 A.M. Charlotte, North
Carolina time on the date of the proposed issuance of such Letter of Credit. If
such application is received after 10:00 A.M. Charlotte, North Carolina time,
the Letter of Credit shall be issued on the next following Business Day.

               (f)  Without duplication of Section 12.07 hereof, the Borrowers
hereby agree to indemnify and hold harmless the Issuer, each other Lender and
the Administrative Agent from and against any and all claims and damages,
losses, liabilities, reasonable costs and expenses which such Issuer, such other
Lender or the Administrative Agent may incur (or which may be claimed against
the Issuer, such other Lender or the Administrative Agent) by any Person by
reason of or in connection with the issuance or transfer of or payment or
failure to pay under any Letter of Credit; provided that the Borrowers shall not
be required to indemnify an Issuer, any other Lender or the Administrative Agent
for any claims, damages, losses, liabilities, costs or expenses to the extent,
but only to the extent, (i) caused by the willful misconduct or gross negligence
of the party to be indemnified or (ii) caused by the failure of the Issuer to
pay under any Letter of Credit after the presentation to it of a request
strictly complying with the terms and conditions of such Letter of Credit,
unless such payment or reimbursement is prohibited by any governmental
authority, law, regulation, court order or decree.

                                       42

<PAGE>

               (g)  Without limiting Borrowers' rights as set forth in Section
3.02(f) above, the obligation of the Borrowers to immediately reimburse an
Issuer or the Administrative Agent for drawings made under Letters of Credit
shall be absolute, unconditional and irrevocable, and shall be performed
strictly in accordance with the terms of this Agreement and such Letters of
Credit and the related applications for any Letter of Credit, under all
circumstances whatsoever, including, without limitation, the following
circumstances:

                  (i)  any lack of validity or enforceability of the Letter of 
Credit, the obligation supported by the Letter of Credit or any other agreement
or instrument relating thereto (collectively, the "Related Documents");

                 (ii)  any amendment or waiver of or any consent to or
departure from all or any of the Related Documents;

                (iii)  the existence of any claim, setoff, defense (other than
the defense of payment in accordance with the terms of this Agreement) or other
rights which a Borrower may have at any time against any beneficiary or any
transferee of a Letter of Credit (or any persons or entities for whom any such
beneficiary or any such transferee may be acting), Administrative Agent, Lenders
or any other person or entity, whether in connection with the Loan Documents,
the Related Documents or any unrelated transaction;

                 (iv)  any breach of contract or other dispute between a 
Borrower and any beneficiary or any transferee of a Letter of Credit (or any
persons or entities for whom such beneficiary or any such transferee may be
acting), Administrative Agent, Lenders or any other Person;

                  (v)  any draft, statement or any other document presented
under the Letter of Credit proving to be forged, fraudulent, invalid or
insufficient in any respect or any statement therein being untrue or inaccurate
in any respect whatsoever;

                 (vi)  any delay, extension of time, renewal, compromise or 
other indulgence or modification granted or agreed to by the Administrative
Agent, with or without notice to or approval by the Borrowers in respect of any
of Borrowers' Obligations under this Agreement; or

                (vii)  any other circumstance or happening whatsoever, whether
or not similar to any of the foregoing; 

provided, however, that nothing contained herein shall be deemed to release an
Issuer or any other Lender of any liability for actual loss arising as a result
of its gross negligence or willful misconduct or out of the wrongful dishonor by
the Issuer of a proper demand for payment made under and strictly complying with
the terms of any Letter of Credit.

                                       43

<PAGE>

         3.03  LETTER OF CREDIT FRONTING FEE. The Borrowers agree to pay to the
Issuer a fee on the aggregate amount available to be drawn on each Outstanding
Letter of Credit at a rate equal to 10 basis points per annum times the
aggregate amount available to be drawn on each Outstanding Letter of Credit. In
addition the Borrowers shall pay to the Administrative Agent for the benefit of
the Lenders on the last Business Day of each quarter a letter of credit fee
based on their Applicable Commitment Percentages equal to the Applicable Margin
times the average daily aggregate Outstanding Letters of Credit during such
quarter. Such payment of fees provided for in this Section 3.03 shall be due
with respect to each outstanding Letter of Credit quarterly in arrears on the
last Business Day of each December, March, June and September and on the
Revolving Credit Termination Date. Such fee shall be calculated on the basis of
a year of 360 days for the actual number of days elapsed.

         3.04  ADMINISTRATIVE FEES AND RESERVES. The Borrowers shall pay to the
Issuer such administrative fee in connection with the Letters of Credit in such
amounts and at such times as such Issuer and the Borrowers shall agree from time
to time and shall pay to the Issuer the customary issuance, amendment and
renewal fees.

                                       44

<PAGE>

                                   ARTICLE IV

                         YIELD PROTECTION AND ILLEGALITY

         4.01  ADDITIONAL COSTS. (a) The Borrowers shall promptly pay to the
Administrative Agent for the account of a Lender from time to time, without
duplication, such amounts as such Lender may determine to be necessary to
compensate it for any costs incurred by such Lender which it determines are
attributable to its making or maintaining any Loan, whether in Dollars or other
Alternate Currency, or its obligation to make any Loans, or the issuance or
maintenance by an Issuer of or such Lender's Participation in any Letter of
Credit issued hereunder, or any reduction in any amount receivable by such
Lender under this Agreement, the Notes or the Letters of Credit in respect of
any of such Loans or such obligation or the Letters of Credit, including
reductions in the rate of return on a Lender's capital (such increases in costs
and reductions in amounts receivable and returns being herein called "Additional
Costs"), resulting from any Regulatory Change which: (i) changes the basis of
taxation of any amounts payable to such Lender under this Agreement or the Notes
in respect of any of such Loans or Letters of Credit (other than taxes imposed
on or measured by the income, revenues or assets); or (ii) imposes or modifies
any reserve, special deposit, or similar requirements relating to any extensions
of credit or other assets of, or any deposits with or other liabilities of, such
Lender (other than any such reserve, deposit or requirement reflected in the
Prime Rate, the Federal Funds Effective Rate, the Applicable Rate, the Absolute
Rate or the LIBOR Rate, in each case computed in accordance with the respective
definitions of such terms set forth in Section 1.01 hereof); or (iii) has or
would have the effect of reducing the rate of return on capital of any such
Lender and the parent corporation of such Lender to a level below that which the
Lender could have achieved but for such Regulatory Change (taking into
consideration such Lender's policies with respect to capital adequacy); or (iv)
imposes any other condition adversely affecting the Administrative Agent or the
Lenders under this Agreement, the Notes or the issuance or maintenance of, or
any Lender's Participation in, the Letters of Credit (or any of such extensions
of credit or liabilities). Each Lender will notify the Borrowers and the
Administrative Agent of any event occurring after the Closing Date which would
entitle it to compensation pursuant to this Section 4.01(a) as promptly as
practicable after it obtains knowledge thereof and determines to request such
compensation.

         (b)  Without limiting the effect of the foregoing provisions of
this Section 4.01, in the event that, by reason of any Regulatory Change, any
Lender either (i) incurs Additional Costs based on or measured by the excess
above a specified level of the amount of a category of deposits or other
liabilities of the Lender which includes deposits by reference to which the
interest rate on Fixed Rate Loans is determined as provided in this Agreement or
a category of extensions of credit or other assets of any Lender

                                       45

<PAGE>

which includes Fixed Rate Loans or (ii) becomes subject to restrictions on the
amount of such a category of liabilities or assets which it may hold, then, if
the Lender so elects by notice to the other Lenders and the Borrowers, the
obligation hereunder of such Lender to make, and to convert Floating Rate Loans
into, Fixed Rate Loans that are the subject of such restrictions shall be
suspended until the date such Regulatory Change ceases to be in effect and the
Borrowers shall, on the last day(s) of the then current Interest Period(s) for
outstanding Fixed Rate Loans convert such Fixed Rate Loans into Floating Rate
Loans; PROVIDED, HOWEVER, that the suspension of such obligation and the
conversion of any Fixed Rate Loans into Floating Rate Loans shall apply only to
any Lender who is affected by such restrictions and who has provided such notice
to the other Lenders, and the obligation of the other Lenders to make, and to
convert Floating Rate Loans into, Fixed Rate Loans shall not be affected by such
restrictions. In the event that the obligation of some, but not all of the
Lenders to make, or to convert Floating Rate Loans into, Fixed Rate Loans is
suspended, then any request by the Borrower during the pendency of such
suspension for a Fixed Rate Loan shall be deemed a request for such Fixed Rate
Loan from the Lender(s) not subject to such suspension and for a Floating Rate
Loan from the Lender(s) who are subject to such suspension, in each case in the
respective amounts based on the Lenders' respective Revolving Credit
Commitments.

         (c)  Determinations by any Lender for purposes of this Section 4.01 of 
the effect of any Regulatory Change on its costs of making or maintaining, or
being committed to make, Loans or by any Lender as issuer of any Letter of
Credit of the effect of any Regulatory Change on its costs in connection with
the issuance or maintenance of, or any other Lender's Participation in, any
Letter of Credit issued hereunder, or on amounts receivable by any Lender in
respect of Loans or Letters of Credit, and of the additional amounts required to
compensate the Lender in respect of any Additional Costs, shall be conclusive
absent manifest error, provided that such determinations are made on a
reasonable basis taking into account such Lender's reasonable policies as to the
allocation of capital, costs and other items. The Lender requesting such
compensation shall furnish to the Authorized Representatives and the
Administrative Agent within one hundred and eighty (180) days of the incurrence
of any Additional Costs for which compensation is sought an explanation of the
Regulatory Change and calculations, in reasonable detail, setting forth such
Lender's determination of any such Additional Costs.

         4.02  SUSPENSION OF LOANS. Anything herein to the contrary
notwithstanding, if, on or prior to the determination of any interest rate for
any Fixed Rate Loan for any Interest Period, the Administrative Agent determines
(which determination made on a reasonable basis shall be conclusive absent
manifest error) that:

               (a) quotations of interest rates for the relevant deposits 
         referred to in the definition of "Base Rate" in

                                       46

<PAGE>

         Section 1.01 hereof or foreign exchange agreements or contracts with
         respect to an Alternative Currency are not being provided in the
         relevant amounts or for the relevant maturities for purposes of
         determining the rate of interest for such Fixed Rate Loan as provided
         in this Agreement; or

               (b) the relevant rates of interest referred to in the definition 
         of "Base Rate" in Section 1.01 hereof upon the basis of which the Fixed
         Rate for such Interest Period and applicable currency is to be
         determined do not adequately reflect the cost to the Lenders of making
         or maintaining such Fixed Rate Loan for such Interest Period or such
         Fixed Rate Loan (which determination shall be made on a reasonable
         basis by the Administrative Agent, and the Person making such
         determination shall furnish the Authorized Representative evidence of
         the facts leading to such determination);

then the Administrative Agent shall give the Authorized Representatives prompt
notice thereof, and so long as such condition remains in effect, the Lenders
shall be under no obligation to make Fixed Rate Loans that are subject to such
condition, or to convert Loans into Fixed Rate Loans that are subject to such
condition, and the Borrowers shall on the last day(s) of the then current
Interest Period(s) for outstanding Fixed Rate Loans of the type subject to such
condition, as applicable, convert such Fixed Rate Loans into a Fixed Rate Loan
if such Fixed Rate Loan is not subject to the same or similar condition, or
Floating Rate Loans, if available hereunder. The Administrative Agent shall give
the Authorized Representatives notice describing in reasonable detail any event
or condition described in this Section 4.02 promptly following the determination
by the Administrative Agent that the availability of Fixed Rate Loans is, or is
to be, suspended as a result thereof.

         4.03  ILLEGALITY. Notwithstanding any other provision of this 
Agreement, in the event that it becomes unlawful for any Lender to honor its
obligation to make or maintain Fixed Rate Loans hereunder, then such Lender
shall promptly notify the Administrative Agent and the Borrowers thereof and
such Lender's obligation to make or continue Fixed Rate Loans that are subject
to such condition, or convert Floating Rate Loans into Fixed Rate Loans that are
subject to such condition, shall be suspended until such time as such Lender may
again make and maintain Fixed Rate Loans, and such Lender's outstanding Fixed
Rate Loans of the type subject to such condition shall be converted into
Floating Rate Loans in accordance with Section 2.09 hereof.

         4.04  COMPENSATION. The Borrowers shall promptly pay to the
Administrative Agent for the benefit of each Lender, upon the request of such
Lender, such amount or amounts as shall be sufficient (in the reasonable
determination of Lender) to compensate it for any loss, cost or expense incurred
by it as a result of:

                                       47

<PAGE>




               (a) any payment, prepayments, conversion or required assignments 
         of a Fixed Rate Loan on a date other than the last day of the Interest
         Period for such Fixed Rate Loan, except for any conversion required
         pursuant to this Article IV; or

               (b) any failure by the Borrowers to borrow, continue or convert 
         into a Fixed Rate Loan on the date for such borrowing, continuation or
         conversion specified in the relevant Borrowing Notice under Article II
         hereof;

such compensation to include, without limitation, an amount equal to the excess,
if any, of (i) the amount of interest which would have accrued on the principal
amount so paid, prepaid or converted or not borrowed for the period from the
date of such payment, prepayment or conversion or failure to borrow or convert
to the last day of the then current Interest Period for such Loan (or, in the
case of a failure to borrow or convert, the Interest Period for such Loan which
would have commenced on the date scheduled for such borrowing or conversion) at
the applicable rate of interest for such Fixed Rate Loan provided for herein
over (ii) the Base Rate (as reasonably determined by the Administrative Agent)
for Dollar deposits, or the Alternative Currency, as the case may be, of amounts
comparable to such principal amount and maturities comparable to such period. In
addition, Borrowers shall pay to the Agent for the benefit of Lenders any costs
associated with the earlier termination of any foreign exchange agreements or
contracts associated with an Alternative Currency. A determination of a Lender
as to the amounts payable pursuant to this Section 4.04 shall be conclusive,
provided that such determinations are made on a reasonable basis. The Lender
requesting compensation under this Section 4.04 shall furnish to the Authorized
Representative and the Administrative Agent calculations in reasonable detail
setting forth such Lender's determination of the amount of such compensation.

         4.05  ALTERNATE LOAN AND LENDER. In the event any Lender suspends the
making of any Fixed Rate Loan pursuant to this Article IV (herein a "Restricted
Lender"), the Restricted Lender's Commitment Percentage of any Fixed Rate Loan
shall bear interest at either the Floating Rate or the Fixed Rate for which the
suspension does not apply, as selected by the applicable Borrower, until the
Restricted Lender once again makes available the applicable Fixed Rate Loan.
Notwithstanding the provisions of Section 2.02(b), interest shall be payable to
the Restricted Lender at the time and manner as paid to those Lenders making
available Fixed Rate Loans.

         4.06  TAXES. All payments by the Borrowers of principal of, and 
interest on, the Loans and all other amounts payable hereunder shall be made
free and clear of and without deduction for any present or future excise, stamp
or other taxes, fees, duties, levies, imposts, charges, deductions, withholdings
or other charges of any nature whatsoever imposed by any taxing authority, but
excluding (i) franchise taxes, (ii) any taxes (other than

                                       48

<PAGE>

withholding taxes) that would not be imposed but for a connection between a
Lender or the Administrative Agent and the jurisdiction imposing such taxes
(other than a connection arising solely by virtue of the activities of such
Lender or the Administrative Agent pursuant to or in respect of this Agreement
or any other Loan Document), (iii) any taxes imposed on or measured by any
Lender's assets, net income, receipts or branch profits and (iv) any taxes
arising after the Closing Date solely as a result of or attributable to Lender
changing its designated lending office after the date such Lender becomes a
party hereto (such non-excluded items being collectively called "Taxes"). In the
event that any withholding or deduction from any payment to be made by the
Borrowers hereunder is required in respect of any Taxes pursuant to any
applicable law, rule or regulation, then the Borrowers will

               (a)  pay directly to the relevant authority the full amount 
         required to be so withheld or deducted;

               (b)  promptly forward to the Administrative Agent an official 
         receipt or other documentation satisfactory to the Administrative Agent
         evidencing such payment to such authority; and

               (c)  pay to the Administrative Agent for the account of the 
         Lender such additional amount or amounts as is necessary to ensure that
         the net amount actually received by each Lender will equal the full
         amount such Lender would have received had no such withholding or
         deduction been required.

         Prior to the date that any Lender or participant organized under the
laws of a jurisdiction outside the United States becomes a party hereto, such
Person shall deliver to the Borrowers and the Administrative Agent such
certificates, documents or other evidence, as required by the Code or Treasury
Regulations issued pursuant thereto, properly completed, currently effective and
duly executed by such Lender or participant establishing that such payment is
(i) not subject to United States Federal backup withholding tax and (ii) not
subject to United States Federal withholding tax under the Code because such
payment is either effectively connected with the conduct by such Lender or
participant of a trade or business in the United States or totally exempt from
United States Federal withholding tax by reason of the application of the
provisions of a treaty to which the United States is a party or such Lender is
otherwise exempt.

         If the Borrowers fail to pay any Taxes when due to the appropriate
taxing authority or fail to remit to the Administrative Agent, for the account
of the respective Lender, the required receipts or other required documentary
evidence, the Borrowers shall indemnify the Lenders for any incremental Taxes,
interest or penalties that may become payable by any Lender as a result of any
such failure. For purposes of this Section 4.06, a distribution

                                       49

<PAGE>

hereunder by the Administrative Agent or any Lender to or for the account of any
Lender shall be deemed a payment by the Borrowers.

         4.07  RESTRICTED LENDER. In the event any Restricted Lender seeks
additional compensation pursuant to this Article IV or is restricted from making
any Fixed Rate Loan under this Agreement, the Borrowers may cause such
Restricted Lender to be replaced by a financial institution reasonably
acceptable to the Administrative Agent which is not similarly restricted and
will not seek such additional compensation. Such Restricted Lender agrees to
execute and to deliver to the Administrative Agent an Assignment and Acceptance
as provided in Section 12.01 hereof upon payment of all amounts owed under this
Agreement to such Restricted Lender.

         4.08  FUNDING. In the event the Borrowers elect to obtain any Loans as
Fixed Rate Loans pursuant to Section 2.01, or elect to continue any Fixed Rate
Loans or convert any portion of the principal amount of any Floating Rate Loans
to Fixed Rate Loans pursuant to Section 2.09, each Lender may, if it so elects,
fulfill its obligation to make or continue any portion of the principal amount
of any Loan as, or to convert any portion of the principal amount of any Loan
into, a Fixed Rate Loan in accordance with any election made by the Borrowers by
causing a foreign branch or Affiliate of such Lender or an international banking
facility created by such Lender to make such Fixed Rate Loan; provided that in
such event such Fixed Rate Loan shall be deemed to have been made by such
Lender, and the obligation of the Borrowers to repay such Fixed Rate Loan shall
nevertheless be to such Lender and shall be deemed to be held by such Lender, to
the extent of such Fixed Rate Loan, for the account of such foreign branch,
Affiliate or international banking facility. In addition, the Borrowers hereby
consent and agree that, for purposes of any determination to be made for
purposes of this Agreement (including Sections 4.01, 4.02, 4.03 and 4.04), it
shall be conclusively assumed that each Lender elected to fund all Fixed Rate
Loans by purchasing Dollar or Alternative Currency deposits, as the case may be,
in its eurodollar office's interbank eurodollar market.

                                       50

<PAGE>

                                    ARTICLE V

                                    ONE LOAN

         5.01  ONE LOAN. All Loans and Advances by the Lenders to Borrowers 
under this Agreement and the Obligations shall constitute a general obligation
of IVAX. Notwithstanding anything contained herein to the contrary, the
Obligations of NHL shall in no event exceed the NHL Sublimit plus interest
thereon and any amounts payable by reason of a foreign currency fluctuation
causing the obligations of NHL to exceed the NHL Sublimit. The Administrative
Agent will maintain a single loan account for Advances to the Borrowers,
however, NHL shall be liable to the Lenders only for the amount of Advances made
to it and interest accrued thereon.

         5.02  GUARANTY. IVAX guarantees to the Lenders the payment in full of
all of the Obligations of NHL to the Lenders when and as due and further
guarantees the due performance by NHL of its duties and covenants made in favor
of the Lenders hereunder when and as due. IVAX agrees that its liability shall
not be impaired or affected by any modification, supplement, extension or
amendment of any contract or agreement to which the parties thereto may
hereafter agree, nor by any delay, extension of time, renewal, compromise or
other indulgence granted by the Lenders with respect to any of the Obligations
of NHL, nor by any other agreements or arrangements whatever with NHL, IVAX
hereby waiving all notice of any such delay, extension, release, substitution,
renewal, compromise or other indulgence, and hereby consenting to be bound
thereby as fully and effectually as if it had expressly agreed thereto in
advance. The liability of IVAX hereunder is direct and unconditional as to all
of the Obligations hereunder, and may be enforced without requiring the Lenders
first to resort to any other right, remedy or security; IVAX shall not have any
right of subrogation, reimbursement or indemnity whatsoever, nor any right of
recourse to security for any of the Obligations hereunder, unless and until all
of said Obligations have been paid in full; nothing shall discharge or satisfy
the liability of IVAX hereunder except the full payment and performance of all
of the Obligations; any and all present and future debts and obligations of a
Borrower to the other are hereby waived and postponed in favor of and
subordinated to the full payment and performance of all present and future
Obligations of the Borrowers to the Lenders.

         5.03  SUBORDINATION. Each Borrower hereby subordinates any claims 
(other than claims evidenced by notes which have been assigned and delivered to
the Lenders), including, without limitation, any other right of payment,
subrogation, contribution, and indemnity that it may have from or against the
other Borrower, and any successor or assign of the other Borrower, including,
without limitation, any trustee, receiver or debtor-in-possession, howsoever
arising, due or owing and whether heretofore, now or

                                       51

<PAGE>

hereafter existing, to all of the Obligations of the other Borrower to the
Lenders.

                                       52

<PAGE>

                                   ARTICLE VI

                     CONDITIONS TO MAKING LOANS AND ISSUING
                                LETTERS OF CREDIT

         6.01  CONDITIONS OF INITIAL ADVANCE AND ISSUANCE OF LETTERS OF CREDIT.
The obligation of the Lenders to make the initial Advance and of any Lender to
issue a Letter of Credit is subject to the conditions precedent that the
Administrative Agent shall have received on the Closing Date, in form and
substance satisfactory to the Administrative Agent and Lenders, the following:

               (a)  executed originals of each of this Agreement, the Notes and
         the other Loan Documents (except the LC Account Agreement), together
         with all schedules and exhibits thereto;

               (b)  favorable written opinions of special counsel to the 
         Borrowers and the Guarantors dated the Closing Date, addressed to the
         Administrative Agent and the Lenders and satisfactory to Smith Helms
         Mulliss & Moore, L.L.P., special counsel to the Administrative Agent,
         substantially in the form of EXHIBITS L AND M attached hereto;

               (c)  resolutions of the boards of directors or other appropriat
         governing body (or of the appropriate committee thereof) of the
         Borrowers and each of the Guarantors certified by its secretary or
         assistant secretary as of the Closing Date, designating (in the case of
         the Borrowers) the office or offices of the Authorized Representative
         and approving and adopting the Loan Documents to be executed by such
         Person, and authorizing the execution and delivery thereof;

               (d)  specimen signatures of officers of the Borrowers and each
         Guarantor executing the Loan Documents on behalf of such Person,
         certified by the secretary or assistant secretary of the Borrowers or
         Guarantor, as applicable;

               (e)  the charter documents of the Borrowers and each Guarantor
         certified as of a recent date by the Secretary of State of its state
         of incorporation;

               (f)  the by-laws of the Borrowers and each domestic Guarantor
         certified as of the Closing Date as true and correct by the secretary
         or assistant secretary of the Person to whom such by-laws relate;

               (g)  certificates issued as of a recent date by the Secretary of
         States of the respective states of incorporation as to the due
         existence and good standing of the Borrowers and each domestic
         Guarantor therein;

               (h)  notice of appointment of the initial Authorized
         Representatives;

                                       53

<PAGE>

               (i)  certificate of Authorized Representatives dated the
         Closing Date demonstrating compliance with the financial covenants
         contained in Sections 9.01, 9.02 and 9.03, as applicable, as of March
         31, 1996, substantially in the form of EXHIBIT F attached hereto;

               (j)  an initial Borrowing Notice;

               (k)  all fees payable by the Borrowers on the Closing Date to
         the Administrative and Syndication Agents;

               (l)  such other documents, instruments, certificates and opinions
         as the Administrative Agent or any Lender may reasonably request on or
         prior to the Closing Date in connection with the consummation of the
         transactions contemplated hereby;

               (m)  NationsBank and BofA must be repaid in full under the
         existing $175,000,000 Revolving Credit Facility and such facility
         terminated; and

               (n)   the uncommitted $15,000,000 line of credit available to
         IVAX from ABN AMRO Bank N.V.and any other uncommitted bid line
         disclosed to the Administrative Agent must be repaid and terminated at
         the Closing Date.

         6.02  CONDITIONS OF LOANS. The obligations of the Lenders to make any
Loans, and the Issuers to issue Letters of Credit hereunder on or subsequent to
the Closing Date are subject to the satisfaction of the following conditions:

               (a)  the Administrative Agent shall have received a notice of
         such borrowing or request if required by Article II hereof;

               (b)  the representations and warranties of the Borrowers set 
         forth in Article VII hereof and in each of the other Loan Documents
         shall be true and correct in all material respects on and as of the
         date of such Advance or issuance of such Letters of Credit, as the case
         may be, with the same effect as though such representations and
         warranties had been made on and as of such date, except to the extent
         that such representations and warranties expressly relate to an earlier
         date and except that the financial statements referred to in Section
         7.01(f)(i) shall be deemed to be those financial statements most
         recently delivered to the Administrative Agent (together with copies
         for each Lender) to Section 8.01 hereof; provided, however, in the
         event the Borrowers shall have disclosed in writing to the Lenders any
         event or condition which has occurred or come into existence subsequent
         to the Closing Date which if it had occurred or come into existence
         prior to the Closing Date would have been disclosed in a schedule to
         this Agreement and the Lenders have elected to

                                       54

<PAGE>

         continue to make Advances hereunder, then such event or condition shall
         be deemed to be disclosed in the relevant schedule hereto;

               (c)  in the case of the issuance of a Letter of Credit, the 
         applicable Borrower shall have executed and delivered to the Issuer an
         Application and Agreement for Letter of Credit in form and content
         acceptable to the Issuer together with such other instruments and
         documents as it shall request;

               (d)  at the time of each such Advance or issuance of each Letter 
         of Credit, as the case may be, no Default or Event of Default specified
         in Article X hereof, shall have occurred and be continuing; and

               (e)  immediately after giving effect to the requested Loan or 
         Letter of Credit (i) the aggregate principal balance of all outstanding
         Syndicated Loans and Participations of each Lender shall not exceed
         such Lender's Revolving Credit Commitment and (ii) the aggregate
         principal balance of all outstanding Loans plus the aggregate amount of
         Outstanding Letters of Credit shall not exceed the Available Revolving
         Credit Commitment.

Each borrowing of Loans and each issuance of a Letter of Credit shall constitute
a representation and warranty by the Borrowers that the conditions set forth in
clauses (b) and (d) above have been satisfied as of the date thereof.

                                       55

<PAGE>

                                   ARTICLE VII

                         REPRESENTATIONS AND WARRANTIES

     7.01  REPRESENTATIONS AND WARRANTIES. Each Borrower represents and
warrants with respect to itself and to its Significant Subsidiaries (which
representations and warranties shall survive the delivery of the documents
mentioned herein and the making of Loans and the issuance of Letters of Credit),
that:

         (a)  ORGANIZATION AND AUTHORITY.

              (i) such Borrower and each Significant Subsidiary is a 
         corporation duly organized and validly existing under the laws of the
         jurisdiction of its incorporation;

             (ii) such Borrower and each Significant Subsidiary (x) has the 
         requisite power and authority to own its properties and assets and to
         carry on its business as now being conducted and as contemplated in the
         Loan Documents, and (y) is qualified to do business in every
         jurisdiction in which failure so to qualify would have a material
         adverse effect on the business or operations of such Borrower or any
         Significant Subsidiary;

            (iii) such Borrower has the power and authority to execute, deliver 
         and perform this Agreement and the Notes, and to borrow hereunder, and
         to execute, deliver and perform each of the other Loan Documents to
         which it is a party;

             (iv) each Guarantor has the power and authority to execute, deliver
         and perform the Guaranty and the other Loan Documents to which it is a
         party; and

              (v) when executed and delivered, each of the Loan Documents to
         which such Borrower or any Guarantor is a party will be the legal,
         valid and binding obligation or agreement, as the case may be, of such
         Borrower or Guarantor, enforceable against such Borrower or Guarantor
         in accordance with its terms, subject to the effect of any applicable
         bankruptcy, moratorium, insolvency, reorganization or other similar law
         affecting the enforceability of creditors' rights generally and to the
         effect of general principles of equity which may limit the availability
         of equitable remedies (whether in a proceeding at law or in equity);

         (b) LOAN DOCUMENTS. The execution, delivery and performance by each
of the Borrowers and each Guarantor of each of the Loan Documents to which such
Borrower or a Guarantor is a party:

                                       56

<PAGE>

               (i)  have been duly authorized by all requisite corporate action
         (including any required shareholder approval) of such Borrower or
         Guarantor signatory thereto required for the lawful execution, delivery
         and performance thereof;

              (ii)  do not violate any provisions of (1) applicable law, rule or
         regulation, (2) any order of any court or other agency of government
         binding on such Borrower, any Guarantor or any other Subsidiary of such
         Borrower, or their respective properties, or (3) the charter documents
         or by-laws of such Borrower or any Guarantor;

             (iii)  will not be in conflict with, result in a breach of or
         constitute an event of default, or an event which, with notice or lapse
         of time, or both, would constitute an event of default, under any
         indenture, material agreement or other material instrument to which
         such Borrower or any Guarantor is a party, or by which the properties
         or assets of such Borrower or any Guarantor is bound;

              (iv)  will not result in the creation or imposition of any Lien
         charge or encumbrance of any nature whatsoever upon any of the
         properties or assets of such Borrower or any Guarantor except any Liens
         in favor of the Administrative Agent and the Lenders created by the
         Loan Documents.

         (c)  SOLVENCY. Such Borrower and each Significant Subsidiary is Solvent
after giving effect to the transactions contemplated by this Agreement and the
other Loan Documents.

         (d)  SUBSIDIARIES AND STOCKHOLDERS. SCHEDULE 7.01(D) to this Agreement
states as of the date hereof the authorized and issued capitalization of each
Significant Subsidiary of each of the Borrowers, the number of shares or other
equity interests of each class of capital stock or interest issued and
outstanding of each such Significant Subsidiary and the number and/or percentage
of outstanding shares or other equity interest (including options, warrants and
other rights to acquire any interest) of each such class of capital stock or
equity interest owned by each Borrower; the outstanding shares or other equity
interests of each such Significant Subsidiary have been duly authorized and
validly issued and are fully paid and nonassessable; and each Borrower owns
beneficially and of record all the shares and other interests it is listed as
owning in SCHEDULE 7.01(D), free and clear of any Lien other than Liens in favor
of the Administrative Agent or the Lenders in connection with this Agreement.

                                       57

<PAGE>

         (e)  OWNERSHIP INTERESTS.  SCHEDULE 7.01(E) contains a list as of the
Closing Date of investments of each of the Borrowers and their Significant
Subsidiaries in any Person;

         (f)  FINANCIAL CONDITION. (i) The Borrowers have heretofore furnished
to the Administrative Agent and the Administrative Agent hereby acknowledges
receipt of the audited consolidated balance sheet of IVAX and its Subsidiaries
as at December 31, 1995 and the notes thereto and the related consolidated
statements of operations, stockholders' equity and cash flows for the Fiscal
Year then ended as audited by Arthur Andersen L.L.P. and as to which Arthur
Andersen L.L.P. has expressed an opinion based on such audit, accompanied by
unaudited consolidating balance sheet of IVAX and its Subsidiaries as at
December 31, 1995 and a related unaudited consolidating statement of operations
for the Fiscal Year then ended. Except as set forth therein, such financial
statements (including the notes thereto) present fairly the financial condition
of IVAX and its Subsidiaries as of the end of such Fiscal Year and results of
their operations and the changes in their stockholders' equity for such Fiscal
Year, all in conformity with Generally Accepted Accounting Principles applied on
a Consistent Basis;

             (ii)  since December 31, 1995, there has been no materia adverse
         change in the condition, financial or otherwise, of the Borrowers and
         their Subsidiaries, each considered as a whole, which has not been
         disclosed in writing by the Borrowers to the Lenders prior to the
         Closing Date, or in the businesses, properties and operations of the
         Borrowers and their Subsidiaries, each considered as a whole, nor have
         such businesses or properties, taken as a whole, been materially
         adversely affected as a result of any fire, explosion, earthquake,
         accident, strike, lockout, combination of workers, flood, embargo or
         act of God;

            (iii)  except as set forth or recorded in the financial statements
         referred to in Section 7.01(f)(i) or in SCHEDULE 7.01(F) or SCHEDULE
         7.01(J) hereto or otherwise disclosed by the Borrowers in writing to
         the Lenders prior to the Closing Date, neither Borrower nor any
         Subsidiary of either Borrower has incurred, other than in the ordinary
         course of business, any material indebtedness, obligations, commitments
         or other liability contingent or otherwise which remain outstanding or
         unsatisfied which in the aggregate would have a material adverse effect
         on the business, operations or condition, financial or otherwise, of
         IVAX and its Subsidiaries, taken as a whole;

         (g)  TITLE TO PROPERTIES.  Each of the Borrowers and their Significant
Subsidiaries have title to all their respective real and personal properties,
subject to no Liens, except for (x) the Liens described in SCHEDULE 7.01(G)

                                       58

<PAGE>

attached hereto and incorporated herein by reference or Liens to be satisfied
with the proceeds of the Loans, and (y) Liens permitted under Section 9.05
hereof;

         (h)  TAXES. Except as set forth in SCHEDULE 7.01(H) hereto or otherwise
disclosed in writing by such Borrower to the Lenders prior to the Closing Date,
such Borrower and its Significant Subsidiaries have filed or caused to be filed
all federal, state and local tax returns which are required to be filed by it
and except for taxes and assessments being contested in good faith and against
which reserves satisfactory to such Borrower's independent certified public
accountants have been established, have paid or caused to be paid all taxes as
shown on said returns or on any assessment received by them, to the extent that
such taxes have become due, except for taxes not paid and tax returns the
failure to file of which would not have a material adverse effect on the
business, operations or condition, financial or otherwise, of IVAX and its
Significant Subsidiaries, taken as a whole;

         (i)  OTHER AGREEMENTS.  Except as set forth in SCHEDULE 7.01(I), or
otherwise disclosed in writing by such Borrower to the Lenders prior to the
Closing Date neither such Borrower nor any Significant Subsidiary of such
Borrower is

              (i)  a party to any judgment, order, decree or any agreement or
         instrument or subject to restrictions materially adversely affecting
         the ability of such Borrower to repay Advances made under this
         Agreement; or

             (ii)  in default in the performance, observance or fulfillment of
         any of the obligations, covenants or conditions contained in any
         agreement or instrument to which such Borrower or any Significant
         Subsidiary of such Borrower is a party, which default has, or if not
         remedied within any applicable grace period could have, a material
         adverse effect on the business, operations or condition, financial or
         otherwise, of IVAX and its Subsidiaries, taken as a whole;

         (j)  LITIGATION. Except as set forth in SCHEDULE 7.01(J) hereto or 
otherwise disclosed in writing by such Borrower to the Lenders prior to the
Closing Date, there is no action, suit or proceeding at law or in equity or by
or before any governmental instrumentality or agency or arbitral body pending,
or, to the knowledge of such Borrower, threatened by or against such Borrower or
any Significant Subsidiary of such Borrower or affecting such Borrower or any
Significant Subsidiary of such Borrower or any properties or rights of such
Borrower or any Significant Subsidiary of such Borrower, which would, if
adversely determined, materially adversely affect the financial condition,
business or operations of such Borrower and its Significant Subsidiaries, taken
as a whole;

                                       59

<PAGE>

         (k)  MARGIN STOCK. The proceeds of the borrowings made pursuant t
Article II hereof will be used by such Borrower only for the purposes set forth
in Section 2.13 hereof. None of such proceeds will be used, directly or
indirectly, for the purpose of purchasing or carrying any margin stock or for
the purpose of reducing or retiring any Indebtedness which was originally
incurred to purchase or carry margin stock or for any other purpose which might
constitute any of the Loans under this Agreement a "purpose credit" within the
meaning of said Regulation U or Regulation X (12 C.F.R. Part 224) of the Board.
Neither such Borrower nor any agent acting in its behalf has taken or will take
any action which might cause this Agreement or any of the documents or
instruments delivered pursuant hereto to violate any regulation of the Board or
to violate the Securities Exchange Act of 1934, as amended, or the Securities
Act of 1933, as amended, or any state securities laws, in each case as in effect
on the date hereof;

         (l)  INVESTMENT COMPANY.  Neither such Borrower nor any Subsidiary is
an "investment company," or an "affiliated person" of, or "promoter" or
"principal underwriter" for, an "investment company," as such terms are defined
in the Investment Company Act of 1940, as amended (15 U.S.C. ss. 80a-1, et
seq.);

         (m)  PATENTS, ETC. Except as set forth in SCHEDULE 7.01(M) hereto or
otherwise disclosed in writing by such Borrower to the Lenders prior to the
Closing Date, such Borrower and its Significant Subsidiaries own or have the
right to use, under valid license agreements or otherwise, all material patents,
licenses, franchises, trademarks, trademark rights, trade names, trade name
rights, trade secrets and copyrights necessary to the conduct of their
businesses as now conducted, without known conflict with any patent, license,
franchise, trademark, trade secrets and confidential commercial or proprietary
information, trade name, copyright, rights to trade secrets or other proprietary
rights of any other Person which conflict is reasonably likely to have a
materially adverse effect on IVAX and its Subsidiaries, taken as a whole;

         (n)  NO UNTRUE STATEMENT. Neither this Agreement nor any other Loan
Document or certificate or document executed and delivered by or on behalf of
such Borrower or any Guarantor in accordance with or pursuant to any Loan
Document contains any misrepresentation or untrue statement of material fact or
omits to state a material fact necessary in order to make any such
representation or statement contained therein, in light of the circumstances
under which it was made, not misleading in any material respect;

                                       60

<PAGE>

         (o)   NO CONSENTS, ETC. Except as set forth in SCHEDULE 7.01(O) hereto
or as otherwise disclosed in writing by such Borrower to the Lenders prior to
the Closing Date, neither the respective businesses or properties of such
Borrower or any Significant Subsidiary of such Borrower, nor any relationship
between such Borrower or any Significant Subsidiary of such Borrower and any
other Person, nor any circumstance in connection with the execution, delivery
and performance of the Loan Documents and the transactions contemplated hereby
is such as to require a consent, approval or authorization of, or filing,
registration or qualification with, any governmental or other authority or any
other Person on the part of such Borrower or any Significant Subsidiary of such
Borrower as a condition to the execution, delivery and performance of, or
consummation of the transactions contemplated by, this Agreement or the other
Loan Documents or if so, such consent, approval, authorization, filing,
registration or qualification has been obtained or effected, as the case may be,
in any case where the failure to obtain such consent, approval, authorization,
filing, registration or qualification would affect the legality, validity or
enforceability of the Loan Documents;

         (p)  ERISA.

              (i)  None of the employee benefit plans maintained at any time by
         such Borrower or any Subsidiary of such Borrower or the trusts created
         thereunder has engaged in a prohibited transaction which could subject
         any such employee benefit plan or trust to a material tax or penalty on
         prohibited transactions imposed under Internal Revenue Code Section
         4975 or ERISA or under any Foreign Benefit Law;

             (ii)  None of the employee benefit plans maintained at any time by
         such Borrower or any Subsidiary of such Borrower which are employee
         pension benefit plans and which are subject to Title IV of ERISA or any
         Foreign Benefit Law or the trusts created thereunder has been
         terminated so as to result in a material liability of such Borrower
         under ERISA or any other Person exercising similar duties and functions
         under any Foreign Benefit Law nor has any such employee benefit plan of
         such Borrower or any Subsidiary of such Borrower incurred any material
         liability to the Pension Benefit Guaranty Corporation established
         pursuant to ERISA, other than for required insurance premiums which
         have been paid or are not yet due and payable; neither such Borrower
         nor any Subsidiary of such Borrower has withdrawn from or caused a
         partial withdrawal to occur with respect to any Multi-employer Plan
         resulting in any assessed and unpaid withdrawal liability; such
         Borrower and the Subsidiaries of such Borrower have made or provided
         for all contributions to all such employee pension benefit plans which
         they maintain and which are required as of the end of the most recent
         fiscal year under each such plan;

                                       61

<PAGE>

         except as disclosed in SCHEDULE 7.01(P), neither such Borrower nor any
         Subsidiary of such Borrower has incurred any accumulated funding
         deficiency with respect to any such plan, whether or not waived; nor
         has there been any reportable event, or other event or condition, which
         presents a material risk of termination of any such employee benefit
         plan by such Pension Benefit Guaranty Corporation or other Person
         exercising similar duties and functions under any Foreign Benefit Law;

            (iii)  Except as disclosed in SCHEDULE 7.01(P), or otherwise
         disclosed in writing to the Administrative Agent prior to the Closing
         Date, the present value of all vested accrued benefits under the
         employee pension benefit plans which are subject to Title IV of ERISA
         or any Foreign Benefit Law, maintained by such Borrower or any
         Subsidiary of such Borrower, did not, as of the most recent valuation
         date for each such plan, exceed the then current value of the assets of
         such employee benefit plans allocable to such benefits;

             (iv)  The consummation of the Loans and the issuance of the Letters
         of Credit provided for in Article II and Article III will not involve
         any prohibited transaction under ERISA or violate any Foreign Benefit
         Law which in either case is not subject to a statutory or
         administrative exemption;

              (v)  To the best of such Borrower's knowledge, each employee
         pension benefit plan subject to Title IV of ERISA or other Foreign
         Benefit Law, maintained by such Borrower or any Subsidiary of such
         Borrower, has been administered in accordance with its terms in all
         material respects and is in compliance in all material respects with
         all applicable requirements of ERISA and other applicable laws,
         regulations and rules and any applicable Foreign Benefit Law;

             (vi)  There has been no withdrawal liability incurred and unpaid 
         with respect to any Multi-employer Plan to which such Borrower or any
         Subsidiary of such Borrower is or was a contributor;

            (vii)  As used in this Agreement, the terms "employee benefit plan,
         "employee pension benefit plan," "accumulated funding deficiency,"
         "reportable event," and "accrued benefits" shall have the respective
         meanings assigned to them in ERISA, and the term "prohibited
         transaction" shall have the meaning assigned to it in Code Section 4975
         and ERISA;

           (viii)  Neither such Borrower nor any Significant Subsidiary of such
         Borrower has any liability not disclosed on any of the financial
         statements furnished to the Lenders pursuant to Section 7.01(f) hereof,
         contingent or otherwise, under any plan or program or the equivalent
         for unfunded post-retirement benefits, including pension, medical and
         death

                                       62

<PAGE>

         benefits, which liability would have a material adverse effect
         on the financial condition of such Borrower or any Subsidiary;

         (q)  NO DEFAULT.  As of the date hereof, there does not exist any
Default or Event of Default hereunder;

         (r)  HAZARDOUS MATERIALS. To the knowledge of such Borrower, such
Borrower and each Significant Subsidiary of such Borrower is in compliance with
all applicable Environmental Laws in all material respects and neither such
Borrower nor any Significant Subsidiary of such Borrower has been notified of
any action, suit, proceeding or investigation which calls into question
compliance by such Borrower or any Significant Subsidiary of such Borrower with
any Environmental Laws or which seeks to suspend, revoke or terminate any
license, permit or approval necessary for the generation, handling, storage,
treatment or disposal of any Hazardous Material the effect of which would have a
materially adverse effect on such Borrower and its Significant Subsidiaries,
taken as a whole;

         (s)  RICO. To the knowledge of such Borrower, neither such Borrower 
nor any Subsidiary of such Borrower is engaged in or has engaged in any course
of conduct that could subject any of their respective properties to any Lien,
seizure or other forfeiture under any criminal law, racketeer influenced and
corrupt organizations law, civil or criminal, or other similar laws the effect
of which would have a material adverse effect on IVAX and its Subsidiaries,
taken as a whole;

         (t)  EMPLOYMENT MATTERS. Except as disclosed on SCHEDULE 7.01(T) 
hereto or as otherwise disclosed in writing by such Borrower to the Lenders
prior to the Closing Date, such Borrower and its Significant Subsidiaries are in
compliance in all material respects with all applicable laws, rules and
regulations pertaining to labor or employment matters, including without
limitation those pertaining to wages, hours, occupational safety and taxation
and there is neither pending or to the knowledge of such Borrower threatened any
material litigation, administrative proceeding nor, to the knowledge of such
Borrower, any investigation, in respect of such matters the effect of which
non-compliance, litigation, administrative proceeding or investigation would
have a material adverse effect on IVAX and its Subsidiaries, taken as a whole.

                                       63

<PAGE>

                                  ARTICLE VIII

                              AFFIRMATIVE COVENANTS

         Until the Obligations have been paid and satisfied in full and this
Agreement has been terminated in accordance with the terms hereof, unless the
Required Lenders shall otherwise consent in writing, each Borrower will and will
cause each Significant Subsidiary of such Borrower to:

         8.01  FINANCIAL REPORTS, ETC. (a) within 120 days after the end of each
Fiscal Year of IVAX, deliver or cause to be delivered to the Administrative
Agent (together with copies for each Lender) (i) consolidated and unaudited
consolidating balance sheets of IVAX and its Subsidiaries, and the notes
thereto, the related consolidated and unaudited consolidating statements of
operations, stockholders' equity and cash flows and the respective notes thereto
for such Fiscal Year, setting forth in the case of the consolidated statements
comparative financial statements for the preceding Fiscal Year, all prepared in
accordance with Generally Accepted Accounting Principles applied on a Consistent
Basis and containing, with respect to the consolidated financial reports,
opinions of any of Arthur Andersen L.L.P., Coopers & Lybrand, Price Waterhouse
L.L.P., KPMG Peat Marwick, Deloitte & Touche, Ernst & Young or other such
independent certified public accountants selected by IVAX and approved by the
Required Lenders, which are unqualified as to the scope of the audit performed
and as to the "going concern" status of such Borrower; (ii) Consolidating
Balance Sheet of NHL and its Subsidiaries for such Fiscal Year; and (iii) a
certificate of an Authorized Representative demonstrating compliance with
Sections 9.01 through 9.03 of this Agreement, which certificate shall be in the
form attached hereto as EXHIBIT F;

         (b)  within 50 days after the end of each quarterly period (except the 
last reporting period of the Fiscal Year), deliver to the Administrative Agent
(together with copies for each Lender) (i) consolidated and consolidating
balance sheets of IVAX and its Subsidiaries as of the end of such reporting
period, the related consolidated and consolidating statements of operations and
cash flows for such reporting period and for the period from the beginning of
the Fiscal Year through the end of such reporting period, accompanied by a
certificate of an Authorized Representative to the effect that such consolidated
financial statements present fairly the financial position of IVAX and its
Subsidiaries as of the end of such reporting period and the results of their
operations and the changes in their financial position for such reporting
period, in conformity with GAAP, subject, however, to year end adjustments with
respect to interim financials, (ii) Consolidating Balance Sheet of NHL and its
Subsidiaries for such reporting period and (iii) a certificate of an Authorized
Representative containing computations for such quarter comparable to that
required pursuant to Section 8.01(a)(iii);

                                       64

<PAGE>

         (c) together with each delivery of the financial statements required by
Section 8.01(a)(i) hereof, deliver to the Administrative Agent (together with
copies for each Lender) a letter from such Borrower's accountants specified in
Section 8.01(a)(i) hereof stating that in performing the audit necessary to
render an opinion on the financial statements delivered under Section
8.01(a)(i), they obtained no knowledge of any Default or Event of Default by
such Borrower in the fulfillment of the terms and provisions of this Agreement
insofar as they relate to financial covenants (which at the date of such
statement remains uncured); and if the accountants have obtained knowledge of
such Default or Event of Default, a statement specifying the nature and period
of existence thereof;

         (d) promptly upon their becoming available to such Borrower, such
Borrower shall deliver to the Administrative Agent (together with copies for
each Lender) a copy of (i) all regular or special reports or effective
registration statements for the sale of securities to the general public on
behalf of such Borrower or the private placement of securities of such Borrower
which such Borrower or any Subsidiary of such Borrower shall file with the
Securities and Exchange Commission (or any successor thereto) or any securities
exchange, (ii) any proxy statement distributed by such Borrower to its
shareholders, bondholders or the financial community in general, and (iii) any
management letter submitted to such Borrower or any of its Significant
Subsidiaries by independent accountants in connection with any annual, interim
or special audit of such Borrower or any of its Subsidiaries; and

         (e) promptly, from time to time, deliver or cause to be delivered to
the Administrative Agent and each Lender such other information regarding such
Borrower's and each Subsidiary of such Borrower's operations, business affairs
and financial condition as the Administrative Agent or such Lender may
reasonably request from an Authorized Representative. The Administrative Agent
and the Lenders are hereby authorized to deliver a copy of any such financial
information delivered hereunder to the Lenders (or any affiliate of any Lender)
or to the Administrative Agent, to any regulatory authority having jurisdiction
over any of the Lenders pursuant to any request therefor, or, subject to Section
12.01(e) hereof, to any other Person who shall acquire or consider the
acquisition of a participation interest in or assignment of any Loan or Letter
of Credit permitted by this Agreement.

         8.02 MAINTAIN PROPERTIES. Maintain all properties necessary to its
operations in good working order and condition (ordinary wear and tear
excepted).

         8.03 EXISTENCE, QUALIFICATION, ETC. Do or cause to be done all things
necessary to preserve and keep in full force and effect its existence and all
material rights and franchises, trade names, trademarks and permits and maintain
its license or qualification to do business as a foreign corporation and good
standing in each

                                       65


<PAGE>


jurisdiction in which its ownership or lease of property or the nature of its
business makes such license or qualification necessary and which are material to
the business of IVAX and its Significant Subsidiaries, taken as a whole.

         8.04 REGULATIONS AND TAXES. Comply in all material respects with or
contest in good faith all statutes and governmental regulations and pay all
taxes, assessments, governmental charges, claims for labor, supplies, rent and
any other obligation which, if unpaid, might become a Lien against any of its
properties and the failure to pay of which would have a material adverse effect
on the financial condition, business or operations of IVAX and its Subsidiaries,
taken as a whole, except liabilities being contested in good faith and against
which adequate reserves have been established.

         8.05 INSURANCE. (i) Keep all of its insurable properties adequately
insured at all times with responsible insurance carriers against loss or damage
by fire and other hazards (excluding environmental hazards) as are customarily
insured against by similar businesses owning such properties similarly situated,
(ii) maintain general public liability insurance at all times with responsible
insurance carriers against liability on account of damage to persons and
property, and (iii) maintain insurance under all applicable workers'
compensation laws (or in the alternative, maintain required reserves if
self-insured for workers' compensation purposes).

         8.06 TRUE BOOKS. Keep true books of record and account in which full,
true and correct entries will be made of all of its material dealings and
transactions, and set up on its books such reserves as may be required by
Generally Accepted Accounting Principles with respect to doubtful accounts and
all taxes, assessments, charges, levies and claims and with respect to its
business in general, and include such reserves in interim as well as year-end
financial statements.

         8.07 RIGHT OF INSPECTION. Permit any Person designated by any Lender or
the Administrative Agent at the Lender's or Administrative Agent's expense, as
the case may be, upon notice to an Authorized Representative, to visit and
inspect any of the properties, corporate books and financial reports of such
Borrower and its Subsidiaries, and upon reasonable prior notice to an Authorized
Representative and at reasonable times to discuss their respective affairs,
finances and accounts with their principal officers and independent certified
public accountants. The Lenders and Administrative Agent shall be provided
copies of such financial information and reports as they may request from an
Authorized Representative, provided that so long as no Event of Default exists
under this Agreement, the Lender or Agent requesting such copies shall pay all
reasonable expenses of producing such copies.

                                       66


<PAGE>


         8.08 OBSERVE ALL LAWS. Conform to and duly observe in all material
respects all laws, rules and regulations and all other valid requirements of any
regulatory authority with respect to the conduct of its business if the failure
to conform to or observe such laws, rules and regulations would have a material
adverse effect on such Borrower or any Significant Subsidiary of such Borrower.

         8.09 COVENANTS EXTENDING TO SUBSIDIARIES. Cause each of its Significant
Subsidiaries to do with respect to itself, its business and its assets, each of
the things required of such Borrower in Sections 8.02 through 8.08, inclusive.

         8.10 OFFICER'S KNOWLEDGE OF DEFAULT. Upon the President, the Chief
Operating Officer, the Chief Financial Officer or the Vice President--Finance of
such Borrower obtaining actual knowledge of any Default or Event of Default
hereunder or under any other obligation of such Borrower or any Significant
Subsidiary where the amount of the obligation is $10,000,000 or greater, cause
such officer to promptly notify the Administrative Agent of the nature thereof,
the period of existence thereof, and what action such Borrower proposes to take
with respect thereto.

         8.11 SUITS OR OTHER PROCEEDINGS. Upon the President, the Chief
Operating Officer, the Chief Financial Officer or the Vice President--Finance of
such Borrower obtaining actual knowledge of any litigation or other proceedings
being instituted against such Borrower or any Significant Subsidiary of such
Borrower, or any attachment, levy, execution or other process being instituted
against any assets of such Borrower or any Significant Subsidiary of such
Borrower, in an aggregate amount greater than $10,000,000 not otherwise covered
by insurance, promptly deliver to the Administrative Agent written notice
thereof stating the nature and status of such litigation, dispute, proceeding,
levy, execution or other process.

         8.12 NOTICE OF DISCHARGE OF HAZARDOUS MATERIAL OR ENVIRONMENTAL
COMPLAINT. Promptly provide to the Administrative Agent true, accurate and
complete copies of any and all notices, complaints, orders, directives, claims,
or citations received by such Borrower or any Significant Subsidiary of such
Borrower from any Governmental Authority relating to any material (a) violation
or alleged violation by such Borrower or any Significant Subsidiary of such
Borrower of any applicable Environmental Laws or OSHA; or (b) liability or
alleged liability of such Borrower or any Significant Subsidiary of such
Borrower for the costs of cleaning up, removing, remediating or responding to a
release of Hazardous Materials.

         8.13 INDEMNIFICATION. Such Borrower hereby agrees to defend, indemnify
and hold the Administrative Agent and the Lenders harmless from and against any
and all claims, losses, liabilities, damages and expenses (including, without
limitation, cleanup costs

                                       67


<PAGE>


and reasonable attorneys' fees) arising directly or indirectly from, out of or
by reason of the handling, storage, treatment, emission or disposal of any
Hazardous Material by or in respect of such Borrower or any Subsidiary of any
such Borrower or property owned or leased or operated by the Borrower or any
Subsidiary. The provisions of this Section 8.13 shall survive repayment of the
Obligations, occurrence of the Revolving Credit Termination Date and expiration
or termination of this Agreement.

         8.14 FURTHER ASSURANCES. At its cost and expense, upon request of the
Administrative Agent, duly execute and deliver or cause to be duly executed and
delivered, to the Administrative Agent such further instruments, documents,
certificates, financing and continuation statements, and do and cause to be done
such further acts that may be reasonably necessary or advisable in the
reasonable opinion of the Administrative Agent to carry out more effectively the
provisions and purposes of this Agreement and the other Loan Documents.

         8.15 ERISA REQUIREMENT. Comply in all material respects with all
requirements of ERISA, to the extent applicable, and any Foreign Benefit Law
applicable to it and furnish to the Administrative Agent as soon as possible and
in any event (i) within thirty (30) days after such Borrower knows or has reason
to know that any reportable event or other event under any Foreign Benefit Law
with respect to any employee benefit plan maintained by such Borrower or any
Subsidiary of such Borrower which could give rise to termination or the
imposition of any material tax or penalty has occurred, written statement of an
Authorized Representative describing in reasonable detail such reportable event
or other event under any Foreign Benefit Law and any action which such Borrower
or applicable Subsidiary of such Borrower proposes to take with respect thereto,
together with a copy of the notice of such reportable event given to the PBGC or
a statement that said notice will be filed with the annual report of the United
States Department of Labor with respect to such plan if such filing has been
authorized, (ii) promptly after receipt thereof, a copy of any notice that such
Borrower or any Subsidiary of such Borrower may receive from the PBGC relating
to the intention of the PBGC to terminate any employee benefit plan or plans of
such Borrower or any Subsidiary of such Borrower or to appoint a trustee to
administer any such plan, and (iii) within 10 days after a filing with the PBGC
pursuant to Section 412(n) of the Code of a notice of failure to make a required
installment or other payment with respect to a plan, a certificate of an
Authorized Representative setting forth details as to such failure and the
action that such Borrower or its affected Subsidiary, as applicable, proposes to
take with respect thereto, together with a copy of such notice given to the
PBGC.

         8.16 CONTINUED OPERATIONS. Continue at all times (i) to conduct its
business and engage principally in the same general line or lines of business
substantially as heretofore conducted or

                                       68


<PAGE>


those lines of business related to the health care industry or personal care
industry, and (ii) preserve, protect and maintain free from Liens its material
patents, copyrights, licenses, trademarks, trademark rights, trade names, trade
name rights, trade secrets and know-how necessary for the conduct of its
operations.

         8.17 USE OF PROCEEDS. Use the proceeds of the Loans solely for the
purposes specified in Section 2.13 hereof.

         8.18 MCGAW. Promptly after the payment in full of the Senior Notes
cause McGaw to execute and deliver to the Administrative Agent for the benefit
of the Lenders an unlimited guaranty agreement in the form of the Guaranty
together with corporate resolutions of McGaw duly adopted and authorizing the
execution and delivery of such guaranty agreement together with an opinion of
counsel to McGaw substantially in the form of the opinion set forth in EXHIBIT
M.

         8.19 SIGNIFICANT SUBSIDIARY. Within thirty (30) days after the end of
any fiscal quarter in which any Subsidiary of a Borrower becomes a Significant
Subsidiary, cause to be delivered to the Administrative Agent for the benefit of
the Lenders each of the following:

                  (a)  a Guaranty executed by such Subsidiary;

                  (b) an opinion of counsel to the Subsidiary dated as of the
         date of delivery of the Guaranty provided for in this Section 8.19 and
         addressed to the Agent and the Lenders, in form and substance
         reasonably acceptable to the Agent, to the effect that:

                           (i) such Subsidiary is duly organized, validly
                  existing and in good standing in the jurisdiction of its
                  formation, has the requisite power and authority to own its
                  properties and conduct its business as then owned and then
                  conducted and proposed to be conducted, and is duly qualified
                  to transact business and is in good standing as a foreign
                  corporation or partnership in each other jurisdiction in which
                  the character of the properties owned or leased, or the
                  business carried on by it, requires such qualification and the
                  failure to be so qualified would reasonably be likely to
                  result in a material adverse effect on its business taken as a
                  whole;

                           (ii) the execution, delivery and performance of the
                  Guaranty described in this Section 8.19 to which such
                  Subsidiary is a signatory has been duly authorized by all
                  requisite corporate or partnership action (including any
                  required shareholder or partner approval), such agreement has
                  been duly executed and delivered and constitutes the valid and
                  binding agreement of such Subsidiary, enforceable against such
                  Subsidiary in accordance with

                                       69


<PAGE>



                  its terms, subject to the effect of any applicable bankruptcy,
                  moratorium, insolvency, reorganization or other similar law
                  affecting the enforceability of creditors' rights generally
                  and to the effect of general principles of equity (whether
                  considered in a proceeding at law or in equity);

                  (c) current copies of the charter documents, including
         partnership agreements and certificate of limited partnership, if
         applicable, and bylaws of such Subsidiary, minutes of duly called and
         conducted meetings (or duly effected consent actions) of the Board of
         Directors, partners, or appropriate committees thereof (and, if
         required by such charter documents, bylaws or by applicable law, of the
         shareholders) of such Subsidiary authorizing the actions and the
         execution and delivery of document described in this Section 8.19.

                                       70


<PAGE>



                                   ARTICLE IX

                               NEGATIVE COVENANTS

         Until the Obligations have been paid and satisfied in full and this
Agreement has been terminated in accordance with the terms hereof, unless the
Required Lenders shall otherwise consent in writing, each Borrower (unless
indicated otherwise) agrees that it will not, nor will it permit any of its
Significant Subsidiaries to:

         9.01 CONSOLIDATED TANGIBLE NET WORTH. Permit Consolidated Tangible Net
Worth to be less than (i) $480,000,000 at December 31, 1995 and (ii) as at the
last day of each succeeding fiscal quarter of IVAX and until (but excluding) the
last day of the next following fiscal quarter of IVAX, the sum of (A) the amount
of Consolidated Tangible Net Worth required to be maintained pursuant to this
Section 9.01 as at the end of the immediately preceding fiscal quarter, plus (B)
50% of Consolidated Net Income (but not any portion of any loss) during the
immediately preceding fiscal quarter of the Borrower ending on such day
(including in Consolidated Net Income, for purposes of this Section 9.01 only,
any net gain or credit of an extraordinary nature determined in accordance with
Generally Accepted Accounting Principles) plus (C) 100% of the consolidated
tangible net worth (so long as positive) of any entity acquired pursuant to a
Permitted Acquisition which is accounted for on a "pooling of interest" basis
plus (D) 100% of the net cash proceeds of any issuance by IVAX of any equity
interests in IVAX. Permit consolidated tangible net worth of NHL and its
Subsidiaries to be less than $1.00.

         9.02 CONSOLIDATED LEVERAGE RATIO. Permit at any time the Consolidated
Leverage Ratio to be more than 3.5 to 1.00.

         9.03  CONSOLIDATED FIXED CHARGE RATIO. Permit at any time the
Consolidated Fixed Charge Ratio to be less than 1.75 to 1.00.

         9.04 INDEBTEDNESS OR GUARANTEED OBLIGATIONS. Incur, create, assume or
permit to exist any Indebtedness or Guaranteed Obligations, howsoever evidenced,
except

              (i) Indebtedness or Guaranteed Obligations existing as of the date
         hereof and as set forth in SCHEDULE 9.04 attached hereto and
         incorporated herein by reference and any Indebtedness arising by reason
         of the refinancing of any Indebtedness described in SCHEDULE 9.04 so
         long as (x) the rate of interest at par is no greater than that paid or
         payable with respect to the Indebtedness to be refinanced, (y) the
         terms of repayment are as favorable as that of the Indebtedness to be
         refinanced, and (z) no additional Lien is created in connection
         therewith;

                                       71


<PAGE>



             (ii) Indebtedness or other Obligations owed the Administrative
         Agent or the Lenders in connection with this Agreement;

            (iii) the Guaranty of the Guarantors;

             (iv) the endorsement of negotiable instruments for deposit or
         collection or similar transactions in the ordinary course of business;

              (v) each Significant Subsidiary existing as of the date hereof of
         a Borrower may incur Indebtedness, including Guaranteed Obligations, of
         up to $25,000,000 (excluding Indebtedness permitted under clauses (i),
         (ii) and (iii) of this Section 9.04) and each Significant Subsidiary
         acquired after the Closing Date may incur Indebtedness greater than
         $25,000,000 PROVIDED such Significant Subsidiary incurred such greater
         amount prior to the date a Borrower acquired such Significant
         Subsidiary; PROVIDED that the aggregate Indebtedness of all
         Subsidiaries (including Indebtedness permitted under clause (i) of this
         Section 9.04 but excluding Indebtedness, including Guaranteed
         Obligations, incurred hereunder and Indebtedness under the Senior
         Notes) shall not exceed 25% of Consolidated Tangible Net Worth
         (including newly acquired Subsidiaries on a pro forma basis);

             (vi) in addition to those items listed in clauses (i) through (v)
         Guaranteed Obligations of IVAX (excluding any item of IVAX or its
         Significant Subsidiaries constituting Indebtedness) the outstanding
         amount of which do not exceed in the aggregate $60,000,000; and

            (vii) in addition to those items listed in (i) through (vi)
         additional Indebtedness of IVAX so long as after giving effect thereto
         no Default or Event of Default exists hereunder.

         9.05 LIENS. Incur, create or permit to exist any pledge, Lien, charge
or other encumbrance of any nature whatsoever with respect to any property or
assets now owned or hereafter acquired by such Borrower or any of its
Significant Subsidiaries, other than

              (i) Liens existing as of the date hereof and as set forth in
         SCHEDULE 7.01(G) attached hereto;

             (ii) Liens imposed by law for taxes, assessments or charges of any
         Governmental Authority for claims not yet due or which are being
         contested in good faith by appropriate proceedings and with respect to
         which adequate reserves or other appropriate provisions are being
         maintained in accordance with Generally Accepted Accounting Principles;

                                       72


<PAGE>


            (iii) statutory Liens of landlords and Liens of carriers,
         warehousemen, mechanics, materialmen and other Liens imposed by law or
         created in the ordinary course of business for amounts not yet due or
         which are being contested in good faith by appropriate proceedings and
         with respect to which adequate reserves or other appropriate provisions
         are being maintained in accordance with Generally Accepted Accounting
         Principles;

             (iv) Liens incurred or deposits made in the ordinary course of
         business (including, without limitation, surety bonds and appeal bonds)
         in connection with workers' compensation, unemployment insurance and
         other types of social security benefits or to secure the performance of
         tenders, bids, leases, contracts (other than for the repayment of
         Indebtedness), statutory obligations and other similar obligations or
         arising as a result of progress payments under government contracts;

              (v) easements (including, without limitation, reciprocal easement
         agreements and utility agreements), rights-of-way, covenants, consents,
         reservations, encroachments, variations and zoning and other
         restrictions, charges or encumbrances (whether or not recorded), which
         do not interfere materially with the ordinary conduct of the business
         of such Borrower or any Significant Subsidiary of such Borrower and
         which do not materially detract from the value of the property to which
         they attach or materially impair the use thereof to such Borrower or
         any Significant Subsidiary of such Borrower; and

             (vi) Liens on property securing Indebtedness assumed in connection
         with a Permitted Acquisition so long as the property securing such
         Indebtedness is acquired (or the Person owing such property is
         acquired) in such Permitted Acquisition.

            (vii) purchase money Liens to secure Indebtedness permitted under
         Section 9.04(vii) hereof so long as such Indebtedness is incurred to
         purchase fixed assets, the Indebtedness represents not less than 75% of
         the purchase price of such assets, and no other property other than the
         property acquired with the proceeds of such Indebtedness secures such
         Indebtedness, provided that the total amount of such Indebtedness
         secured by purchase money Liens, including that described in SCHEDULE
         7.01(G) but excluding those securing Indebtedness paid with the
         proceeds of the Loan, at no time exceeds 10% of Consolidated
         Shareholders' Equity.

         9.06 TRANSFER OF ASSETS. Sell, lease, transfer or otherwise dispose of
(i) any interest in any Significant Subsidiary provided that if either of the
Specialty Chemicals Group or the Personal Care Product Group become Significant
Subsidiaries, IVAX may dispose of either one or both of such groups PROVIDED (A)
no Default or Event of Default would result from such disposition, and

                                       73


<PAGE>


(B) since March 1, 1996 IVAX has not made contributions to such groups without
fair consideration, of net assets which exceed, in the aggregate $20,000,000 in
book value and (C) Significant Subsidiaries of IVAX have not made contributions,
loans or advances to such groups of any assets, which exceed, in the aggregate,
$1,000,000 in book value; or (ii) any other asset of Borrower which has a book
value or sales price in excess of $50,000,000 unless the Borrower shall have
furnished the Administrative Agent with a certificate in the form of EXHIBIT F
demonstrating that after giving effect to such transfer on a pro forma
historical basis as at the most recent date for which a certificate has been
delivered to the Administrative Agent under Section 8.01 hereof such transfer
will not result in a Default or Event of Default hereunder; PROVIDED, HOWEVER,
that IVAX (x) may sell, transfer, spin off or otherwise dispose of Specialty
Chemicals Group or Personal Care Products Group without furnishing such
certificate to the Administrative Agent if the total assets of such group
disposed of is less than $100,000,000 and $75,000,000, respectively, and (y) may
engage in the Receivables Program; PROVIDED, FURTHER, that the Borrowers and
their Significant Subsidiaries may transfer assets to one another.

         9.07 INVESTMENTS; ACQUISITIONS. Purchase, own, invest in or otherwise
acquire, directly or indirectly, any stock or other securities or all or
substantially all of the assets, or make or permit to exist any interest
whatsoever in any other Person or permit to exist any loans or advances to any
Person; PROVIDED, Borrowers and their Significant Subsidiaries may make loans or
advances to, maintain investments or invest in or acquire, without duplication
or aggregation

              (i) Eligible Securities;

             (ii) eighty percent (80%) or more of the stock or other equity
         interests, or all or substantially all of the assets of another Person
         (or a line of business or division of such other Person) provided that
         such acquisition is a Permitted Acquisition;

            (iii) investments existing as of the date hereof and as set forth in
         SCHEDULE 7.01(D) and SCHEDULE 7.01(E) attached hereto and loans and
         advances listed on SCHEDULE 9.07(iii) attached hereto;

             (iv) accounts receivable arising and trade credit granted in the
         ordinary course of business and any securities received in satisfaction
         or partial satisfaction thereof in connection with accounts of
         financially troubled Persons to the extent reasonably necessary in
         order to prevent or limit loss;

              (v) investments in securities rated BBB+ and Baa1 or better by S&P
         and Moody's, respectively;

                                       74


<PAGE>


             (vi) loans and advances to or cash investments in any other Person
         which is less than 80% owned by such Borrower in an aggregate
         outstanding amount (to be determined at the time of any such loan,
         advance or investment) not to exceed 7.5% of Consolidated Shareholders'
         Equity;

            (vii) loans and advances to and investments in Subsidiaries of which
         more than 80% of the outstanding stock is owned by such Borrower and is
         not a Guarantor in an aggregate outstanding amount (to be determined at
         the time of any such loan, advance or investment) not to exceed 7.5% of
         Consolidated Shareholders' Equity;

           (viii) loans, advances and investments in Guarantors; and

             (ix) investments made with the common stock of Borrower or, to the
         extent not prohibited under Section 9.11, investments made in any
         Person with noncash assets of the Borrower or its Subsidiaries so long
         as after giving effect to such investment no Default or Event of
         Default shall exist hereunder giving effect to any such investment on a
         pro forma basis.

         9.08 MERGER OR CONSOLIDATION. (a) Consolidate with or merge into any
other Person, or (b) permit any other Person to merge into it; provided,
however, (i) any Significant Subsidiary of a Borrower may merge or transfer all
or substantially all of its assets into or consolidate with any other
Significant Subsidiary or a Borrower, (ii) any Person may merge with a Borrower
or any Significant Subsidiary if such Borrower or such Significant Subsidiary
shall be the survivor thereof and such merger shall not cause, create or result
in the occurrence on any Default or Event of Default hereunder and (iii) any
Significant Subsidiary may merge into any Subsidiary if such Subsidiary shall do
all things pursuant to Section 8.19 to become a Significant Subsidiary.

         9.09 RESTRICTED PAYMENTS. In respect of IVAX, declare or pay in respect
of any Four-Quarter Period any dividends (other than those payable solely in
capital stock) or distributions, in reduction of capital or otherwise in respect
of any equity interest, or purchase, redeem or otherwise retire any such equity
interest in excess of 35% of Consolidated Net Income for such Four- Quarter
Period; PROVIDED that no distribution shall be made to the extent such
distribution would result in the occurrence of any Default or Event of Default
hereunder, including without limitation any violation of any of the other
provisions of Article IX hereof.

         9.10 CHANGE IN CONTROL. Cause, suffer or permit any Person or group of
Persons other than the owners, if any, of more than 49% of outstanding
securities of IVAX as of the Closing Date having voting rights in the election
of directors, to own or control, directly or indirectly, more than 49% of the
outstanding securities of (on a fully diluted basis and taking into account any

                                       75


<PAGE>


outstanding securities or contract rights exercisable, exchangeable or
convertible into equity interests) IVAX having voting rights in the election of
directors.

         9.11 TRANSACTIONS WITH AFFILIATES. Enter into any transaction after the
date hereof, including, without limitation, the purchase, sale, leasing or
exchange of property, real or personal, or the rendering of any service, with
any Affiliate of such Borrower that is not a Subsidiary, except (a) that such
Persons may render services to such Borrower or its Subsidiaries for
compensation at the same rates generally paid by Persons engaged in the same or
similar businesses for the same or similar services and (b) in the ordinary
course of and pursuant to the reasonable requirements of such Borrower's (or any
Subsidiary's) business consistent with past practice of such Borrower and its
Subsidiaries and upon fair and reasonable terms no less favorable to such
Borrower (or any Subsidiary) than would be obtained in a comparable arm's-length
transaction with a Person not an Affiliate.

         9.12 ERISA. With respect to all employee pension benefit plans
maintained by such Borrower or any Subsidiary of such Borrower:

              (i) terminate any of such employee pension benefit plans so as to
         incur any liability to the Pension Benefit Guaranty Corporation
         established pursuant to ERISA or to any other Person exercising similar
         duties and functions under any Foreign Benefit Law;

             (ii) allow or suffer to exist any prohibited transaction involving
         any of such employee pension benefit plans or any trust created
         thereunder which would subject such Borrower or a Subsidiary of such
         Borrower to a tax or penalty or other liability (A) on prohibited
         transactions imposed under Internal Revenue Code Section 4975 or ERISA
         or (B) under any Foreign Benefit Law;

            (iii) fail to pay to any such employee pension benefit plan any
         contribution which it is obligated to pay under the terms of such plan;

             (iv) allow or suffer to exist any accumulated funding deficiency,
         whether or not waived, with respect to any such employee pension
         benefit plan;

              (v) allow or suffer to exist any occurrence of a reportable event
         or any other event or condition, which presents a material risk of
         termination by the Pension Benefit Guaranty Corporation of any such
         employee pension benefit plan that is a Single Employer Plan, which
         termination could result in any liability (A) to the Pension Benefit
         Guaranty Corporation or (B) under any Foreign Benefit Law; or

                                       76


<PAGE>


             (vi) incur any withdrawal liability with respect to any
         Multi-employer Plan.

         9.13  FISCAL YEAR.  Change its Fiscal Year.

         9.14 DISSOLUTION, ETC. Wind up, liquidate or dissolve (voluntarily or
involuntarily) or commence or suffer any proceedings seeking any such winding
up, liquidation or dissolution, except in connection with the merger or
consolidation of Subsidiaries into each other or into a Borrower permitted
pursuant to Section 9.08. Nothing contained herein shall prevent the
liquidation, dissolution or winding up of a Subsidiary so long as the assets of
such Subsidiary are transferred to the Borrower, a Significant Subsidiary or a
Subsidiary that shall become a significant Subsidiary pursuant to Section 8.19,
by operation of law or otherwise.

         9.15 RATE HEDGING OBLIGATIONS. Incur any Rate Hedging Obligations or
enter into any agreements, arrangements, devices or instruments relating to Rate
Hedging Obligations except (i) those entered into with respect to Indebtedness
of such Borrower or its Significant Subsidiaries, and (ii) those which are
entered into in order to minimize risk associated with transactions arising in
the ordinary course of business and are not entered into for speculative
purpose.

                                       77


<PAGE>


                                    ARTICLE X

                       EVENTS OF DEFAULT AND ACCELERATION

         10.01 EVENTS OF DEFAULT. If any one or more of the following events
(herein called "Events of Default") shall occur for any reason whatsoever (and
whether such occurrence shall be voluntary or involuntary or come about or be
effected by operation of law or pursuant to or in compliance with any judgment,
decree or order of any court or any order, rule or regulation of any
administrative or governmental body), that is to say:

                  (a) if default shall be made in the due and punctual payment
         of the principal of any Loan when and as the same shall be due and
         payable whether pursuant to any provision of Article II or Article III
         hereof, at maturity, by acceleration or otherwise; or

                  (b) if default shall be made in the due and punctual payment
         of any amount of interest on any Loan, Reimbursement Obligation or of
         any fees or other amounts payable to the Lenders or the Administrative
         Agent under the Loan Documents within five Business Days of the date on
         which the same shall be due and payable; or

                  (c) if default shall be made in the performance or observance
         of any covenant set forth in Section 8.07 which is not cured within
         three Business Days after receipt of notice of such default, or if
         default shall be made in the performance or observance of any covenant
         set forth in Sections 8.06, 8.10, 8.18, 8.19 or 9.04 through 9.15
         hereof;

                  (d) if a default shall be made in the performance or
         observance of, or shall occur under, any covenant, agreement or
         provision contained in this Agreement or the Notes (other than as
         described in clauses (a), (b) or (c) above) and such default shall
         continue for 30 or more days after the earlier of receipt of notice of
         such default by the Authorized Representative from the Administrative
         Agent or the date that the President, Chief Financial Officer, Chief
         Operating Officer or Vice President--Finance of either of the Borrowers
         becomes aware of such default, or if a default shall be made in the
         performance or observance of, or shall occur under, any covenant,
         agreement or provision contained in any of the other Loan Documents
         (beyond any applicable grace period, if any, contained therein) or in
         any instrument or document evidencing or creating any obligation,
         guaranty, or Lien in favor of the Administrative Agent or the Lenders
         or delivered to the Administrative Agent or the Lenders in connection
         with or pursuant to this Agreement or any of the Obligations (beyond
         any applicable grace period, if any, contained therein), or if any Loan
         Document ceases to be in full force and effect (other than by reason of
         any action by the Administrative Agent), or

                                       78


<PAGE>


         if without the written consent of the Administrative Agent, this
         Agreement or any other Loan Document shall be disaffirmed by either of
         the Borrowers or any Guarantor or shall terminate, be terminable or be
         terminated or become void or unenforceable for any reason whatsoever
         (other than in accordance with its terms in the absence of default or
         by reason of any action by the Administrative Agent); or

                  (e) if a default shall occur, which is not waived or cured
         within any applicable cure period, (i) in the payment of any principal,
         interest, premium or other amounts with respect to any Indebtedness
         (other than the Loans) of either of the Borrowers or of any Significant
         Subsidiary in an amount not less than $10,000,000 in the aggregate
         outstanding, or (ii) in the performance, observance or fulfillment of
         any term or covenant contained in any agreement or instrument under or
         pursuant to which any such Indebtedness may have been issued, created,
         assumed, guaranteed or secured by either of the Borrowers or any
         Significant Subsidiary, and such default shall continue for more than
         the period of grace, if any, therein specified, or if such default
         shall permit the holder of any such Indebtedness to accelerate the
         maturity thereof; or

                  (f) if any representation, warranty or other statement of fact
         contained herein or any other Loan Document or in any writing,
         certificate, report or statement at any time furnished to the
         Administrative Agent or any Lender by or on behalf of the Borrowers or
         any Guarantor pursuant to or in connection with this Agreement or the
         other Loan Documents, or otherwise, shall be false or misleading in any
         material respect when given or on the date as of which the facts set
         forth therein are stated or certified, as the case may be; or

                  (g) if either of the Borrowers or any Significant Subsidiary
         shall be unable to pay its debts generally as they become due; file a
         petition to take advantage of any insolvency statute; make an
         assignment for the benefit of its creditors; commence a proceeding for
         the appointment of a receiver, trustee, liquidator or conservator of
         itself or of the whole or any substantial part of its property; file a
         petition or answer seeking reorganization or arrangement or similar
         relief under the federal bankruptcy laws or any other applicable law or
         statute; or

                  (h) if a court of competent jurisdiction shall enter an order,
         judgment or decree appointing a custodian, receiver, trustee,
         liquidator or conservator of either of the Borrowers or any Significant
         Subsidiary or of the whole or any substantial part of its properties
         and such order, judgment or decree continues unstayed and in effect for
         a period of sixty (60) days, or approve a petition filed against either
         of the Borrowers or any Significant Subsidiary seeking reorganization

                                       79


<PAGE>


         or arrangement or similar relief under the federal bankruptcy laws or
         any other applicable law or statute of the United States of America or
         any state, which petition is not dismissed within thirty (30) days; or
         if, under the provisions of any other law for the relief or aid of
         debtors, a court of competent jurisdiction shall assume custody or
         control of either of the Borrowers or any Significant Subsidiary or of
         the whole or any substantial part of its properties, which control is
         not relinquished within sixty (60) days; or if there is commenced
         against either of the Borrowers or any Significant Subsidiary any
         proceeding or petition seeking reorganization, arrangement or similar
         relief under the federal bankruptcy laws or any other applicable law or
         statute of the United States of America or any state which proceeding
         or petition remains undismissed for a period of thirty (30) days; or if
         either of the Borrowers or any Significant Subsidiary takes any action
         to indicate its consent to or approval of any such proceeding or
         petition; or

                  (i) if (i) any judgment where the amount not covered by
         insurance (or the amount as to which the insurer denies liability) is
         in excess of $10,000,000 is rendered against either of the Borrowers or
         any Subsidiary, or (ii) there is any attachment, injunction or
         execution against any of the Borrowers' or any Subsidiary's properties
         for any amount in excess of $10,000,000; and such judgment, attachment,
         injunction or execution remains unpaid, unstayed, undischarged,
         unbonded or undismissed for a period of thirty (30) days; or

                  (j) if either of the Borrowers or any Significant Subsidiary
         shall, other than in the ordinary course of business (as determined by
         past practices), suspend all or any part of its operations material to
         the conduct of the business of either of the Borrowers or IVAX and its
         Subsidiaries, taken as a whole; or

                  (k) if (i) either of the Borrowers or any Subsidiary shall
         engage in any prohibited transaction (as described in Section 9.14(ii)
         hereof), which is not subject to a statutory or administrative
         exemption, involving any employee pension benefit plan of either of the
         Borrowers or any Subsidiary, (ii) any accumulated funding deficiency
         (as referred to in Section 9.14(iv) hereof), whether or not waived,
         shall exist with respect to any Single Employer Plan, (iii) a
         reportable event (as referred to in Section 9.14(v) hereof) (other than
         a reportable event for which the statutory notice requirement to the
         Pension Benefit Guaranty Corporation has been waived by regulation)
         shall occur with respect to, or proceedings shall commence to have a
         trustee appointed, or a trustee shall be appointed to administer or to
         terminate, any Single Employer Plan, which reportable event or
         institution or proceedings is, in the reasonable opinion of the
         Required Lenders, likely to result in the termination of such Single
         Employer Plan for

                                       80


<PAGE>


         purposes of Title IV of ERISA, and in the case of such a reportable
         event, the continuance of such reportable event shall be unremedied for
         sixty (60) days after notice of such reportable event pursuant to
         Section 4043(a), (c) or (d) of ERISA is given, as the case may be, (iv)
         any Single Employer Plan shall terminate for purposes of Title IV of
         ERISA, and such termination results in a material liability of either
         of the Borrowers or any Subsidiary to such Single Employer Plan or the
         Pension Benefit Guaranty Corporation, (v) either of the Borrowers or
         any Subsidiary shall withdraw from a Multi- employer Plan for purposes
         of Title IV of ERISA, and, as a result of any such withdrawal, either
         of the Borrowers or any Subsidiary shall incur withdrawal liability to
         such Multi- employer Plan, or (vi) any other event or condition shall
         occur or exist with respect to any Single Employer Plan or
         Multi-employer Plan; and in each case in clauses (i) through (vi) of
         this Section 10.01(k), such event or condition, together with all other
         such events or conditions, if any, would subject either of the
         Borrowers or any Subsidiary to any tax, penalty or other liabilities
         equal to or in excess of $10,000,000, and in each such case the event
         or condition is not remedied to the satisfaction of the Required
         Lenders within ninety (90) days after the earlier of (i) receipt of
         notice of such event or condition by the Authorized Representative from
         the Administrative Agent or (ii) either of the Borrowers becomes aware
         of such event or condition; notwithstanding the foregoing, if either of
         the Borrowers or any Subsidiary maintains an employee pension benefit
         plan subject to Title IV of ERISA under which at any time the present
         value of vested accrued benefits exceeds the then current value of the
         assets of such plan allocable to such benefits, the existence of such
         excess shall not constitute an Event of Default so long as no
         accumulated funding deficiency exists that could subject either of the
         Borrowers or any Subsidiary to any tax under Internal Revenue Code
         Section 4971 with respect to such plan; or

                  (l)  if either of the Borrowers or any Significant
         Subsidiary shall breach any of the terms or conditions of any agreement
         under which any Rate Hedging Obligation in a notional amount in excess
         of $10,000,000 permitted pursuant to Section 9.15 is created and such
         breach shall continue beyond any grace period, if any, relating thereto
         pursuant to the terms of such Obligation, or either of the Borrowers or
         any Significant Subsidiary shall disaffirm or seek to disaffirm any
         such agreement or any of its obligations thereunder; or

                  (m) if the Senior Notes have not been paid in full by April 1,
         1997;

then, and in any such event and at any time thereafter, if such Event of Default
or any other Event of Default shall have not been waived,

                                       81


<PAGE>


                  (A) either or both of the following actions may be taken: (i)
         the Administrative Agent, with the consent of the Required Lenders,
         may, and at the direction of the Required Lenders shall, declare any
         obligation of the Lenders to make further Loans or issue Letters of
         Credit terminated, whereupon the obligation of each Lender to make
         further Loans or issue Letters of Credit, hereunder shall terminate
         immediately, and (ii) the Administrative Agent shall at the direction
         of the Required Lenders, at their option, declare by notice to the
         Borrowers any or all of the Obligations to be immediately due and
         payable, and the same, including all interest accrued thereon and all
         other obligations of the Borrowers to the Administrative Agent and the
         Lenders, shall forthwith become immediately due and payable without
         presentment, demand, protest, notice or other formality of any kind,
         all of which are hereby expressly waived, anything contained herein or
         in any instrument evidencing the Obligations to the contrary
         notwithstanding; PROVIDED, however, that notwithstanding the above, if
         there shall occur an Event of Default under clause (g) or (h) above,
         then the obligation of the Lenders to lend and issue Letters of Credit
         hereunder shall automatically terminate and any and all of the
         Obligations shall be immediately due and payable without the necessity
         of any action by the Administrative Agent or the Required Lenders or
         notice to the Administrative Agent or the Lenders;

                  (B) The Borrowers shall, upon demand of the Administrative
         Agent or the Required Lenders, deposit cash with the Administrative
         Agent in accordance with the LC Account Agreement in an amount equal to
         the amount of any Letters of Credit remaining undrawn or unpaid, as
         collateral security for the repayment of any future drawings or
         payments under such Letters of Credit and the Borrowers shall forthwith
         deposit and pay such amounts and such amounts shall be held by the
         Administrative Agent pursuant to the terms of the applicable
         Application and Agreement for Letter of Credit;

                  (C) the Administrative Agent and the Lenders shall have all of
         the rights and remedies available under the Loan Documents or under any
         applicable law. In addition, from and after the occurrence of a Default
         or Event of Default the indebtedness evidenced by the Notes shall bear
         interest at the Default Rate and the Unused Fee shall be 20 basis
         points.

         10.02 ADMINISTRATIVE AGENT TO ACT. In case any one or more Events of
Default shall occur and not have been waived, the Administrative Agent may, and
at the direction of the Required Lenders shall, proceed to protect and enforce
their rights or remedies either by suit in equity or by action at law, or both,

                                       82


<PAGE>



whether for the specific performance of any covenant, agreement or other
provision contained herein or in any other Loan Document, or to enforce the
payment of the Obligations or any other legal or equitable right or remedy.

         10.03 CUMULATIVE RIGHTS. No right or remedy herein conferred upon the
Lenders or the Administrative Agent is intended to be exclusive of any other
rights or remedies contained herein or in any other Loan Document, and every
such right or remedy shall be cumulative and shall be in addition to every other
such right or remedy contained herein and therein or now or hereafter existing
at law or in equity or by statute, or otherwise.

         10.04 NO WAIVER. No course of dealing between the Borrowers and any
Lender or the Administrative Agent or any failure or delay on the part of any
Lender or the Administrative Agent in exercising any rights or remedies under
any Loan Document or otherwise available to it shall operate as a waiver of any
rights or remedies and no single or partial exercise of any rights or remedies
shall operate as a waiver or preclude the exercise of any other rights or
remedies hereunder or of the same right or remedy on a future occasion.

         10.05 DEFAULT. The Administrative Agent and the Lenders shall have no
right to accelerate any of the Loans upon, or to institute any action or
proceeding before any court to realize upon collateral as a result of, the
occurrence of any Default which shall not also constitute an Event of Default;
PROVIDED, however, nothing contained in this sentence shall in any respect
impair or adversely affect the right, power and authority of the Administrative
Agent and the Lenders (i) to take any action expressly required or permitted to
be taken under the Loan Documents upon the occurrence of any Default (and
including any action or proceeding which the Administrative Agent may determine
to be necessary or appropriate in furtherance of any such expressly authorized
action) and (ii) to take any action provided under the Loan Documents or
otherwise available by statute, at law or in equity upon the occurrence of any
Default.

         10.06 ALLOCATION OF PROCEEDS. If an Event of Default has occurred and
not been waived, and the maturity of the Notes has been accelerated pursuant to
Article X hereof, all payments received by the Administrative Agent under the
Loan Documents, in respect of any principal of or interest on the Obligations or
any other amounts payable by the Borrowers hereunder shall be applied by the
Administrative Agent in the following order:

              (i) amounts due to the Lenders pursuant to Sections 2.10, 3.03,
8.13, 12.05 and 12.11 hereof;

             (ii) amounts due to (A) each Issuer pursuant to Section 3.04
hereof, and (B) the Administrative Agent pursuant to Section 11.11 hereof;

                                       83


<PAGE>


            (iii) payments of interest on Loans, to be applied for the ratable
benefit of the Lenders;

             (iv) payments of principal on Loans, to be applied for the ratable
benefit of the Lenders;

              (v) payment of cash amounts to the Administrative Agent in respect
of Outstanding Letters of Credit pursuant to Section 10.01(B) hereof;

             (vi) payment of Obligations owed a Lender or Lenders pursuant to
Swap Agreements on a pro rata basis according to amounts owed;

            (vii) payments of all other amounts due under this Agreement, if
any, to be applied for the ratable benefit of the Lenders; and

           (viii) any surplus remaining after application as provided for
herein, to the Borrowers or otherwise as may be required by applicable law.

         With respect to the books of any Lender, such Lender may apply the
payments received by it against obligations owed it hereunder as it may elect.

                                       84


<PAGE>


                                   ARTICLE XI

                                   THE AGENTS

         11.01 APPOINTMENT. Each Lender hereby irrevocably designates and
appoints NationsBank as the Administrative Agent of the Lenders under this
Agreement, and each of the Lenders hereby irrevocably authorizes the
Administrative Agent as the agent for such Lender, to take such action on its
behalf under the provisions of this Agreement and the other Loan Documents and
to exercise such powers as are expressly delegated to the Administrative Agent
by the terms of this Agreement, together with such other powers as are
reasonably incidental thereto. The Administrative Agent shall not have any
duties or responsibilities, except those expressly set forth herein, or any
fiduciary relationship with any of the Lenders, and no implied covenants,
functions, responsibilities, duties, obligations or liabilities shall be read
into this Agreement or otherwise exist against the Administrative Agent.

         11.02 ATTORNEYS-IN-FACT. The Administrative Agent may execute any of
its duties under this Agreement by or through agents or attorneys-in-fact and
shall be entitled to advice of counsel concerning all matters pertaining to such
duties. The Agents shall not be responsible for the negligence, gross negligence
or willful misconduct of any agents or attorneys-in-fact selected by either of
them with reasonable care.

         11.03 LIMITATION ON LIABILITY. The Administrative Agent nor any of its
officers, directors, employees, agents or attorneys-in-fact shall be liable to
the Lenders for any action lawfully taken or omitted to be taken by it or them
under or in connection with this Agreement except for its or their own gross
negligence or willful misconduct. The Administrative Agent nor any of its
affiliates shall be responsible in any manner to any of the Lenders for any
recitals, statements, representations or warranties made by the Borrowers or any
of their Subsidiaries, or any officer or representative thereof contained in
this Agreement or in any of the other Loan Documents, or in any certificate,
report, statement or other document referred to or provided for in or received
by the Administrative Agent under or in connection with this Agreement, or for
the value, validity, effectiveness, genuineness, enforceability or sufficiency
of this Agreement or any of the other Loan Documents, or for any failure of the
Borrowers to perform their obligations thereunder, or for any recitals,
statements, representations or warranties made, or for the value, validity,
effectiveness, genuineness, enforceability or sufficiency of any collateral. The
Administrative Agent shall not be under any obligation to any of the Lenders to
ascertain or to inquire as to the observance or performance of any of the terms,
covenants or conditions of this Agreement or any of the other Loan Documents on
the part of the Borrowers or to inspect the properties, books or records of the
Borrowers or their Subsidiaries.

                                       85


<PAGE>


         11.04 RELIANCE. The Administrative Agent shall be entitled to rely, and
shall be fully protected in relying, upon any Note, writing, resolution, notice,
consent certificate, affidavit, letter, cablegram, telegram, telecopy or telex
message, statement, order or other document or conversation believed by it to be
genuine and correct and to have been signed, sent or made by the proper Person
or Persons and upon advice and statements of legal counsel (including, without
limitation, counsel to the Borrowers), independent accountants and other experts
selected by the Administrative Agent. The Administrative Agent may deem and
treat the payee of any Note as the owner thereof for all purposes unless an
Assignment shall have been filed with and accepted by the Administrative Agent.
The Administrative Agent shall be fully justified in failing or refusing to take
any action under this Agreement unless it shall first receive advice or
concurrence of the Lenders or the Required Lenders as provided in this Agreement
or it shall first be indemnified to its satisfaction by the Lenders against any
and all liability and expense which may be incurred by it by reason of taking or
continuing to take any such action. The Administrative Agent shall in all cases
be fully protected in acting, or in refraining from acting, under this Agreement
in accordance with a request of the Required Lenders, and such request and any
action taken or failure to act pursuant thereto shall be binding upon all the
Lenders and all present and future holders of the Notes.

         11.05 NOTICE OF DEFAULT. Neither Agent shall be deemed to have
knowledge or notice of the occurrence of any Default or Event of Default
hereunder unless such Agent has received notice from a Lender, the Authorized
Representatives or the Borrowers referring to this Agreement, describing such
Default or Event of Default and stating that such notice is a "notice of
default". In the event that the Administrative Agent receives such a notice, the
Administrative Agent shall promptly give notice thereof to the Lenders. The
Administrative Agent shall take such action with respect to such Default or
Event of Default as shall be reasonably directed by the Required Lenders;
provided that, unless and until the Administrative Agent shall have received
such directions, the Administrative Agent may (but shall not be obligated to)
take such action, or refrain from taking such action, with respect to such Event
of Default as it shall deem advisable in the best interests of the Lenders.

         11.06 NO REPRESENTATIONS. Each Lender expressly acknowledges that
neither of the Administrative Agent nor any of its affiliates has made any
representations or warranties to it and that no act by the Administrative Agent
hereafter taken, including any review of the affairs of the Borrowers or any of
their Subsidiaries, shall be deemed to constitute any representation or warranty
by the Administrative Agent to any Lender. Each Lender represents to the
Administrative Agent that it has, independently and without reliance upon the
Administrative Agent or any other Lender, and based on such documents and
information as it has deemed

                                       86


<PAGE>


appropriate, made its own appraisal of and investigation into the financial
condition, creditworthiness, affairs, status and nature of the Borrowers and
their Subsidiaries and made its own decision to enter into this Agreement. Each
Lender also represents that it will, independently and without reliance upon the
Administrative Agent or any other Lender, and based on such documents and
information as it shall deem appropriate at the time, continue to make its own
credit analysis, appraisals and decisions in taking or not taking action under
this Agreement and to make such investigation as it deems necessary to inform
itself as to the status and affairs, financial or otherwise, of the Borrowers
and their Subsidiaries. Except for notices, reports and other documents
expressly required to be furnished to the Lenders by the Administrative Agent
hereunder, the Administrative Agent shall not have any duty or responsibility to
provide any Lender with any credit or other information concerning the affairs,
financial condition or business of the Borrowers or any of their Subsidiaries
which may come into the possession of the Administrative Agent or any of its
affiliates.

         11.07 INDEMNIFICATION. The Lenders agree to indemnify the
Administrative Agent in its capacity as such (to the extent not reimbursed by
the Borrowers and without limiting any obligations of the Borrowers or any
Subsidiary so to do), ratably according to the respective principal amount of
the Notes held by it (or, if no Notes are outstanding, ratably in accordance
with its Applicable Commitment Percentages as then in effect) from and against
any and all liabilities, obligations, losses, damages, penalties, actions,
judgments, suits, costs, expenses or disbursements of any kind or nature
whatsoever which may at any time (including without limitation at any time
following the payment of the Notes) be imposed on, incurred by or asserted
against the Administrative Agent in any way relating to or arising out of this
Agreement or any other document contemplated by or referred to herein or the
transactions contemplated hereby or any action taken or omitted by the
Administrative Agent under or in connection with any of the foregoing; provided
that no Lender shall be liable for the payment of any portion of such
liabilities, obligations, losses, damages, penalties, actions, judgments, suits,
costs, expenses or disbursements resulting from the gross negligence or willful
misconduct of the Administrative Agent. The agreements in this subsection shall
survive the payment of any of the Obligations and the termination of this
Agreement.

         11.08 LENDER. The Administrative Agent and its affiliates may make
loans to, accept deposits from and generally engage in any kind of business with
the Borrowers and their Subsidiaries as though it was not the Administrative
Agent hereunder. With respect to its Loans made or renewed by it and any Note
issued to it, the Administrative Agent shall have the same rights and powers
under this Agreement as any Lender and may exercise the same as though it were
not an Agent, and the terms "Lender" and "Lenders" shall,

                                       87


<PAGE>


unless the context otherwise indicates, include each Agent in its individual 
capacity.

         11.09 RESIGNATION. If the Administrative Agent shall resign as
Administrative Agent under this Agreement then the Required Lenders may appoint,
with the consent, so long as there shall not have occurred and be continuing a
Default or Event of Default, of the Borrowers, which consent shall not be
unreasonably withheld, a successor Administrative Agent for the Lenders, which
successor Administrative Agent shall be a commercial bank organized or
authorized to do business under the laws of the United States or any state
thereof, having a combined surplus and capital of not less than $500,000,000,
whereupon such successor Administrative Agent shall succeed to the rights,
powers and duties of the former Administrative Agent and the obligations of the
former Administrative Agent shall be terminated and canceled, without any other
or further act or deed on the part of such former Administrative Agent or any of
the parties to this Agreement; PROVIDED, however, that the former Administrative
Agent's resignation shall not become effective until such successor
Administrative Agent has been appointed and has succeeded of record to all
right, title and interest in any collateral held by the Administrative Agent;
PROVIDED, FURTHER, that if the Required Lenders and, if applicable, the
Borrowers cannot agree as to a successor Administrative Agent within ninety (90)
days after such resignation, the Administrative Agent shall appoint a successor
Administrative Agent which satisfies the criteria set forth above in this
Section 11.09 for a successor Administrative Agent and the parties hereto agree
to execute whatever documents are necessary to effect such action under this
Agreement or any other document executed pursuant to this Agreement; PROVIDED,
however that in such event all provisions of this Agreement and the Loan
Documents, shall remain in full force and effect. After any retiring
Administrative Agent's resignation hereunder as Administrative Agent, the
provisions of this Article XI shall inure to its benefit as to any actions taken
or omitted to be taken by it while it was Administrative Agent under this
Agreement.

         11.10 SHARING OF PAYMENTS, ETC. Each Lender agrees that if it shall,
through the exercise of a right of banker's lien, set-off, counterclaim or
otherwise, obtain payment with respect to its Obligations (other than pursuant
to Article IV) which results in its receiving more than its pro rata share of
the aggregate payments with respect to all of the Obligations (other than any
payment pursuant to Article IV), then (A) such Lender shall be deemed to have
simultaneously purchased from the other Lenders a share in their Obligations so
that the amount of the Obligations held by each of the Lenders shall be pro rata
and (B) such other adjustments shall be made from time to time as shall be
equitable to insure that the Lenders share such payments ratably; PROVIDED,
however, that for purposes of this Section 11.10 the term "pro rata" shall be
determined with respect to both the Revolving Credit Commitment of each Lender
and to the Total Revolving Credit

                                       88


<PAGE>


Commitments after subtraction in each case of amounts, if any, by which any such
Lender has not funded its share of the outstanding Loans and Reimbursement
Obligations. If all or any portion of any such excess payment is thereafter
recovered from the Lender which received the same, the purchase provided in this
Section 11.10 shall be rescinded to the extent of such recovery, without
interest. The Borrowers expressly consent to the foregoing arrangements and
agree that each Lender so purchasing a portion of the other Lenders' Obligations
may exercise all rights of payment (including, without limitation, all rights of
set-off, banker's lien or counterclaim) with respect to such portion as fully as
if such Lender were the direct holder of such portion.

         11.11 ADMINISTRATIVE FEES. The Borrowers shall pay to the
Administrative Agent an annual administrative fee in such amount as the
Borrowers and the Administrative Agent have agreed, such fee to be paid annually
in advance beginning on the Closing Date.

                                       89


<PAGE>



                                   ARTICLE XII

                                  MISCELLANEOUS

         12.01  ASSIGNMENTS AND PARTICIPATIONS.

         (a) At any time after the Closing Date each Lender may, with the prior
consent of the Administrative Agent, the Syndication Agent and the Borrowers,
which consents shall not be unreasonably withheld (it being understood that
consent may be withheld by the Borrowers if such assignment would subject the
Borrowers to the payment of any additional amounts pursuant to the provisions of
Article IV hereof), assign to one or more banks or financial institutions all or
a portion of its rights and obligations under this Agreement (including, without
limitation, all or a portion of the Notes payable to its order); PROVIDED, that
(i) each such assignment shall be of a constant, and not a varying, percentage
of all of the assigning Lender's rights and obligations (including Loans and
Participations) under this Agreement, (ii) for each assignment involving the
issuance and transfer of Notes, the assigning Lender shall execute an Assignment
and Acceptance and the Borrowers hereby consent to execute replacement Notes to
give effect to the assignment, (iii) the minimum Revolving Credit Commitment
which shall be assigned is $5,000,000 (together with which the assigning
Lender's applicable portion of Participations and the Letter of Credit
Commitment shall also be assigned) in the case of Lenders existing on the
Closing Date and $10,000,000 (together with which the assigning Lender's
applicable portion of Participations and the Letter of Credit Commitment shall
also be assigned) in the case of any financial institution becoming a Lender
after the Closing Date and (iv) such assignee shall have an office located in
the United States. Upon such execution, delivery, approval and acceptance, from
and after the effective date specified in each Assignment and Acceptance, (x)
the assignee thereunder shall be a party hereto and, to the extent that rights
and obligations hereunder or under such Notes have been assigned or negotiated
to it pursuant to such Assignment and Acceptance have the rights and obligations
of a Lender hereunder and a holder of such Notes and (y) the assignor thereunder
shall, to the extent that rights and obligations hereunder or under such Notes
have been assigned or negotiated by it pursuant to such Assignment and
Acceptance, relinquish its rights and be released from its obligations under
this Agreement. No assignee shall have the right to further assign its rights
and obligations pursuant to this Section 12.01. Any Lender who makes an
assignment shall pay to the Administrative Agent a one-time administrative fee
of $4,000.00 which fee shall not be reimbursed by the Borrowers.

         (b) By executing and delivering an Assignment and Acceptance, the
Lender assignor thereunder and the assignee thereunder confirm to and agree with
each other and the other parties hereto as follows: (i) the assignment made
under such Assignment and Acceptance is made under such Assignment and
Acceptance without

                                       90


<PAGE>


recourse; (ii) such assigning Lender makes no representation or warranty and
assumes no responsibility with respect to the financial condition of the
Borrowers or any Subsidiary or the performance or observance by the Borrowers or
any Subsidiary of any of their obligations under any Loan Document or any other
instrument or document furnished pursuant hereto; (iii) such assignee confirms
that it has received a copy of this Agreement, together with copies of the
financial statements delivered pursuant to Section 7.01 or Section 8.01, as the
case may be, and such other Loan Documents and other documents and information
as it has deemed appropriate to make its own credit analysis and decision to
enter into such Assignment and Acceptance; (iv) such assignee will,
independently and without reliance upon the Administrative Agent, such assigning
Lender or any other Lender and based on such documents and information as it
shall deem appropriate at the time, continue to make its own credit decisions in
taking or not taking action under this Agreement; (v) such assignee appoints and
authorizes the Administrative Agent to take such action as agents on its behalf
and to exercise such powers under this Agreement, the Notes and the other Loan
Documents as are delegated to the Administrative Agent by the terms hereof and
thereof, together with such powers as are reasonably incidental thereto; and
(vi) such assignee agrees that it will perform in accordance with their terms
all of the obligations which by the terms of this Agreement are required to be
performed by it as a Lender and a holder of such Notes.

         (c) The Administrative Agent shall maintain at its address referred to
herein a copy of each Assignment and Acceptance delivered to and accepted by it.

         (d) Upon its receipt of an Assignment and Acceptance executed by an
assigning Lender, the Administrative Agent shall give prompt notice thereof to
Borrowers.

         (e) Each Lender may sell participations at its expense, and subject to
the prior written approval by Borrowers of such participant, which approval
shall not be unreasonably withheld, to one or more banks or other entities as to
all or a portion of its rights and obligations under this Agreement; PROVIDED,
that (i) such Lender's obligations under this Agreement shall remain unchanged,
(ii) such Lender shall remain solely responsible to the other parties hereto for
the performance of such obligations, (iii) such Lender shall remain the holder
of any Note issued to it for the purpose of this Agreement, (iv) such
participations shall be in a minimum amount of $5,000,000 and shall include an
allocable portion of such Lender's Participation, and (v) Borrowers, the
Administrative Agent and the other Lenders shall continue to deal solely and
directly with such Lender in connection with such Lender's rights and
obligations under this Agreement and with regard to any and all payments to be
made under this Agreement; PROVIDED, that the participation agreement between a
Lender and its participants may provide that such Lender will obtain the
approval

                                       91


<PAGE>


of such participant prior to such Lender's agreeing to any amendment or waiver
of any provisions of this Agreement which would (A) extend the maturity of any
scheduled payment of the Obligations, (B) reduce the interest rates, unused fee
or Letter of Credit fee hereunder, (C) increase or extend the Revolving Credit
Termination Date or the Revolving Credit Commitment of the Lender granting the
participation or (D) release any Guarantor, and (vi) the sale of any such
participations which require Borrowers to file a registration statement with the
United States Securities and Exchange Commission or under the securities
regulations or laws of any state shall not be permitted.

         (f) So long as no Default or Event of Default exist hereunder, the
Borrowers may, with the prior written consent of the Administrative Agent, cause
any Lender to be replaced by a financial institution not a party to this
Agreement by (i) delivering to the Administrative Agent an Assignment and
Acceptance executed by such financial institution whereby such financial
institution accepts assignment of the Revolving Credit Commitment of the Lender
to be replaced and (ii) causing there to be delivered to the Lender an amount
equal to the Applicable Commitment Percentage of the Revolving Credit Debit
Balance of the Lender to be replaced. Upon receipt by the Lender to be replaced
of notice from the Administrative Agent of fulfillment of the conditions set
forth above, the Lender to be replaced agrees to execute the Assignment and
Acceptance and upon receipt of payment of all Obligations owing to it, together
with any amounts payable pursuant to Section 4.04 as a result of such required
assignment shall deliver to the Administrative Agent its Notes marked paid all
in the manner set forth in Section 12.01(a); provided, however, that the
Borrowers shall be responsible for the payment of the administrative fee
described therein.

         (g) Notwithstanding anything to the contrary contained herein or in any
of the other Loan Documents, any Lender may assign all or any portion of its
rights and obligations under the Loan Documents and the Notes to any affiliate
of such Lender, and any Lender may pledge all or any portion of its interest
under the Loan Documents and the Notes to any Federal Reserve Bank as security
for obligations of such Lender to the Board, without the consent of the
Borrower, the Agent or any other Lender and without the payment of the
administrative fee referred to in Section 12.01(a). Any Lender making an
assignment pursuant to this subsection shall give notice of such assignment to
the Borrowers and the Administrative Agent.

         12.02 NOTICES. Any notice shall be conclusively deemed to have been
received by any party hereto and be effective on the day on which delivered to
such party (against receipt therefor) at the address set forth below or such
other address as such party shall specify to the other parties in writing (or,
in the case of notice by telecopy, telegram or telex (where the receipt of such
message is verified by return), when received at such telecopy or telex number
as may from time to time be specified in written or verbal

                                       92


<PAGE>


notice to the other parties hereto or otherwise received), or if sent prepaid by
certified or registered mail return receipt requested on the third Business Day
after the day on which mailed, addressed to such party at said address:

                  (a)      if to the Borrowers:

                           IVAX Corporation
                           4400 Biscayne Boulevard, 12th Floor
                           Miami, Florida 33137-3227
                           Attention:  General Counsel
                           Telephone:  (305) 575-6037
                           Telefacsimile:  (305) 575-6048

                  (b)  if to the Administrative Agent:

                           NationsBank, N.A.
                           100 S.E. Second Street, 14th Floor
                           Miami, Florida 33131
                           Attention:  Corporate Finance
                           Telephone:     305-533-2421
                           Telefacsimile: 305-533-2437

                           with a copy to:

                           NationsBank, N.A.
                           Independence Center, 15th Floor
                           Charlotte, North Carolina  28255
                           Attention:  Tonya Sloan,
                                       Corporate Credit Support - Agency
                                       Services
                           Telephone:     704-388-3916
                           Telefacsimile: 704-386-9923

                  (c)      if to the Syndication Agent:

                           BA Securities, Inc.
                           335 Madison Avenue, 5th Floor
                           New York, New York 10017
                           Attention: Robert Karen
                           Telephone: (212) 503-7945
                           Telefacsimile: (212) 503-7355

                  (d)  if to the Lenders:

                           At the addresses set forth on the signature pages
                           hereof and on the signature page of each Assignment
                           and Acceptance.

         12.03 SETOFF. The Borrowers agrees that the Administrative Agent and
each Lender shall have a lien for all the Obligations of the Borrowers upon all
deposits or deposit accounts, of any kind, or any interest in any deposits or
deposit accounts thereof, now or

                                       93


<PAGE>


hereafter pledged, mortgaged, transferred or assigned to the Administrative
Agent or such Lender or otherwise in the possession or control of the
Administrative Agent or such Lender (other than for safekeeping) for any purpose
for the account or benefit of the Borrowers and including any balance of any
deposit account or of any credit of the Borrowers with the Administrative Agent
or such Lender, whether now existing or hereafter established, hereby
authorizing the Administrative Agent and each Lender at any time or times with
or without prior notice to apply such balances or any part thereof to such of
the Obligations of the Borrowers to the Lenders then past due and in such
amounts as they may elect, and whether or not the collateral or the
responsibility of other Persons primarily, secondarily or otherwise liable may
be deemed adequate. For the purposes of this paragraph, all remittances and
property shall be deemed to be in the possession of the Administrative Agent or
such Lender as soon as the same may be put in transit to it by mail or carrier
or by other bailee. Notwithstanding the foregoing, the amount of set off with
respect to deposits of NHL shall be limited to the amount set forth in Section
5.01.

         12.04 SURVIVAL. All covenants, agreements, representations and
warranties made herein shall survive the making by the Lenders of the Loans and
the expiration of the Letters of Credit and the execution and delivery to the
Lenders of this Agreement and the Notes and shall continue in full force and
effect so long as any of Obligations remain outstanding or any Lender has any
commitment hereunder or the Borrowers have continuing obligations hereunder
unless otherwise provided herein. Whenever in this Agreement, any of the parties
hereto is referred to, such reference shall be deemed to include the successors
and permitted assigns of such party and all covenants, provisions and agreements
by or on behalf of the Borrowers which are contained in this Agreement, the
Notes and the other Loan Documents shall inure to the benefit of the successors
and permitted assigns of the Lenders or any of them. Neither Borrower shall
assign any of its rights or obligations hereunder without the consent of all
Lenders.

         12.05 EXPENSES. The Borrowers agree (a) to pay or reimburse the
Administrative Agent for all of its reasonable and customary out-of-pocket costs
and expenses incurred in connection with the preparation, negotiation and
execution of, and any amendment, supplement or modification to, this Agreement
or any of the other Loan Documents (including travel expenses relating to
closing), and the consummation of the transactions contemplated hereby and
thereby up to the amount previously agreed to, including, without limitation,
(x) the reasonable and customary fees and disbursements of counsel to the
Administrative Agent, which shall not exceed the amount previously agreed to,
(y) the reasonable costs of in-house legal services incurred by the Syndication
Agent and (z) the reasonable out-of-pocket fees and expenses relating to
syndication and closing of the transaction provided herein of up to the amount
previously agreed to; (b) to pay or reimburse the Administrative

                                       94


<PAGE>


Agent and the Lenders for all their reasonable costs and expenses incurred in
connection with the enforcement or preservation of any rights under this
Agreement and the other Loan Documents, including without limitation, the
reasonable fees and disbursements of their counsel and any payments in
indemnification or otherwise payable by the Lenders to the Administrative Agent
pursuant to the Loan Documents, (c) to pay, indemnify and hold the
Administrative Agent and the Lenders harmless from any and all recording and
filing fees and any and all liabilities with respect to, or resulting from any
failure to pay or delay in paying, documentary, stamp, excise and other similar
taxes, if any, which may be payable or determined to be payable in connection
with the execution and delivery of this Agreement or any other Loan Documents,
or consummation of any amendment, supplement or modification of, or any waiver
or consent under or in respect of, this Agreement or any other Loan Documents,
and (d) to pay, indemnify, and hold the Administrative Agent and the Lenders
harmless from and against any and all other liabilities, obligations, losses,
damages, penalties, actions, judgments, suits, costs, expenses or disbursements
of any kind or nature whatsoever with respect to the execution, delivery,
enforcement, performance and administration of this Agreement and the other Loan
Documents or in any respect relating to the transactions contemplated hereby or
thereby, (all the foregoing, collectively, the "indemnified liabilities");
PROVIDED, HOWEVER, that the Borrowers shall have no obligation hereunder with
respect to indemnified liabilities arising from (i) the willful misconduct or
gross negligence of or the willful breach of the Loan Documents by the party
seeking indemnification, (ii) legal proceedings commenced against the
Administrative Agent or any Lender by any security holder or creditor thereof
arising out of and based upon rights afforded any such security holder or
creditor solely in its capacity as such, (iii) any taxes imposed upon the
Administrative Agent or any Lender other than the documentary, stamp, excise and
similar taxes described in clause (c) above or any tax resulting from any
Regulatory Change, which tax would be payable to Lenders by Borrowers pursuant
to Article IV hereof, (iv) taxes imposed and costs and expenses incurred as a
result of a transfer or assignment of any Note, participation or assignment of a
portion of its rights or (v) any taxes imposed upon or any costs or expenses
incurred by any transferee of any Note. The agreements in this subsection shall
survive repayment of the Notes and all other Obligations hereunder.

         12.06 AMENDMENTS. No amendment, modification or waiver of any provision
of this Agreement or any of the Loan Documents and no consent by the Lenders to
any departure therefrom by the Borrowers shall be effective unless such
amendment, modification or waiver shall be in writing and signed by the Required
Lenders or by the Administrative Agent with the written consent of the Required
Lenders, and the same shall then be effective only for the period and on the
conditions and for the specific instances and purposes specified in such
writing; PROVIDED, however, that, no such amendment, modification or waiver

                                       95


<PAGE>


              (i) which changes, extends or waives any provision of Section
         11.10 or this Section 12.06, the amount of or the due date of any
         scheduled installment of or the rate of interest payable on any
         Obligation, changes the definition of Required Lenders, which permits
         an assignment by Borrowers of their Obligations hereunder, which
         reduces the required consent of Lenders provided hereunder (other than
         as provided in Section 4.05 hereof), which increases, decreases or
         extends the Revolving Credit Commitment of any Lender or which
         increases or extends the Letter of Credit Facility or which waives any
         condition to the making of any Loan or issuing any Letter of Credit
         shall be effective unless in writing and signed by each of the Lenders;
         PROVIDED, however, the Required Lenders may in their sole discretion
         waive any Default or Event of Default (other than any Default or Event
         of Default under Section 10.01(a), (b), (g) or (h));

             (ii) which releases a Guarantor shall be effective unless with the
         written consent of each of the Lenders; or

            (iii) which affects the rights, privileges, immunities or
         indemnities of the Administrative Agent shall be effective unless in
         writing and signed by the Administrative Agent.

Notwithstanding any provision of the other Loan Documents to the contrary, as
between the Administrative Agent and the Lenders, execution by the
Administrative Agent shall not be deemed conclusive evidence that the
Administrative Agent has obtained the written consent of the Required Lenders.
No notice to or demand on the Borrowers in any case shall entitle the Borrowers
to any other or further notice or demand in similar or other circumstances,
except as otherwise expressly provided herein. No delay or omission on any
Lender's or either Agent's part in exercising any right, remedy or option shall
operate as a waiver of such or any other right, remedy or option or of any
Default or Event of Default.

         12.07 COUNTERPARTS. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed an
original, and it shall not be necessary in making proof of this Agreement to
produce or account for more than one such fully-executed counterpart.

         12.08 WAIVERS BY BORROWERS. In any litigation in any court with respect
to, in connection with, or arising out of this Agreement, the Loans, any of the
Notes, any of the other Loan Documents, the Obligations, or any instrument or
document delivered pursuant to this Agreement or the other Loan Documents, or
the validity, protection, interpretation, collection or enforcement thereof, or
any other claim or dispute howsoever arising between the Borrowers and the
Lenders or the Administrative Agent, the Borrowers and each Lender and the
Administrative Agent hereby

                                       96


<PAGE>


waives, to the extent permitted by applicable law, trial by jury in connection
with any such litigation.

         12.09 TERMINATION. The termination of this Agreement shall not affect
any rights of the Borrowers, the Lenders or the Agents or any obligation of the
Borrowers, the Lenders or the Agents, arising prior to the effective date of
such termination, and the provisions hereof shall continue to be fully operative
until all transactions entered into or rights created or obligations incurred
prior to such termination have been fully disposed of, concluded or liquidated
and the Obligations arising prior to or after such termination have been
irrevocably paid in full. The rights granted to the Administrative Agent for the
benefit of the Lenders hereunder and under the other Loan Documents shall
continue in full force and effect, notwithstanding the termination of this
Agreement, until all of the Obligations have been paid in full after the
termination hereof (other than Obligations in the nature of continuing
indemnities or expense reimbursement obligations not yet due and payable) or the
Borrowers have furnished the Lenders and the Administrative Agent with an
indemnification satisfactory to the Administrative Agent and each Lender with
respect thereto. All representations, warranties, covenants, waivers and
agreements contained herein shall survive termination hereof until payment in
full of the Obligations unless otherwise provided herein. Notwithstanding the
foregoing, if after receipt of any payment of all or any part of the
Obligations, any Lender is for any reason compelled to surrender such payment to
any Person because such payment is determined to be void or voidable as a
preference, impermissible setoff, a diversion of trust funds or for any other
reason, this Agreement shall continue in full force and the Borrowers shall be
liable to, and shall indemnify and hold such Lender harmless for, the amount of
such payment surrendered until such Lender shall have been finally and
irrevocably paid in full. The provisions of the foregoing sentence shall be and
remain effective notwithstanding any contrary action which may have been taken
by the Lenders in reliance upon such payment, and any such contrary action so
taken shall be without prejudice to the Lenders' rights under this Agreement and
shall be deemed to have been conditioned upon such payment having become final
and irrevocable.

         12.10 GOVERNING LAW. (A) ALL DOCUMENTS EXECUTED PURSUANT TO THE
TRANSACTIONS CONTEMPLATED HEREIN, INCLUDING, WITHOUT LIMITATION, THIS AGREEMENT
AND EACH OF THE LOAN DOCUMENTS SHALL BE DEEMED TO BE CONTRACTS MADE UNDER, AND
FOR ALL PURPOSES SHALL BE CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS AND
JUDICIAL DECISIONS OF THE STATE OF FLORIDA. THE BORROWERS HEREBY SUBMIT TO THE
JURISDICTION AND VENUE OF THE STATE AND FEDERAL COURTS OF FLORIDA FOR THE
PURPOSES OF RESOLVING DISPUTES HEREUNDER OR FOR THE PURPOSES OF COLLECTION.

         (B)   PURSUANT TO THE ABOVE SUBMISSION TO JURISDICTION, NHL AGREES
THAT SERVICE OF ALL PLEADINGS, COMPLAINTS, WRITS, PROCESS OR SUMMONSES IN ANY
SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH

                                       97


<PAGE>


FORUM MAY BE MADE UPON ARMANDO TABERNILLA, THE GENERAL COUNSEL OF IVAX
("TABERNILLA") AT THE ADDRESS PROVIDED FOR NOTICES TO IVAX HEREUNDER (THE
"PROCESS AGENT"), AND NHL HEREBY IRREVOCABLY APPOINTS THE PROCESS AGENT ITS
AGENT AND TRUE AND LAWFUL ATTORNEY- IN-FACT IN ITS NAME, PLACE AND STEAD TO
ACCEPT AND ACKNOWLEDGE ON ITS BEHALF SUCH SERVICE BROUGHT IN ANY SUCH COURT. NHL
AGREES AND CONSENTS THAT ANY SUCH SERVICE UPON NHL SHALL BE TAKEN AND HELD TO BE
VALID PERSONAL SERVICE UPON NHL WHETHER NHL SHALL THEN BE DOING, OR ANY TIME
SHALL HAVE DONE, BUSINESS WITHIN THE STATE OF FLORIDA, THAT THE FAILURE OF THE
PROCESS AGENT TO ACTUALLY GIVE NOTICE OF ANY SUCH SERVICE TO NHL SHALL NOT
IMPAIR OR AFFECT THE VALIDITY OF SUCH SERVICE OR OF ANY JUDGMENT BASED THEREON,
AND NHL WAIVES ALL CLAIM OF ERROR BY REASON OF ANY SUCH SERVICE. ANY NOTICE,
PROCESS, PLEADINGS OR OTHER PAPERS SERVED UPON THE PROCESS AGENT FOR NHL SHALL,
AT THE SAME TIME, BE SENT BY AN AUTHORIZED METHOD DESCRIBED ABOVE FOR THE GIVING
OF NOTICE HEREUNDER TO NHL AT ITS ADDRESS SET FORTH ABOVE. NHL HEREBY FURTHER
IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS IN ANY SUIT, ACTION OR PROCEEDING
IN SAID COURTS BY THE MAILING THEREOF BY THE AGENT BY REGISTERED OR CERTIFIED
MAIL, POSTAGE PREPAID, TO NHL AT THE ADDRESS FOR GUARANTOR SPECIFIED IN SECTION
12.02. NHL ACKNOWLEDGES THAT, IN APPOINTING SAID AGENT, IT IS ITS INTENTION THAT
SUCH SERVICE SHALL BE DEEMED TO SATISFY THE REQUIREMENTS OF ALL LAWS AND RULES
OF THE CHIEF EXECUTIVE OFFICE GOVERNING SERVICE OF PROCESS, WHETHER NOW OR
HEREAFTER IN EFFECT. NHL FURTHER AGREES THAT IN THE EVENT TABERNILLA IS NO
LONGER GENERAL COUNSEL OF IVAX, THEN IVAX SHALL PROMPTLY DESIGNATE A REPLACEMENT
PROCESS AGENT FOR ALL PURPOSES OF THIS AGREEMENT.

         12.11 INDEMNIFICATION. (a) In consideration of the execution and
delivery of this Agreement by the Administrative Agent and each Lender and the
extension of the Revolving Credit Commitments, the Borrowers hereby indemnify,
exonerate and hold each Agent and each Lender and each of their respective
officers, directors, employees and agents (collectively, the "Indemnified
Parties") free and harmless from and against any and all actions, causes of
action, suits, losses, costs, liabilities and damages, and expenses incurred in
connection therewith (irrespective of whether any such Indemnified Party is a
party to the action for which indemnification hereunder is sought), including
reasonable attorneys' fees and disbursements (collectively, the "Indemnified
Liabilities"), incurred by the Indemnified Parties or any of them as a result
of, or arising out of, or relating to any transaction financed or to be financed
in whole or in part, directly or indirectly, with the proceeds of any Loan or
supported by any Letter of Credit, except for any such Indemnified Liabilities
arising for the account of a particular Indemnified Party by reason of the bad
faith, gross negligence or willful misconduct of, or willful breach of the Loan
Documents by, such Indemnified Party or an officer, co-officer, director,
co-director, employee, co- employee, agent or co-agent of such Indemnified Party
or a transfer or disposition of a Note by an Indemnified Party, and if and to
the extent that the foregoing undertaking may be unenforceable for any

                                       98


<PAGE>


reason, the Borrowers hereby agree to make the maximum contribution to the
payment and satisfaction of each of the Indemnified Liabilities which is
permissible under applicable law.

(b) If a claim is to be made by a party entitled to indemnification under this
Section 12.11 or Section 8.13 against the indemnifying party, the party entitled
to such indemnification shall give written notice to the indemnifying party
promptly after the party entitled to indemnification receives actual notice of
any claim, action, suit, loss, cost, liability, damage or expense incurred or
instituted for which the indemnification is sought. If requested by either of
the Borrowers in writing, and so long as no Default or Event of Default shall
have occurred and be continuing, such indemnitee shall contest the validity,
applicability and/or amount of such suit, action, or cause of action to the
extent such contest may be conducted in good faith on legally supportable
grounds. If any lawsuit or enforcement action is filed against any party
entitled to the benefit of indemnity under this Section 12.11, written notice
thereof shall be given to the indemnifying party as soon as practicable (and in
any event within 15 days after the service of the citation or summons).
Notwithstanding the foregoing, the failure so to notify the indemnifying party
as provided in this Section 12.11 will relieve indemnifying party from liability
hereunder only if and to the extent that such failure results in the forfeiture
by the indemnifying party of substantive rights and defenses. After such notice,
if the indemnifying party shall acknowledge in writing to the indemnified party
that the indemnifying party shall be obligated under the terms of its indemnity
hereunder in connection with such lawsuit or action, then, so long as no Default
or Event of Default shall occur and be continuing, the indemnifying party shall
be entitled, if it so elects, to take control of the defense and investigation
of such lawsuit or action and to employ and engage counsel of its own choice
reasonably acceptable to the indemnified party to handle and defend the same, at
the indemnifying party's cost, risk and expense, PROVIDED, HOWEVER, that the
indemnifying party and its counsel shall proceed with diligence and in good
faith with respect thereto and the indemnifying party shall not enter into any
settlement of any claim without the consent of the party entitled to
indemnification if such settlement shall admit liability by the indemnified
party. If (i) the engagement of such counsel by the indemnifying party would
present a conflict of interest which would prevent such counsel from effectively
defending such action on behalf of the indemnified party, (ii) the defendants
in, or targets of, any such lawsuit or action include both the indemnified party
and indemnifying party, and the indemnified party reasonably concludes that
there may be legal defenses available to it that are different from or in
addition to those available to the indemnifying party, (iii) the indemnifying
party fails to assume the defense of the lawsuit or action or to employ counsel
reasonably satisfactory to such indemnified party, in either case in a timely
manner, or (iv) a Default or Event of Default shall occur and be continuing,
then such indemnified party may employ

                                       99


<PAGE>


separate counsel to represent or defend it in any such action or proceeding and
the indemnifying party will pay the fees and disbursements of such counsel,
provided, however, that each indemnitee shall endeavor, but shall not be
obligated, in connection with any matter covered by this Section 12.11 which
also involves other indemnities, to use reasonable efforts to avoid unnecessary
duplication of efforts by counsel for all indemnities and provided further, that
in no event shall the Borrowers be liable for the fees and expenses of more than
one separate firm for the indemnified parties. The indemnified party shall
cooperate (with all out of pocket costs and expenses associated therewith to be
paid by the indemnifying party) in all reasonable respects with the indemnifying
party and such attorneys in the investigation, trial and defense of such lawsuit
or action and any appeal arising therefrom; provided, however, that the
indemnified party may, at its own cost (except as set forth in, and in
accordance with, the foregoing sentence), participate in the investigation,
trial and defense of such lawsuit or action and any appeal arising therefrom. If
the indemnifying party has acknowledged to the indemnified party its obligation
to indemnify hereunder, the indemnified party, so long as no Default or Event of
Default shall have occurred and be continuing, shall not settle such lawsuit or
enforcement action without the prior written consent of the indemnifying party
and, if the indemnifying party has not so acknowledged its obligation, the
indemnified party shall not settle such lawsuit or enforcement action within 20
days' prior written notice to the indemnifying party.

         12.12 HEADINGS AND REFERENCES. The headings of the Articles and
Sections of this Agreement are inserted for convenience of reference only and
are not intended to be a part of, or to affect the meaning or interpretation of
this Agreement. Words such as "hereof", "hereunder", "herein" and words of
similar import shall refer to this Agreement in its entirety and not to any
particular Section or provisions hereof, unless so expressly specified. As used
herein, the singular shall include the plural, and the masculine shall include
the feminine or a neutral gender, and vice versa, whenever the context requires.

         12.13 SEVERABILITY. If any provision of this Agreement or the other
Loan Documents shall be determined to be illegal or invalid as to one or more of
the parties hereto, then such provision shall remain in effect with respect to
all parties, if any, as to whom such provision is neither illegal nor invalid,
and in any event all other provisions hereof shall remain effective and binding
on the parties hereto.

         12.14 ENTIRE AGREEMENT. This Agreement, together with the other Loan
Documents, constitutes the entire agreement between the parties with respect to
the subject matter hereof and supersedes all previous proposals, negotiations,
representations, commitments and other communications between or among the
parties, both oral and written, with respect thereto.

                                       100


<PAGE>


         12.15 AGREEMENT CONTROLS. In the event that any term of any of the Loan
Documents other than this Agreement conflicts with any term of this Agreement,
the terms and provisions of this Agreement shall control.

         12.16 USURY SAVINGS CLAUSE. Notwithstanding any other provision herein,
the aggregate interest rate charged under any of the Notes, including all
charges or fees in connection therewith deemed in the nature of interest under
Florida law, shall not exceed the Highest Lawful Rate (as such term is defined
below). If the rate of interest (determined without regard to the preceding
sentence) under this Agreement at any time exceeds the Highest Lawful Rate (as
defined below), the outstanding amount of the Loans made hereunder shall bear
interest at the Highest Lawful Rate until the total amount of interest due
hereunder equals the amount of interest which would have been due hereunder if
the stated rates of interest set forth in this Agreement had at all times been
in effect. In addition, if when the Loans made hereunder are repaid in full the
total interest due hereunder (taking into account the increase provided for
above) is less than the total amount of interest which would have been due
hereunder if the stated rates of interest set forth in this Agreement had at all
times been in effect, then to the extent permitted by law, the Borrowers shall
pay to the Administrative Agent an amount equal to the difference between the
amount of interest paid and the amount of interest which would have been paid if
the Highest Lawful rate had at all times been in effect. Notwithstanding the
foregoing, it is the intention of the Lenders and the Borrowers to conform
strictly to any applicable usury laws. Accordingly, if any lender contracts for,
charges, or receives any consideration which constitutes interest in excess of
the Highest Lawful rate, then any such excess shall be cancelled automatically
and, if previously paid, shall at such Lender's option be applied to the
outstanding amount of the Loans made hereunder or be refunded to the Borrowers.
As used in this paragraph, the term "Highest Lawful Rate" means the maximum
lawful interest rate, if any, that at any time or from time to time may be
contracted for, charged, or received under the laws applicable to such Lender
which are presently in effect or, to the extent allowed by law, under such
applicable laws which may hereafter be in effect and which allow a higher
maximum nonusurious interest rate than applicable laws now allow.

         12.17 CONFIDENTIALITY. Except as provided in Section 8.01(e) hereof,
the Lenders shall hold all non-public information obtained pursuant to the
requirements of this Agreement in accordance with their customary procedures for
handling confidential information of this nature but may, in any event, make
disclosures reasonably required in connection with the contemplated transfer or
assignment of any of the Loans or participations or as required or requested by
any legal process; PROVIDED that, unless specifically prohibited by applicable
law or court order, each Lender shall endeavor in good faith to notify the
Borrowers of any request under legal process by any governmental agency or
representative thereof for

                                       101


<PAGE>


disclosure of such information; however, failure to give notice in good faith
shall not give rise to liability.

         12.18 ACCOUNTS RECEIVABLE. Notwithstanding any provision contained in
this Agreement, to the extent not otherwise prohibited by law, the IVAX and its
Subsidiaries (individually a "Transferor" and collectively the "Transferors")
may transfer to D&N Holding Company, a wholly-owned Subsidiary of IVAX (herein
called "D&N"), all or substantially all of Transferors' respective accounts
receivable (the "Transferred Property") provided (i) such transfer to D&N shall
occur not earlier than the third Business Day preceding December 31 of each
calendar year, (ii) the Transferor shall reacquire title to the Transferred
Property free of all Liens (other than any permitted under this Agreement) not
later than the third Business Day following such December 31, (iii) there shall
be delivered to an office of the Administrative Agent outside the State of
Florida and endorsed in favor of the Administrative Agent as security for the
Obligations a promissory note of D&N evidencing its obligation to pay for the
accounts receivable transferred to D&N, which note shall be promptly returned to
D&N upon the transfer by D&N of such Transferred Property to the Transferor of
such property, (iv) IVAX shall deliver to the Administrative Agent a written
statement of an Authorized Representative to the effect that, to the best of his
knowledge, no Liens, judgments or encumbrances exist against D&N Holding that
would attach to any of the Transferred Property in favor of any Person, and (v)
in calculating all financial covenants contained in Article VIII hereof, the
transfer of such accounts receivable shall be disregarded.

                                       102


<PAGE>


         IN WITNESS WHEREOF, the parties hereto have caused this instrument to
be made, executed and delivered by their duly authorized officers as of the day
and year first above written.

                                         IVAX CORPORATION
                                               
WITNESS:                                 BY:   /s/ MICHAEL W. FIPPS
                                            ----------------------------------
                                              Name:  Michael W. Fipps
                                              Title: Senior Vice President
/s/ JEFFREY EISENBERG                                and Chief Financial Officer
- ------------------------
/s/ SUGEET MACHANDA
- ------------------------


                                         NORTON HEALTHCARE, LIMITED

WITNESS:                                 BY:  /s/ MICHAEL W. FIPPS
                                            ----------------------------------
                                              Name:  Michael W. Fipps
/s/ JEFFREY EISENBERG                         Title: Attorney-In-Fact
- ------------------------
/s/ SUGEET MACHANDA
- ------------------------


                                       103


<PAGE>


COMMITMENT:                              NATIONSBANK, National Association
$38,000,000                              as Administrative Agent for the Lenders

                                         By: /s/ ASHLEY M. CRABTREE
                                            ----------------------------------
                                             Name:  Ashley M. Crabtree
                                             Title: Vice President

                                          NATIONSBANK, National Association

                                          By:/s/ ASHLEY M. CRABTREE
                                             -------------------------------- 
                                             Name:  Ashley M. Crabtree
                                             Title: Vice President

                                          Lending Office:

                                          101 N. Tryon Street, 15th Floor
                                          Independence Center
                                          Charlotte, North Carolina 28255

                                          Wire Transfer Instructions:
                                          NationsBank, National Association
                                          Charlotte, North Carolina
                                          ABA# 053000196
                                          Corporate Credit Support
                                          Reference:  IVAX Corporation
                                          Attention:  Corporate Credit Support
                                                        Account No.: #1366212163
                                                        REF. IVAX CORPORATION

                                       104


<PAGE>


Commitment                                BANK OF AMERICA ILLINOIS, as Lender
$38,000,000

                                          By:/s/ LAURENS F. SCHAAD, JR.
                                             ---------------------------------
                                             Name:  Laurens F. Schaad, Jr.
                                             Title: Vice President

                                          Lending Office:
                                          231 S. LaSalle Street
                                          Chicago, Illinois  60697

                                          Wire Transfer Instructions:
                                          Bank of America Illinois
                                          Chicago, Illinois  60697
                                          ABA# 0710 00039
                                          Reference:  IVAX Corporation
                                          Attention:  Fred Fischer
                                          Account No.: 47-03421

                                       105


<PAGE>


Commitment                                ABN AMRO BANK N.V., Co-Agent
$30,000,000
                                          By:  ABN AMRO NORTH AMERICAN, INC.,
                                               as Agent

                                         
                                           By:/s/ RICHARD LAVINA
                                             --------------------------------
                                           Name: Richard Lavina 
                                                -----------------------------
                                           Title: Group Vice President

                                          
                                           By:/s/ DEBORAH DAY OROZCO
                                             ---------------------------------
                                            Name:Deborah Day Orozco
                                            Title: Vice President

                                           Lending Office:
                                           200 S. Biscayne Boulevard, 22nd Floor
                                           Miami, Florida  33131

                                           Wire Transfer Instructions:
                                           ABN AMRO Bank Miami
                                           Miami, Florida  33131
                                           ABA# 066010869
                                           Reference:  IVAX Corporation
                                           Account No.: 511180636610 Loan Adm.

                                       106


<PAGE>


Commitment                                  CITICORP, USA, Co-Agent
$30,000,000

                                            By:  /s/ THOMAS D. STOTT
                                               ------------------------------
                                             Name: Thomas D. Stott
                                             Title: Vice President

                                            Lending Office:
                                            399 Park Avenue
                                            New York, New York 10043

                                            Wire Transfer Instructions:
                                            Citibank, N.A.
                                            New York, New York 11120
                                            ABA# 021-0000-89
                                            Reference: IVAX Corporation
                                            Attention: Ronald Shamah
                                            Account No.: 40548046

                                       107


<PAGE>


Commitment                                BARNETT BANK OF SOUTH FLORIDA, N.A.
$26,000,000

                                          By:/s/ GUILLERMO G. CASTILLO
                                               -------------------------------
                                          Name: Guillermo G. Castillo
                                          Title: Vice President

                                          Lending Office:
                                          701 Brickell Avenue
                                          Miami, Florida  33131
                                            
                                          Wire Transfer Instructions:
                                          Barnett Bank of Jacksonville
                                          Jacksonville, Florida
                                          ABA# 063-000047
                                          Reference:  IVAX Corporation
                                          Attention:  Commercial Loan Operations

                                       108


<PAGE>


Commitment                                  THE BANK OF NEW YORK
$20,000,000

                                            By:/s/ H. STEPHEN GRIFFITH
                                               ------------------------------
                                             Name:H. Stephen Griffith
                                             Title:Senior Vice President

                                            Lending Office:
                                            One Wall Street
                                            New York, New York  10286

                                            Wire Transfer Instructions:
                                            The Bank of New York
                                            New York, New York  10286
                                            ABA# 021000018
                                            Reference:  IVAX Corporation
                                            Attention:  Commercial Loan Dept.,
                                                        Lorna O. Alleyne
                                            Account No.: GLA #111556

                                       109


<PAGE>


Commitment                              THE BANK OF NOVA SCOTIA
$20,000,000

                                        By: /s/ FRANK F. SANDLER
                                           ---------------------------------
                                          Name: Frank F. Sandler
                                          Title:Relationship Manager

                                        Lending Office:
                                        600 Peachtree Street, N.E.
                                        Suite 2700
                                        Atlanta, Georgia  30308

                                        Wire Transfer Instructions:
                                        The Bank of Nova Scotia, New York Agency
                                        New York, New York  10006
                                        ABA# 026002532
                                        Reference:  IVAX Corporation 
                                        For further credit to: Atlanta Agency
                                        Attention:  Jefrey Jones
                                        Account No.: 0606634

                                        SCOTIABANK (U.K.) LIMITED

                                        By: /s/ P.D. GIRLING   
                                           ----------------------------------
                                         Name: P.D. Girling
                                         Title: Manager

                                        Lending Office:
                                        33 Finsbury Square
                                        London, England  EC2A 18B

                                        Wire Transfer Instructions:
                                        The Bank of Nova Scotia
                                        New York, USA - Swift: N0SCU533
                                        ABA# 026002532
                                        Favour of: ScotiaBank (U.K.) Limited
                                        Attention: David Sparkes
                                        Account No.: 7294-34

                                       110


<PAGE>


Commitment                            THE BANK OF TOKYO-MITSUBISHI TRUST CO.
$20,000,000

                                      By: /s/ M. SHERIDAN SUNIER
                                         -----------------------------------
                                       Name: M. Sheridan Sunier
                                       Title: Vice President

                                      Lending Office:
                                      1251 Avenue of the Americas
                                      12th Floor
                                      New York, New York 10020-1104
                                     
                                      Wire Transfer Instructions:
                                      The Bank of Tokyo-Mitsubishi Trust Company
                                      New York, New York 10020-1104
                                      ABA# 0260-0968-7
                                      Reference: IVAX Corporation
                                      Attention: Loan Operations Dept.
                                      Account No.: 97770477

                                       111


<PAGE>



Commitment                              COMMERZBANK AG, ATLANTA AGENCY
$20,000,000

                                        By: /s/ HARRY P. YERGEY /s/ MARK WORTMAN
                                           ------------------------------------
                                         Name: Harry P. Yergey      Mark Wortman
                                         Title:Vice President       AVP

                                        Lending Office:
                                        1230 Peachtree Street
                                        Suite 3500
                                        Atlanta, Georgia  30309

                                        Wire Transfer Instructions:
                                        Commerzbank AG
                                        New York, New York
                                        ABA# 026008044
                                        Reference: IVAX Corporation, #2004182
                                        Account No.: F/C Atlanta Agency

                                       112


<PAGE>


Commitment                                  CREDIT LYONNAIS NEW YORK BRANCH
$20,000,000

                                            By: /s/ ROBERT IVOSEVICH
                                               ------------------------------
                                             Name: Robert Ivosevich
                                             Title:Senior Vice President

                                            CREDIT LYONNAIS ATLANTA AGENCY

                                            By:/s/ ROBERT IVOSEVICH
                                             Name: Robert Ivosevich
                                             Title: Senior Vice President

                                            Lending Office:
                                            1301 Avenue of the Americas
                                            New York, New York  10019

                                            Wire Transfer Instructions:
                                            Credit Lyonnais New York
                                            New York, New York  10019
                                            ABA# 0260-0807-3
                                            Account #01.24173.0001.00
                                            For further credit to:
                                              Credit Lyonnais Atlanta Agency
                                            Reference:  IVAX Corporation
                                            Attention:  Loan Servicing

                                       113


<PAGE>


Commitment                      DEUTSCHE BANK AG NEW YORK BRANCH
$20,000,000                     and/or CAYMAN ISLANDS BRANCH

                                By: /s/ STEPHAN A. WIEDEMANN /s/ IAIN STEWART
                                   -------------------------------------------
                                Name: Stephan A. Wiedemann     Iain Stewart
                                Title: Vice President  Assistant Vice President

                                Lending Office:
                                31 W. 52nd Street
                                New York, New York 10019

                                Wire Transfer Instructions:
                                Deutsche Bank AG New York Branch
                                New York, New York
                                ABA# 026003780
                                Reference: IVAX Corporation
                                Attention: ______________________
                                Account No.: ____________________

                                       114


<PAGE>



Commitment                                  THE FIRST NATIONAL BANK OF CHICAGO
$20,000,000

                                            By:/s/ ROBERT H. WOLOHAN
                                               ------------------------------
                                             Name:Robert H. Wolohan
                                             Title:Corporate Banking Officer

                                            Lending Office:
                                            The First National Bank of Chicago
                                            One First National Plaza
                                            Suite 0167, 1-10
                                            Chicago, Illinois 60670

                                            Wire Transfer Instructions:
                                            The First National Bank of Chicago
                                            Chicago, Illinois 60670
                                            ABA# 071000013
                                            Reference: IVAX Corporation
                                            Attention: DES Incoming Clearing
                                                       Account
                                            Account No.: 7521-7653

                                       115


<PAGE>


Commitment                             THE INDUSTRIAL BANK OF JAPAN, LIMITED
$20,000,000                                            

                                       By:/s/ JUNYA FUJIWARA
                                          --------------------------------
                                        Name: Junya Fujiwara
                                        Title: Senior Vice President and
                                               Deputy General Manager

                                       Lending Office:
                                       The Industrial Bank of Japan, Ltd.
                                       191 Peachtree Street, N.E.
                                       Suite 3600
                                       Atlanta, Georgia  30303-1757

                                       Wire Transfer Instructions:
                                       The Industrial Bank of Japan, Ltd.,
                                        New York Branch
                                       New York, New York
                                       ABA# 026008345
                                       Reference: IVAX Corporation
                                       For further credit to: IBJ Atlanta 
                                        Agency
                                       Account No.: 2601-21014

                                       116


<PAGE>



Commitment                                 THE SAKURA BANK, LIMITED
$20,000,000                                ATLANTA AGENCY

                                           By:/s/ HIROYASU IMANISHI
                                              --------------------------------
                                            Name: Hiroyasu Imanishi
                                            Title:Vice President and Sr. Manager

                                           Lending Office:
                                           245 Peachtree Center Avenue, N.E.
                                           Suite 2703
                                           Atlanta, Georgia  30303

                                           Wire Transfer Instructions:
                                           Morgan Guaranty Trust Co. of New York
                                           New York, New York
                                           ABA# 021 000 238
                                           Reference:  IVAX Corporation
                                           Account Name: The Sakura Bank, Ltd.,
                                                          New York
                                           Account No.: 631-22-624
                                           In favor of: MTKB, Atlanta,
                                                         A/C 8000100-1

                                       117


<PAGE>



Commitment                            THE SUMITOMO BANK, LIMITED, ATLANTA AGENCY
$20,000,000

                                      By: /s/ MASAYUKI FUKUSHIMA
                                          ----------------------------------
                                       Name: Masayuki Fukushima
                                       Title: Joint General Manager

                                      Lending Office:
                                      The Sumitomo Bank, Limited
                                      133 Peachtree Street
                                      Suite 3210
                                      Atlanta, Georgia 30303

                                      Wire Transfer Instructions:
                                      Morgan Guaranty Trust Co. of New York
                                      New York, New York
                                      ABA# 021 000 238
                                      Attention: The Sumitomo Bank, New York
                                      For further credit to: The Sumitomo
                                         Bank, Atlanta Agency
                                      Account No.: 819008

                                       118


<PAGE>


Commitment                                 COOPERATIEVE CENTRALE
18,000,000                                  RAIFFEISEN-BOERENLEENBANK, 
                                            B.A., "RABOBANK NEDERLAND",
                                            NEW YORK BRANCH

                                            By:/s/ ANGELA R. REILLY
                                               ------------------------------
                                             Name: Angela R. Reilly
                                             Title:Vice President

                                            By: /s/ W. JEFFREY VOLLACK
                                               ------------------------------
                                             Name: W. Jeffrey Vollack
                                             Title Vice President, Manager
                             

                                            Lending Office:
                                            245 Park Avenue
                                            New York, New York 10167
                                            Attn: Corporate Services Department
                                            Tel: 212-916-7800
                                            Fax: 212-818-0233

                                            Wire Transfer Instructions:
                                            Bank of New York
                                            ABA# 021000018
                                            A/C Rabobank New York
                                            A/C #802 6002533
                                            Reference: IVAX Corporation

                                       119


<PAGE>


Commitment                                  THE FIRST NATIONAL BANK OF BOSTON
$15,000,000

                                            By: /s/ CORNELIA W. NEWELL
                                               ------------------------------
                                             Name:Cornelia W. Newell
                                             Title: Director
 
                                            Lending Office:
                                            100 Federal Street
                                            MS 01-10-01
                                            Boston, Massachusetts 02110

                                            Wire Transfer Instructions:
                                            The First National Bank of Boston
                                            Boston, Massachusetts 02110
                                            ABA# 011-000-390
                                            Attention: Commercial Loan Services
                                                       Samuel Zuvekas
                                            Reference: IVAX Corporation

                                       120


<PAGE>


Commitment                                  NATIONAL WESTMINSTER BANK PLC,
$15,000,000                                 NEW YORK BRANCH AND
                                            NATIONAL WESTMINSTER
                                            BANK PLC, NASSAU BRANCH

                                            By:/s/ PETER STRINGER
                                               -------------------------------
                                             Name: Peter Stringer
                                             Title: Senior Vice President

                                            Lending Office:

                                            NATIONAL WESTMINISTER BANK PLC-
                                             NASSAU BRANCH
                                            175 WATER STREET
                                            NEW YORK, NY  10038 19TH FLOOR
                                            ---------------------------------

                                            Wire Transfer Instructions:

                                            NATWEST BANK PLC
                                            NEW YORK, NY
                                            ABA# 026002749
                                            Reference:  IVAX Corporation
                                            Attention:  Margaret Beardsley
                                            Account No.: 8906815

                                       121


<PAGE>



Commitment                                  WACHOVIA BANK OF GEORGIA, N.A.
$15,000,000

                                            By: /s/ LEO L. BALTZ
                                               --------------------------------
                                             Name: Leo L. Baltz
                                             Title: Vice President

                                            Lending Office:
                                            191 Peachtree Street
                                            Atlanta, Georgia 30303

                                            Wire Transfer Instructions:

                                            Wachovia Bank of Georgia, N.A.

                                            Atlanta, Georgia 30303

                                            ABA# 061000010

                                            Reference: IVAX Corporation
                                            Attention: Karen Mathews
                                            Account No.: 18 800 621

                                       122



                                                                      EXHIBIT 11

<TABLE>
<CAPTION>
                        IVAX CORPORATION AND SUBSIDIARIES
                    COMPUTATION OF EARNINGS (LOSS) PER SHARE
                      (In thousands, except per share data)

PERIOD ENDED JUNE 30,                                         THREE MONTHS                      SIX MONTHS
                                                          1996             1995            1996             1995
                                                     ------------     ------------    ------------     ------------
<S>                                                  <C>              <C>             <C>              <C>
PRIMARY EARNINGS (LOSS) PER COMMON SHARE:

     Income (loss) before extraordinary items        $    (13,931)    $     28,125    $     21,965     $     51,428
     Extraordinary items, net of tax                       (2,072)             (20)         (2,073)              34
                                                     ------------     ------------    ------------     ------------
     Net income (loss) for primary computation       $    (16,003)    $     28,105    $     19,892     $     51,462
                                                     ============     ============    ============     ============
     Average number of common and dilutive
         common equivalent shares-primary                 121,015          118,741         121,858          118,061
                                                     ============     ============    ============     ============
     Earnings (loss) before extraordinary items      $       (.11)    $        .24    $        .18     $        .44
                                                     ============     ============    ============     ============
     Net earnings (loss)                             $       (.13)    $        .24    $        .16     $        .44
                                                     ============     ============    ============     ============

FULLY DILUTED EARNINGS (LOSS) PER COMMON SHARE:

     Income (loss) before extraordinary items        $    (13,931)    $     28,125    $     21,965     $     51,428
     Adjustment for interest expense on 9.00%
         Convertible Subordinated Debentures,
         net of tax                                              -              21               -               41
                                                     -------------    ------------    ------------     ------------
     Adjusted income (loss) before extraordinary
         items for fully diluted calculation              (13,931)          28,146          21,965           51,469
     Extraordinary items, net of tax                       (2,072)             (20)         (2,073)              34
                                                     ------------     ------------    ------------     ------------
     Net income (loss) for fully diluted computation $    (16,003)    $     28,126    $     19,892     $     51,503
                                                     ============     ============    ============     ============
     Average number of common and dilutive
         common equivalent shares-fully diluted           121,015          119,030         121,882          118,586
                                                     ============     ============    ============     ============
     Earnings (loss) before extraordinary items      $       (.11)    $        .24    $        .18     $        .43
                                                     ============     ============    ============     ============
     Net earnings (loss)                             $       (.13)    $        .24    $        .16     $        .43
                                                     ============     ============    ============     ============

AVERAGE NUMBER OF COMMON SHARES AND
     DILUTIVE COMMON SHARES EQUIVALENTS

Primary shares:
     Average number of common shares outstanding          121,015          114,841         120,423          114,586
     Incremental shares for options and warrants                -            3,900           1,435            3,475
                                                    -------------     ------------    ------------     ------------
                                                          121,015          118,741         121,858          118,061
                                                    =============     ============    ============     ============

Fully diluted shares:
     Average number of common shares outstanding          121,015          114,841         120,423          114,586
     Incremental shares for options and warrants                -            3,903           1,459            3,714
     Conversion equivalent of 9.00% Convertible
         Subordinated Debentures                                -              286               -              286
                                                    -------------     ------------    ------------     ------------
                                                          121,015          119,030         121,882          118,586
                                                    =============     ============    ============     ============

</TABLE>


<TABLE> <S> <C>

<ARTICLE>                      5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM IVAX
CORPORATION'S FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1996, AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                   1,000
       
<S>                                                <C>
<PERIOD-TYPE>                                      6-MOS
<FISCAL-YEAR-END>                                          DEC-31-1996
<PERIOD-END>                                               JUN-30-1996
<CASH>                                                          16,808
<SECURITIES>                                                         0
<RECEIVABLES>                                                  378,288<F1>
<ALLOWANCES>                                                         0
<INVENTORY>                                                    310,009
<CURRENT-ASSETS>                                               812,961
<PP&E>                                                         406,335<F2>
<DEPRECIATION>                                                       0
<TOTAL-ASSETS>                                               1,504,807
<CURRENT-LIABILITIES>                                          502,819
<BONDS>                                                        111,271
                                                0
                                                          0
<COMMON>                                                        12,146
<OTHER-SE>                                                     838,774
<TOTAL-LIABILITY-AND-EQUITY>                                 1,504,807
<SALES>                                                        273,883
<TOTAL-REVENUES>                                               273,883
<CGS>                                                          191,078
<TOTAL-COSTS>                                                  191,078
<OTHER-EXPENSES>                                                     0
<LOSS-PROVISION>                                                 2,706
<INTEREST-EXPENSE>                                               6,206
<INCOME-PRETAX>                                                (31,679)
<INCOME-TAX>                                                   (19,466)
<INCOME-CONTINUING>                                            (13,931)
<DISCONTINUED>                                                       0
<EXTRAORDINARY>                                                 (2,072)
<CHANGES>                                                            0
<NET-INCOME>                                                   (16,003)
<EPS-PRIMARY>                                                     (.13)
<EPS-DILUTED>                                                     (.13)
<FN>
<F1>AMOUNT SHOWN IS NET OF ALLOWANCES.
<F2>AMOUNT SHOWN IS NET OF ACCUMULATED DEPRECIATION AND AMORTIZATION.
</FN>
        


</TABLE>

IVAX                               EXHIBIT 99            IVAX Corporation
                                                         4400 Biscayne Boulevard
                                                         Miami, Florida 33137
                                                         Telephone 305-575-6000

                              FOR IMMEDIATE RELEASE

                   IVAX ANNOUNCES 1996 SECOND QUARTER RESULTS

         Miami, Florida -- August 2, 1996 -- IVAX Corporation (AMEX:IVX) today
announced a net loss for the 1996 second quarter of $16.0 million, or $.13 per
common share, compared to net income of $28.1 million, or $.24 per common share,
for the second quarter of 1995. IVAX' results for the three months ended June
30, 1996 are significantly below the $.04 to $.06 cents per share ($.06 to $.08
per share before extraordinary items) forecast by IVAX in a June 27, 1996 news
release, primarily due to higher than anticipated levels of customer inventory
credits and the establishment of additional reserves for customer inventory
returns. Included in IVAX' earnings for the second quarter and first half of
1996 is a one-time tax benefit of $.06 per share, and an extraordinary charge of
$.02 per share.

         Net revenues for the 1996 second quarter were $273.9 million, compared
to $306.7 million for the 1995 second quarter. Gross profit for the second
quarter of 1996 was $82.8 million, compared to $129.8 million for the second
quarter of 1995. Loss before income taxes, minority interest and extraordinary
items in the 1996 second quarter was $31.7 million, compared to income before
income taxes, minority interest and extraordinary items of $37.8 million for the
1995 second quarter.

         Primary net earnings per share for the first half of 1996 were $.16,
compared to $.44 for the first half of 1995. Fully diluted net earnings per
share for the first six months of 1996 were $.16, compared to $.43 for the first
six months of 1995. Net income for the first six months of 1996 was $19.9
million, compared to $51.5 million for the same period in 1995.

         Net revenues for the first half of 1996 were $607.9 million, compared
to $587.8 million reported for the first half of 1995. Gross profit for the
first six months was $227.3 million, compared to $249.6 million for the same
period in 1995. Income before income taxes, minority interest and extraordinary
items was $12.5 million in the first half of 1996, compared to $70.3 million for
the same period in 1995.

         IVAX' consolidated 1996 second quarter tax benefit reflects the
recognition of a deferred tax asset of $7.1 million by McGaw following an
adjustment resulting from an Internal Revenue Service examination.

         IVAX' second quarter results include an extraordinary charge of $2.1
million (net of tax) relating to the redemption of McGaw's 10-3/8% Senior Notes,
which increased the second quarter net loss per share by $.02.

         In its June news release, IVAX stated that significant customer
inventories of important U.S. generic drugs, price declines for certain generic
drugs, and related credits provided to customers would adversely affect its
second quarter financial results. Since its June forecast,


<PAGE>

IVAX Corporation Press Release
August 2, 1996
Page 2 of 5

IVAX identified significantly higher than estimated inventory levels for certain
customers, largely relating to the introduction of an unusually large number of
U.S. generic drugs in 1995 and 1996. Accordingly, inventory credits and reserves
for returns were higher than originally estimated. In total, inventory credits,
return reserves, and other allowances relating to the U.S. generic drug business
were approximately $43.6 million higher than the average levels IVAX has
experienced in recent prior quarters.

         During the 1996 second quarter, price declines in the U.S. generic drug
business reduced margins, and significant customer inventories resulted in lower
reorders from certain key accounts. Although IVAX operates in a highly
competitive environment and price declines were significant during the second
quarter, prices for IVAX' important generic products, in general, have not
materially declined since IVAX' June 27 forecast. Reorders are expected to
improve as customer inventories are depleted.

         IVAX is a party to a revolving credit facility with a syndicate of
banks. As a result of IVAX' second quarter results, IVAX is presently out of
compliance with the facility's fixed charge ratio covenant, which constitutes a
technical default under the facility. Accordingly, the $281.8 million
outstanding under the facility as of June 30, 1996, ordinarily classified as
long term debt on IVAX' balance sheet, has been classified as short term debt.
IVAX is seeking a waiver of this default, and is hopeful that a waiver will be
granted shortly. IVAX believes that it has a strong balance sheet, with a debt
to total capital ratio of less than 32% and, if the waiver is granted and the
amounts outstanding under the facility are reclassified as long term debt, a
current ratio of 3.7.

         Phillip Frost, M.D., IVAX' Chairman and Chief Executive Officer, said
"Clearly, we have experienced a very disappointing quarter. We believe, however,
that the challenges unique to this period in our history are now behind us. The
broader challenges of the generic drug industry as a whole, and its tremendous
opportunities, remain. We will meet these challenges with strategies honed and
improved as a result of this most difficult quarter. More significantly, we will
continue to exploit the industry's opportunities with a science team that has
led the industry in U.S. generic drug approvals, and with a distribution network
that is among the most extensive in the industry."

         "In evaluating our strategies, we have taken a hard look at our U.S.
generic drug business. We have determined that, although we will not be blind to
opportunities outside our organization to improve shareholder value, we must
focus our resources on improving value from within. We have instituted actions
to enhance the profitability of our U.S. generics business. We will also be
expanding our management team and consolidating manufacturing facilities."

         "In addition, we have begun to moderate those selling initiatives in
our U.S. generics business which can create high levels of inventory in the
distribution channels, and to develop a base of long term customer contracts and
arrangements. We believe this will permit us to


<PAGE>

IVAX Corporation Press Release
August 2, 1996
Page 3 of 5

distribute sales more evenly over the quarter and, accordingly, reduce heavy
end-of-quarter selling."

         Dr. Frost concluded "Our fundamental business and its underlying
strategies remain intact: the U.S. market for generic drugs doubled over the
last three years to more than $6 billion, and industry experts generally expect
it to double yet again over the next three to five years. Only a limited number
of companies are positioned to meaningfully participate in this rapidly growing
market and, among them, IVAX is certainly very well positioned."

         IVAX Corporation, headquartered in Miami, Florida, is a holding company
with subsidiaries engaged primarily in the research, development, manufacture
and marketing of health care products, including generic and branded
pharmaceuticals, intravenous solutions and related products, and in vitro
diagnostics.

         STATEMENTS MADE IN THIS PRESS RELEASE, INCLUDING THOSE RELATING TO
EXPECTATIONS OF INCREASED REORDERS, RECEIPT OF A CREDIT FACILITY WAIVER,
EARNINGS DISTRIBUTION, AND THE GENERIC DRUG INDUSTRY, ARE FORWARD LOOKING AND
ARE MADE PURSUANT TO THE SAFE HARBOR PROVISIONS OF THE SECURITIES LITIGATION
REFORM ACT OF 1995. SUCH STATEMENTS INVOLVE RISKS AND UNCERTAINTIES WHICH MAY
CAUSE RESULTS TO DIFFER MATERIALLY FROM THOSE SET FORTH IN THESE STATEMENTS.
AMONG OTHER THINGS, ADDITIONAL COMPETITION FROM EXISTING AND NEW COMPETITORS
WILL IMPACT REORDERS; THE CREDIT FACILITY WAIVER IS SUBJECT TO THE DISCRETION OF
THE BANK SYNDICATE; AND IVAX' ABILITY TO DISTRIBUTE EARNINGS MORE EVENLY OVER
FUTURE QUARTERS IS SUBJECT TO INDUSTRY PRACTICES AND PURCHASING DECISIONS BY
EXISTING AND POTENTIAL CUSTOMERS. IN ADDITION, THE U.S. GENERIC DRUG INDUSTRY IS
HIGHLY PRICE COMPETITIVE, WITH PRICING DETERMINED BY MANY FACTORS, INCLUDING THE
NUMBER AND TIMING OF PRODUCT INTRODUCTIONS. ALTHOUGH THE PRICE OF A GENERIC
PRODUCT GENERALLY DECLINES OVER TIME AS COMPETITORS INTRODUCE ADDITIONAL
VERSIONS OF THE PRODUCT, THE ACTUAL DEGREE AND TIMING OF PRICE COMPETITION IS
NOT PREDICTABLE. IN ADDITION TO THE FACTORS SET FORTH ELSEWHERE IN THIS RELEASE,
THE ECONOMIC, COMPETITIVE, GOVERNMENTAL, TECHNOLOGICAL AND OTHER FACTORS
IDENTIFIED IN IVAX' FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION, COULD
AFFECT THE FORWARD LOOKING STATEMENTS CONTAINED IN THIS PRESS RELEASE.

                                    * * * * *

                                    CONTACTS:

Michael W. Fipps                     - or -                   Joseph C. Jones
Senior Vice President - Finance                               Vice President -
and Chief Financial Officer                                   Investor Relations
305-575-6123                                                  305-575-6042

IVAX Corporation press releases are available at no charge through PR Newswire's
Company News On-Call facsimile service and/or Web Site. For a menu of IVAX'
press releases or to retrieve a specific release, call 800-758-5804, extension
457725, or use the Internet via http://www.prnewswire.com.


<PAGE>

IVAX Corporation Press Release
August 2, 1996
Page 4 of 5

<TABLE>
<CAPTION>
RESULTS OF OPERATIONS                                                     THREE MONTHS                        SIX MONTHS
PERIOD ENDED JUNE 30,                                                1996              1995              1996             1995
                                                                 -----------       -----------       -----------      -----------
(In thousands, except per share data)
<S>                                                              <C>               <C>               <C>              <C>
Net revenues                                                     $   273,883       $   306,684       $   607,928      $   587,764

Cost of sales                                                        191,078           176,849           380,648          338,211
                                                                 -----------       -----------       -----------      -----------
    Gross profit                                                      82,805           129,835           227,280          249,553

Selling, general and administrative                                   86,893            69,288           166,356          137,310

Research and development                                              18,085            16,479            34,607           31,664

Amortization                                                           2,797             2,559             5,360            4,942

Merger expenses                                                            -                 -               184                -
                                                                 -----------       -----------       -----------      -----------
    Total operating expenses                                         107,775            88,326           206,507          173,916
                                                                 -----------       -----------       -----------      -----------
    Income (loss) from operations                                    (24,970)           41,509            20,773           75,637

    Total other expense, net                                          (6,709)           (3,736)           (8,239)          (5,365)
                                                                 -----------       -----------       -----------      -----------
    Income (loss) before income taxes,
      minority interest and extraordinary items                      (31,679)           37,773            12,534           70,272

Provision (benefit) for income taxes                                 (19,466)            8,793           (13,333)          16,653
                                                                 -----------       -----------       -----------      -----------
    Income (loss) before minority interest and
      extraordinary items                                            (12,213)           28,980            25,867           53,619

Minority interest                                                     (1,718)             (855)           (3,902)          (2,191)
                                                                 -----------       -----------       -----------      -----------
    Income (loss) before extraordinary items                         (13,931)           28,125            21,965           51,428

Extraordinary items - Gains (losses) on
  extinguishment of debt, net of tax                                  (2,072)              (20)           (2,073)              34
                                                                 -----------       -----------       -----------      -----------
    NET INCOME (LOSS)                                            $   (16,003)      $    28,105       $    19,892      $    51,462
                                                                 ===========       ===========       ===========      ===========

EARNINGS (LOSS) PER SHARE:
    PRIMARY:
      Earnings (loss) before extraordinary items                 $     (0.11)      $      0.24       $      0.18      $      0.44
      Extraordinary items                                              (0.02)                -             (0.02)               -
                                                                 -----------       -----------       -----------      -----------
      Net earnings (loss)                                        $     (0.13)      $      0.24       $      0.16      $      0.44
                                                                 ===========       ===========       ===========      ===========
    FULLY DILUTED:
      Earnings (loss) before extraordinary items                 $     (0.11)      $      0.24       $      0.18      $      0.43
      Extraordinary items                                              (0.02)                -             (0.02)               -
                                                                 -----------       -----------       -----------      -----------
      Net earnings (loss)                                        $     (0.13)      $      0.24       $      0.16      $      0.43
                                                                 ===========       ===========       ===========      ===========
AVERAGE SHARES OUTSTANDING:
    Primary                                                          121,015           118,741           121,858          118,061
                                                                 ===========       ===========       ===========      ===========
    Fully Diluted                                                    121,015           119,030           121,882          118,586
                                                                 ===========       ===========       ===========      ===========
</TABLE>


<PAGE>

IVAX Corporation Press Release
August 2, 1996
Page 5 of 5

<TABLE>
<CAPTION>
CONDENSED BALANCE SHEETS                                           JUNE 30,      DECEMBER 31,
(In thousands)                                                       1996            1995
                                                                ------------     ------------
<S>                                                             <C>              <C>
ASSETS
Current assets                                                  $    812,961     $    676,818
Property, plant and equipment, net                                   406,335          385,419
Other assets                                                         285,511          273,073
                                                                ------------     ------------
    Total assets                                                $  1,504,807     $  1,335,310
                                                                ============     ============
LIABILITIES AND SHAREHOLDERS' EQUITY
Current portion of long-term debt                               $    284,065     $      3,521
Other current liabilities                                            218,754          202,392
Long-term debt                                                       111,271          298,857
Other long-term liabilities                                           26,736           26,314
Minority interest                                                     13,061           15,054
Shareholders' equity                                                 850,920          789,172
                                                                ------------     ------------
    Total liabilities and shareholders' equity                  $  1,504,807     $  1,335,310
                                                                ============     ============
</TABLE>

<TABLE>
<CAPTION>
BUSINESS SEGMENT FINANCIAL HIGHLIGHTS
PERIOD ENDED JUNE 30,                                                    THREE MONTHS                       SIX MONTHS
(In thousands)                                                       1996            1995             1996              1995
                                                                 -----------     -----------      -----------       -----------
<S>                                                              <C>             <C>              <C>               <C>
NET REVENUES:
   Pharmaceuticals                                               $   147,997     $   181,764      $   360,127       $   340,496
   Intravenous products                                               84,840          87,592          168,043           170,839
   Other operations                                                   41,419          37,690           80,663            76,871
   Intersegment eliminations                                            (373)           (362)            (905)             (442)
                                                                 -----------     -----------      -----------       -----------
                Total                                            $   273,883     $   306,684      $   607,928       $   587,764
                                                                 ===========     ===========      ===========       ===========
GROSS PROFIT:
   Pharmaceuticals                                               $    33,605     $    77,478      $   132,989       $   147,246
   Intravenous products                                               29,569          36,498           56,397            68,989
   Other operations                                                   19,631          15,859           37,894            33,318
                                                                 -----------     -----------      -----------       -----------
                Total                                            $    82,805     $   129,835      $   227,280       $   249,553
                                                                 ===========     ===========      ===========       ===========
INCOME (LOSS) FROM OPERATIONS:
   Pharmaceuticals                                               $   (25,991)    $    34,226      $    20,979       $    60,851
   Intravenous products                                                5,544          11,696            8,058            19,473
   Other operations                                                    1,331             524            2,608             2,299
   Corporate expenses and other                                       (5,854)         (4,937)         (10,872)           (6,986)
                                                                 -----------     -----------      -----------       -----------
                Total                                            $   (24,970)    $    41,509      $    20,773       $    75,637
                                                                 ===========     ===========      ===========       ===========
</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission